{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Instructions\n",
    "\n",
    "We first downloaded the files from this link <http://nlp.stanford.edu/software/stanford-corenlp-full-2017-06-09.zip> \n",
    "\n",
    "Then we dragged the pubmed folder into that same folder, with the copied abstracts (if you don't want to re-download them all again).\n",
    "\n",
    "There are a few files you will need to make sure are present:\n",
    "\n",
    "`lexparser-gui.bat                  \n",
    "lexparser-gui.command              \n",
    "lexparser-gui.sh                   \n",
    "lexparser-lang-train-test.sh       \n",
    "lexparser-lang.sh                  \n",
    "lexparser.bat                      \n",
    "lexparser.sh                       `\n",
    "\n",
    "You will also need to add the `edu` folder that can be found here:\n",
    "<https://www.dropbox.com/s/t9uk4z1xznpo0jz/jars.zip?dl=0>\n",
    "\n",
    "Add the .zip extension to the `stanford-corenlp-3.8.0-models.jar` file, and unzip it. Copy that `edu` folder and paste it in to your home directory."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Parsing the Pubmed Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "import pubmed.utils as pb\n",
    "import json\n",
    "import re\n",
    "from collections import defaultdict\n",
    "from pprint import pprint\n",
    "import string\n",
    "# utf-8 support\n",
    "import codecs\n",
    "import nltk\n",
    "# spit abstracts to sentences\n",
    "from nltk.tokenize import sent_tokenize\n",
    "import ast\n",
    "\n",
    "#pandas!\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     /Users/lisabarcelo/nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nltk.download('punkt')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  % Total    % Received % Xferd  Average Speed   Time    Time     Time  Current\n",
      "                                 Dload  Upload   Total   Spent    Left  Speed\n",
      "100 92095    0 92095    0     0  48007      0 --:--:--  0:00:01 --:--:-- 61030\n"
     ]
    }
   ],
   "source": [
    "!curl \"https://docs.google.com/spreadsheets/d/1f70DUcOGq1KXx_Mwi_4CpIudBASF6WFgFjtDxmwN1Oc/pub?output=tsv\" -o sent_files/glp_sent.tsv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "pmid\tlabel\tcomponent\tsentence\r",
      "\r\n",
      "0,\"27142747\tpositive\tsafflower\tCasein (1% w/v), safflower oil (3.35% w/v), sucrose (50mM) and rebaudioside A (12.5mM) stimulated GLP-1 release from intestinal segments, whereas casein only stimulated PYY and CCK release.\"\r",
      "\r\n",
      "122,036,174\tneutral\tpheasant\tThe distribution of Glucagon-like peptide 1 (GLP-1) was investigated in the gastrointestinal tract of the pheasant using immunohistochemistry.\r",
      "\r\n",
      "222,036,174\tneutral\tpheasant\tOur findings indicate that GLP-1 might have an inhibitory effect on gastric and crop emptying and on acid secretion also in the pheasant.\r",
      "\r\n",
      "3,\"26634904\tneutral\twhiting\tHere, we investigated the effect of a FPH, Slimpro(), obtained from blue whiting (Micromesistius poutassou) muscle by enzymatic hydrolysis, on body composition and on stimulating cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) secretion.\"\r",
      "\r\n",
      "4,\"27149948\tneutral\toncorhynchus kisutch\tThe objectives of this study were to compare seasonal feeding behavior of non-transgenic wild-type (NT) and GH-transgenic (T) coho salmon (Oncorhynchus kisutch), and to examine the effects of intraperitoneal injections of the appetite-regulating peptides cholecystokinin (CCK-8), bombesin (BBS), glucagon-like peptide-1 (GLP-1), and alpha-melanocyte-stimulating hormone (-MSH) on feeding behavior.\"\r",
      "\r\n",
      "525,060,691\tpositive\tginseng\tOur previous studies have showed that ginseng total saponins (GTS) exhibited antidiabetic effects partly via modulating GLP-1 release.\r",
      "\r\n",
      "6,\"21209017\tpositive\tl-glutamine\tPreviously we have reported that, cycloart-23-ene-3, 25-diol (called as B2) and L-glutamine stimulated glucagon like peptide-1 (GLP-1) (7-36) amide secretion diabetic rats.\"\r",
      "\r\n",
      "7,\"25811109\tpositive\tl-glutamine\tL-glutamine triggers glucagon-like peptide-1 (GLP-1) release from L cells in vitro and when ingested pre-meal, decreases postprandial glycaemia and increases circulating insulin and GLP-1 in type 2 diabetes (T2D) patients.\"\r",
      "\r\n",
      "8,\"25811109\tneutral\tl-glutamine\tIn a randomized study with a crossover design, T2D patients (n = 10, 6 men) aged 65.1 5.8, with glycosylated hemoglobin (HbA1c) 6.6% 0.7% (48 8 mmol/mol), received oral L-glutamine (25 g), protein (25 g) or water, followed by an intravenous glucose bolus (0.3 g/kg) and hyperglycemic glucose clamp for 2 h. Blood was frequently collected for analyses of glucose, serum insulin and plasma total and active GLP-1 and area under the curve of glucose, insulin, total and active GLP-1 excursions calculated.\"\r",
      "\r\n"
     ]
    }
   ],
   "source": [
    "!head sent_files/glp_sent.tsv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Overwriting sent_files/for_SSA.py\n"
     ]
    }
   ],
   "source": [
    "%%writefile sent_files/for_SSA.py\n",
    "\n",
    "import re \n",
    "for item in open(\"sent_files/glp_sent.tsv\",\"r\"):\n",
    "    sent_id, sentiment, compound, sentence = item.split(\"\\t\",3)\n",
    "    \n",
    "    #Some of the replacements were throwing off the parser, I am trying one at a time...\n",
    "    sentence = sentence.replace(\";\",\"\")\n",
    "    sentence = sentence.replace(\"-\",\" \")\n",
    "    sentence = sentence.replace(\"%\",\"\")\n",
    "    #sentence = re.sub(\"\\d+\",\"\",re.sub(r'[^\\w\\s]','',sentence))\n",
    "    print sentence.encode('utf-8')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "!python2 sent_files/for_SSA.py > sent_files/ssa_glp.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sentence\r",
      "\r\n",
      "\r\n",
      "Casein (1 w/v), safflower oil (3.35 w/v), sucrose (50mM) and rebaudioside A (12.5mM) stimulated GLP 1 release from intestinal segments, whereas casein only stimulated PYY and CCK release.\"\r",
      "\r\n",
      "\r\n",
      "The distribution of Glucagon like peptide 1 (GLP 1) was investigated in the gastrointestinal tract of the pheasant using immunohistochemistry.\r",
      "\r\n",
      "\r\n",
      "Our findings indicate that GLP 1 might have an inhibitory effect on gastric and crop emptying and on acid secretion also in the pheasant.\r",
      "\r\n",
      "\r\n",
      "Here, we investigated the effect of a FPH, Slimpro(), obtained from blue whiting (Micromesistius poutassou) muscle by enzymatic hydrolysis, on body composition and on stimulating cholecystokinin (CCK) and glucagon like peptide 1 (GLP 1) secretion.\"\r",
      "\r\n",
      "\r\n"
     ]
    }
   ],
   "source": [
    "!head sent_files/ssa_glp.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "!chmod a+x lexparser.sh"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Testing with PCFG Model*\n",
    "\n",
    "*notice I made a change to the lexparser file to allow for more memory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# !cat ./lexparser.sh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# %%timeit\n",
    "# ! ./lexparser.sh  sent_files/ssa_acetaminophen.txt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Testing with RNN Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# !cat ./lexparser_rnn.sh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# %%timeit\n",
    "# ! ./lexparser_rnn.sh  sent_files/ssa_acetaminophen.txt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Test with Caseless PCFG  Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# !cat ./lexparser_caseless.sh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz ... done [0.7 sec].\n",
      "Parsing file: sent_files/ssa_glp.txt\n",
      "Parsing [sent. 1 len. 44]: sentence Casein -LRB- 1 % w/v -RRB- , safflower oil -LRB- 3.35 % w/v -RRB- , sucrose -LRB- 50mM -RRB- and rebaudioside A -LRB- 12.5 mM -RRB- stimulated GLP-1 release from intestinal segments , whereas casein only stimulated PYY and CCK release . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN sentence) (NN Casein))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD 1) (NN %))\n",
      "              (NP (NNP w/v)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NNP safflower) (NNP oil))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD 3.35) (NN %))\n",
      "              (NP (NNP w/v)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NNP sucrose))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NNP 50mM))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (NNP rebaudioside) (NNP A)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 12.5) (NNS mM))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBN stimulated)\n",
      "      (NP (JJ GLP-1) (NN release))\n",
      "      (PP (IN from)\n",
      "        (NP (JJ intestinal) (NNS segments)))\n",
      "      (, ,)\n",
      "      (SBAR (IN whereas)\n",
      "        (S\n",
      "          (NP (NNP casein))\n",
      "          (ADVP (RB only))\n",
      "          (VP (VBN stimulated)\n",
      "            (NP\n",
      "              (NP (NNP PYY))\n",
      "              (CC and)\n",
      "              (NP (NNP CCK) (NNP release)))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "compound(Casein-2, sentence-1)\n",
      "nsubj(stimulated-28, Casein-2)\n",
      "nummod(%-5, 1-4)\n",
      "dep(Casein-2, %-5)\n",
      "appos(%-5, w/v-6)\n",
      "compound(oil-10, safflower-9)\n",
      "conj:and(Casein-2, oil-10)\n",
      "nsubj(stimulated-28, oil-10)\n",
      "nummod(%-13, 3.35-12)\n",
      "dep(oil-10, %-13)\n",
      "appos(%-13, w/v-14)\n",
      "conj:and(Casein-2, sucrose-17)\n",
      "nsubj(stimulated-28, sucrose-17)\n",
      "appos(sucrose-17, 50mM-19)\n",
      "cc(Casein-2, and-21)\n",
      "compound(A-23, rebaudioside-22)\n",
      "conj:and(Casein-2, A-23)\n",
      "nsubj(stimulated-28, A-23)\n",
      "nummod(mM-26, 12.5-25)\n",
      "appos(Casein-2, mM-26)\n",
      "root(ROOT-0, stimulated-28)\n",
      "amod(release-30, GLP-1-29)\n",
      "dobj(stimulated-28, release-30)\n",
      "case(segments-33, from-31)\n",
      "amod(segments-33, intestinal-32)\n",
      "nmod:from(stimulated-28, segments-33)\n",
      "mark(stimulated-38, whereas-35)\n",
      "nsubj(stimulated-38, casein-36)\n",
      "advmod(stimulated-38, only-37)\n",
      "advcl(stimulated-28, stimulated-38)\n",
      "dobj(stimulated-38, PYY-39)\n",
      "cc(PYY-39, and-40)\n",
      "compound(release-42, CCK-41)\n",
      "dobj(stimulated-38, release-42)\n",
      "conj:and(PYY-39, release-42)\n",
      "\n",
      "Parsing [sent. 2 len. 21]: The distribution of Glucagon-like peptide 1 -LRB- GLP-1 -RRB- was investigated in the gastrointestinal tract of the pheasant using immunohistochemistry .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT The) (NN distribution))\n",
      "        (PP (IN of)\n",
      "          (NP (JJ Glucagon-like) (NNP peptide) (CD 1))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NNP GLP-1))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN investigated)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ gastrointestinal) (NN tract))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT the) (NN pheasant))\n",
      "                (VP (VBG using)\n",
      "                  (ADVP (RB immunohistochemistry)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(distribution-2, The-1)\n",
      "nsubjpass(investigated-11, distribution-2)\n",
      "case(peptide-5, of-3)\n",
      "amod(peptide-5, Glucagon-like-4)\n",
      "nmod:of(distribution-2, peptide-5)\n",
      "nummod(peptide-5, 1-6)\n",
      "appos(distribution-2, GLP-1-8)\n",
      "auxpass(investigated-11, was-10)\n",
      "root(ROOT-0, investigated-11)\n",
      "case(tract-15, in-12)\n",
      "det(tract-15, the-13)\n",
      "amod(tract-15, gastrointestinal-14)\n",
      "nmod:in(investigated-11, tract-15)\n",
      "case(pheasant-18, of-16)\n",
      "det(pheasant-18, the-17)\n",
      "nmod:of(tract-15, pheasant-18)\n",
      "acl(pheasant-18, using-19)\n",
      "advmod(using-19, immunohistochemistry-20)\n",
      "\n",
      "Parsing [sent. 3 len. 24]: Our findings indicate that GLP-1 might have an inhibitory effect on gastric and crop emptying and on acid secretion also in the pheasant .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (NNS findings))\n",
      "    (VP (VBP indicate)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP GLP-1))\n",
      "          (VP (MD might)\n",
      "            (VP (VB have)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ inhibitory) (NN effect))\n",
      "                (PP\n",
      "                  (PP (IN on)\n",
      "                    (NP (NN gastric)\n",
      "                      (CC and)\n",
      "                      (NN crop) (NN emptying)))\n",
      "                  (CC and)\n",
      "                  (PP (IN on)\n",
      "                    (NP (JJ acid) (NN secretion)))))\n",
      "              (PP\n",
      "                (ADVP (RB also))\n",
      "                (IN in)\n",
      "                (NP (DT the) (NN pheasant))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(findings-2, Our-1)\n",
      "nsubj(indicate-3, findings-2)\n",
      "root(ROOT-0, indicate-3)\n",
      "mark(have-7, that-4)\n",
      "nsubj(have-7, GLP-1-5)\n",
      "aux(have-7, might-6)\n",
      "ccomp(indicate-3, have-7)\n",
      "det(effect-10, an-8)\n",
      "amod(effect-10, inhibitory-9)\n",
      "dobj(have-7, effect-10)\n",
      "dobj(have-7, effect-10')\n",
      "conj:and(effect-10, effect-10')\n",
      "case(emptying-15, on-11)\n",
      "compound(emptying-15, gastric-12)\n",
      "cc(gastric-12, and-13)\n",
      "conj:and(gastric-12, crop-14)\n",
      "compound(emptying-15, crop-14)\n",
      "nmod:on(effect-10, emptying-15)\n",
      "cc(effect-10, and-16)\n",
      "case(secretion-19, on-17)\n",
      "amod(secretion-19, acid-18)\n",
      "nmod:on(effect-10', secretion-19)\n",
      "advmod(pheasant-23, also-20)\n",
      "case(pheasant-23, in-21)\n",
      "det(pheasant-23, the-22)\n",
      "nmod:in(have-7, pheasant-23)\n",
      "\n",
      "Parsing [sent. 4 len. 46]: Here , we investigated the effect of a FPH , Slimpro -LRB- -RRB- , obtained from blue whiting -LRB- Micromesistius poutassou -RRB- muscle by enzymatic hydrolysis , on body composition and on stimulating cholecystokinin -LRB- CCK -RRB- and glucagon-like peptide-1 -LRB- GLP-1 -RRB- secretion . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB Here))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD investigated)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN effect))\n",
      "            (PP (IN of)\n",
      "              (NP (DT a) (NN FPH))))\n",
      "          (, ,)\n",
      "          (NP (NNP Slimpro) (NNP -LRB-))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (VP (VBN obtained)\n",
      "          (PP (IN from)\n",
      "            (NP (NNP blue) (NNP whiting)\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP Micromesistius) (NNP poutassou))\n",
      "                (-RRB- -RRB-))\n",
      "              (NN muscle)))\n",
      "          (PP (IN by)\n",
      "            (NP (JJ enzymatic) (NNS hydrolysis))))\n",
      "        (, ,))\n",
      "      (PP\n",
      "        (PP (IN on)\n",
      "          (NP (NN body) (NN composition)))\n",
      "        (CC and)\n",
      "        (PP (IN on)\n",
      "          (S\n",
      "            (VP (VBG stimulating)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NNP cholecystokinin))\n",
      "                  (PRN (-LRB- -LRB-) (NNP CCK) (-RRB- -RRB-)))\n",
      "                (CC and)\n",
      "                (NP (NNP glucagon-like) (NNP peptide-1)\n",
      "                  (PRN (-LRB- -LRB-) (JJ GLP-1) (-RRB- -RRB-))\n",
      "                  (NNP secretion))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "advmod(investigated-4, Here-1)\n",
      "nsubj(investigated-4, we-3)\n",
      "root(ROOT-0, investigated-4)\n",
      "det(effect-6, the-5)\n",
      "dobj(investigated-4, effect-6)\n",
      "case(FPH-9, of-7)\n",
      "det(FPH-9, a-8)\n",
      "nmod:of(effect-6, FPH-9)\n",
      "compound(-LRB--12, Slimpro-11)\n",
      "appos(effect-6, -LRB--12)\n",
      "acl(effect-6, obtained-15)\n",
      "case(muscle-23, from-16)\n",
      "compound(muscle-23, blue-17)\n",
      "compound(muscle-23, whiting-18)\n",
      "compound(poutassou-21, Micromesistius-20)\n",
      "appos(muscle-23, poutassou-21)\n",
      "nmod:from(obtained-15, muscle-23)\n",
      "case(hydrolysis-26, by-24)\n",
      "amod(hydrolysis-26, enzymatic-25)\n",
      "nmod:by(obtained-15, hydrolysis-26)\n",
      "case(composition-30, on-28)\n",
      "compound(composition-30, body-29)\n",
      "nmod:on(investigated-4, composition-30)\n",
      "cc(composition-30, and-31)\n",
      "mark(stimulating-33, on-32)\n",
      "nmod:on(investigated-4, stimulating-33)\n",
      "conj:and(composition-30, stimulating-33)\n",
      "dobj(stimulating-33, cholecystokinin-34)\n",
      "appos(cholecystokinin-34, CCK-36)\n",
      "cc(cholecystokinin-34, and-38)\n",
      "compound(secretion-44, glucagon-like-39)\n",
      "compound(secretion-44, peptide-1-40)\n",
      "dep(secretion-44, GLP-1-42)\n",
      "dobj(stimulating-33, secretion-44)\n",
      "conj:and(cholecystokinin-34, secretion-44)\n",
      "\n",
      "Parsing [sent. 5 len. 69]: The objectives of this study were to compare seasonal feeding behavior of non-transgenic wild-type -LRB- NT -RRB- and GH-transgenic -LRB- T -RRB- coho salmon -LRB- Oncorhynchus kisutch -RRB- , and to examine the effects of intraperitoneal injections of the appetite-regulating peptides cholecystokinin -LRB- CCK-8 -RRB- , bombesin -LRB- BBS -RRB- , glucagon-like peptide-1 -LRB- GLP-1 -RRB- , and alpha-melanocyte-stimulating hormone -LRB- - MSH -RRB- on feeding behavior . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NNS objectives))\n",
      "      (PP (IN of)\n",
      "        (NP (DT this) (NN study))))\n",
      "    (VP (VBD were)\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (TO to)\n",
      "            (VP (VB compare)\n",
      "              (NP\n",
      "                (NP (JJ seasonal) (VBG feeding) (NN behavior))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ non-transgenic) (NN wild-type))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP NT))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (CC and)\n",
      "                    (NP (JJ GH-transgenic) (-LRB- -LRB-) (NN T) (-RRB- -RRB-) (JJ coho) (NN salmon))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP Oncorhynchus) (NNP kisutch))\n",
      "                      (-RRB- -RRB-)))))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (VP (TO to)\n",
      "            (VP (VB examine)\n",
      "              (NP\n",
      "                (NP (DT the) (NNS effects))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ intraperitoneal) (NNS injections))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (NP (DT the) (JJ appetite-regulating) (NNS peptides) (NN cholecystokinin))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP CCK-8))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP (NNP bombesin))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP BBS))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP (JJ glucagon-like) (NN peptide-1))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP GLP-1))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP\n",
      "                          (NP (JJ alpha-melanocyte-stimulating) (NN hormone))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP -) (NNP MSH))\n",
      "                            (-RRB- -RRB-))))))))\n",
      "              (PP (IN on)\n",
      "                (NP (VBG feeding) (NN behavior))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "det(objectives-2, The-1)\n",
      "nsubj(were-6, objectives-2)\n",
      "case(study-5, of-3)\n",
      "det(study-5, this-4)\n",
      "nmod:of(objectives-2, study-5)\n",
      "root(ROOT-0, were-6)\n",
      "mark(compare-8, to-7)\n",
      "ccomp(were-6, compare-8)\n",
      "amod(behavior-11, seasonal-9)\n",
      "amod(behavior-11, feeding-10)\n",
      "dobj(compare-8, behavior-11)\n",
      "case(wild-type-14, of-12)\n",
      "amod(wild-type-14, non-transgenic-13)\n",
      "nmod:of(behavior-11, wild-type-14)\n",
      "appos(wild-type-14, NT-16)\n",
      "cc(wild-type-14, and-18)\n",
      "amod(salmon-24, GH-transgenic-19)\n",
      "compound(salmon-24, T-21)\n",
      "amod(salmon-24, coho-23)\n",
      "nmod:of(behavior-11, salmon-24)\n",
      "conj:and(wild-type-14, salmon-24)\n",
      "compound(kisutch-27, Oncorhynchus-26)\n",
      "appos(wild-type-14, kisutch-27)\n",
      "cc(compare-8, and-30)\n",
      "mark(examine-32, to-31)\n",
      "ccomp(were-6, examine-32)\n",
      "conj:and(compare-8, examine-32)\n",
      "det(effects-34, the-33)\n",
      "dobj(examine-32, effects-34)\n",
      "case(injections-37, of-35)\n",
      "amod(injections-37, intraperitoneal-36)\n",
      "nmod:of(effects-34, injections-37)\n",
      "case(cholecystokinin-42, of-38)\n",
      "det(cholecystokinin-42, the-39)\n",
      "amod(cholecystokinin-42, appetite-regulating-40)\n",
      "compound(cholecystokinin-42, peptides-41)\n",
      "nmod:of(injections-37, cholecystokinin-42)\n",
      "appos(cholecystokinin-42, CCK-8-44)\n",
      "nmod:of(injections-37, bombesin-47)\n",
      "conj:and(cholecystokinin-42, bombesin-47)\n",
      "appos(bombesin-47, BBS-49)\n",
      "amod(peptide-1-53, glucagon-like-52)\n",
      "nmod:of(injections-37, peptide-1-53)\n",
      "conj:and(cholecystokinin-42, peptide-1-53)\n",
      "appos(peptide-1-53, GLP-1-55)\n",
      "cc(cholecystokinin-42, and-58)\n",
      "amod(hormone-60, alpha-melanocyte-stimulating-59)\n",
      "nmod:of(injections-37, hormone-60)\n",
      "conj:and(cholecystokinin-42, hormone-60)\n",
      "compound(MSH-63, --62)\n",
      "appos(hormone-60, MSH-63)\n",
      "case(behavior-67, on-65)\n",
      "amod(behavior-67, feeding-66)\n",
      "nmod:on(examine-32, behavior-67)\n",
      "\n",
      "Parsing [sent. 6 len. 21]: Our previous studies have showed that ginseng total saponins -LRB- GTS -RRB- exhibited antidiabetic effects partly via modulating GLP-1 release .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (JJ previous) (NNS studies))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN showed)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ ginseng) (JJ total) (NNS saponins))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP GTS))\n",
      "                (-RRB- -RRB-)))\n",
      "            (VP (VBD exhibited)\n",
      "              (NP (JJ antidiabetic) (NNS effects))\n",
      "              (PP (RB partly) (IN via)\n",
      "                (S\n",
      "                  (VP (VBG modulating)\n",
      "                    (NP (JJ GLP-1) (NN release))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(studies-3, Our-1)\n",
      "amod(studies-3, previous-2)\n",
      "nsubj(showed-5, studies-3)\n",
      "aux(showed-5, have-4)\n",
      "root(ROOT-0, showed-5)\n",
      "mark(exhibited-13, that-6)\n",
      "amod(saponins-9, ginseng-7)\n",
      "amod(saponins-9, total-8)\n",
      "nsubj(exhibited-13, saponins-9)\n",
      "appos(saponins-9, GTS-11)\n",
      "ccomp(showed-5, exhibited-13)\n",
      "amod(effects-15, antidiabetic-14)\n",
      "dobj(exhibited-13, effects-15)\n",
      "advmod(modulating-18, partly-16)\n",
      "mark(modulating-18, via-17)\n",
      "advcl(exhibited-13, modulating-18)\n",
      "amod(release-20, GLP-1-19)\n",
      "dobj(modulating-18, release-20)\n",
      "\n",
      "Parsing [sent. 7 len. 32]: Previously we have reported that , cycloart-23-ene-3 , 25-diol -LRB- called as B2 -RRB- and L-glutamine stimulated glucagon like peptide-1 -LRB- GLP-1 -RRB- -LRB- 7-36 -RRB- amide secretion diabetic rats . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (ADVP (RB Previously))\n",
      "      (NP (PRP we))\n",
      "      (VP (VBP have)\n",
      "        (VP (VBN reported)\n",
      "          (NP\n",
      "            (NP (DT that))\n",
      "            (, ,)\n",
      "            (ADJP (JJ cycloart-23-ene-3) (, ,) (JJ 25-diol)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN called)\n",
      "              (PP (IN as)\n",
      "                (NP (NN B2))))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (NNP L-glutamine) (NNP stimulated) (NNP glucagon))\n",
      "        (PP (IN like)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN peptide-1))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP GLP-1))\n",
      "                (-RRB- -RRB-)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (CD 7-36))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (VP (VBP amide)\n",
      "        (NP (NNP secretion) (NNP diabetic) (NNS rats))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "advmod(reported-4, Previously-1)\n",
      "nsubj(reported-4, we-2)\n",
      "aux(reported-4, have-3)\n",
      "root(ROOT-0, reported-4)\n",
      "dobj(reported-4, that-5)\n",
      "amod(25-diol-9, cycloart-23-ene-3-7)\n",
      "amod(that-5, 25-diol-9)\n",
      "dep(reported-4, called-11)\n",
      "case(B2-13, as-12)\n",
      "nmod:as(called-11, B2-13)\n",
      "cc(reported-4, and-15)\n",
      "compound(glucagon-18, L-glutamine-16)\n",
      "compound(glucagon-18, stimulated-17)\n",
      "nsubj(amide-27, glucagon-18)\n",
      "case(peptide-1-20, like-19)\n",
      "nmod:like(glucagon-18, peptide-1-20)\n",
      "appos(peptide-1-20, GLP-1-22)\n",
      "appos(peptide-1-20, 7-36-25)\n",
      "conj:and(reported-4, amide-27)\n",
      "compound(rats-30, secretion-28)\n",
      "compound(rats-30, diabetic-29)\n",
      "dobj(amide-27, rats-30)\n",
      "\n",
      "Parsing [sent. 8 len. 37]: L-glutamine triggers glucagon-like peptide-1 -LRB- GLP-1 -RRB- release from L cells in vitro and when ingested pre-meal , decreases postprandial glycaemia and increases circulating insulin and GLP-1 in type 2 diabetes -LRB- T2D -RRB- patients . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP L-glutamine))\n",
      "    (VP\n",
      "      (VP (VBZ triggers)\n",
      "        (NP (JJ glucagon-like)\n",
      "          (UCP\n",
      "            (NP\n",
      "              (NP (JJ peptide-1)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP GLP-1))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NN release))\n",
      "              (PP (IN from)\n",
      "                (NP\n",
      "                  (NP (NNP L) (NNS cells))\n",
      "                  (PP (IN in)\n",
      "                    (NP (NNP vitro))))))\n",
      "            (CC and)\n",
      "            (ADJP\n",
      "              (WHADVP (WRB when))\n",
      "              (JJ ingested)))\n",
      "          (NN pre-meal)))\n",
      "      (, ,)\n",
      "      (VP (VBZ decreases)\n",
      "        (NP (NNP postprandial) (NNP glycaemia)))\n",
      "      (CC and)\n",
      "      (VP (VBZ increases)\n",
      "        (S\n",
      "          (VP (VBG circulating)\n",
      "            (NP\n",
      "              (NP (NN insulin))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (ADJP (JJ GLP-1)\n",
      "                  (PP (IN in)\n",
      "                    (NP (NN type) (CD 2))))\n",
      "                (NN diabetes)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP T2D))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS patients)))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "nsubj(triggers-2, L-glutamine-1)\n",
      "nsubj(decreases-19, L-glutamine-1)\n",
      "nsubj(increases-23, L-glutamine-1)\n",
      "root(ROOT-0, triggers-2)\n",
      "amod(pre-meal-17, glucagon-like-3)\n",
      "amod(release-8, peptide-1-4)\n",
      "appos(release-8, GLP-1-6)\n",
      "compound(pre-meal-17, release-8)\n",
      "case(cells-11, from-9)\n",
      "compound(cells-11, L-10)\n",
      "nmod:from(release-8, cells-11)\n",
      "case(vitro-13, in-12)\n",
      "nmod:in(cells-11, vitro-13)\n",
      "cc(release-8, and-14)\n",
      "advmod(ingested-16, when-15)\n",
      "conj:and(release-8, ingested-16)\n",
      "compound(pre-meal-17, ingested-16)\n",
      "dobj(triggers-2, pre-meal-17)\n",
      "conj:and(triggers-2, decreases-19)\n",
      "compound(glycaemia-21, postprandial-20)\n",
      "dobj(decreases-19, glycaemia-21)\n",
      "cc(triggers-2, and-22)\n",
      "conj:and(triggers-2, increases-23)\n",
      "xcomp(increases-23, circulating-24)\n",
      "dobj(circulating-24, insulin-25)\n",
      "cc(insulin-25, and-26)\n",
      "amod(patients-35, GLP-1-27)\n",
      "case(type-29, in-28)\n",
      "nmod:in(GLP-1-27, type-29)\n",
      "nummod(type-29, 2-30)\n",
      "compound(patients-35, diabetes-31)\n",
      "appos(patients-35, T2D-33)\n",
      "dobj(circulating-24, patients-35)\n",
      "conj:and(insulin-25, patients-35)\n",
      "\n",
      "Parsing [sent. 9 len. 107]: In a randomized study with a crossover design , T2D patients -LRB- n = 10 , 6 men -RRB- aged 65.1 5.8 , with glycosylated hemoglobin -LRB- HbA1c -RRB- 6.6 % 0.7 % -LRB- 48 8 mmol/mol -RRB- , received oral L-glutamine -LRB- 25 g -RRB- , protein -LRB- 25 g -RRB- or water , followed by an intravenous glucose bolus -LRB- 0.3 g/kg -RRB- and hyperglycemic glucose clamp for 2 h. Blood was frequently collected for analyses of glucose , serum insulin and plasma total and active GLP-1 and area under the curve of glucose , insulin , total and active GLP-1 excursions calculated . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ randomized) (NN study))\n",
      "        (PP (IN with)\n",
      "          (NP (DT a) (NN crossover) (NN design)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (JJ T2D) (NNS patients))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NNP n) (NNP =) (CD 10))\n",
      "          (, ,)\n",
      "          (NP (CD 6) (NNS men)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBN aged)\n",
      "      (NP\n",
      "        (QP (CD 65.1) (CD 5.8)))\n",
      "      (, ,)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ glycosylated) (NN hemoglobin))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP HbA1c))\n",
      "              (-RRB- -RRB-)))\n",
      "          (ADJP\n",
      "            (ADJP\n",
      "              (NP (CD 6.6) (NN %))\n",
      "              (NP (CD 0.7) (NN %)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (QP (CD 48) (CD 8))\n",
      "                (NNS mmol/mol))\n",
      "              (-RRB- -RRB-)))\n",
      "          (, ,)\n",
      "          (VP (VBN received)\n",
      "            (SBAR\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (JJ oral) (NN L-glutamine))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (QP (CD 25) (CD g)))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN protein))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP\n",
      "                          (QP (CD 25) (CD g)))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (CC or)\n",
      "                    (NP (NN water)))\n",
      "                  (, ,))\n",
      "                (VP (VBD followed)\n",
      "                  (PP (IN by)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT an) (JJ intravenous) (NN glucose) (NNS bolus))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 0.3) (NN g/kg))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (CC and)\n",
      "                      (NP (JJ hyperglycemic) (NN glucose) (NN clamp))))\n",
      "                  (SBAR (IN for)\n",
      "                    (S\n",
      "                      (NP (CD 2) (NNP h.) (NN Blood))\n",
      "                      (VP (VBD was)\n",
      "                        (ADVP (RB frequently))\n",
      "                        (VP (VBN collected)\n",
      "                          (PP (IN for)\n",
      "                            (NP\n",
      "                              (NP (NNS analyses))\n",
      "                              (PP (IN of)\n",
      "                                (NP (NN glucose) (, ,) (NN serum) (NN insulin)\n",
      "                                  (CC and)\n",
      "                                  (NN plasma) (NN total)\n",
      "                                  (CC and)\n",
      "                                  (JJ active) (NNS GLP-1)\n",
      "                                  (CC and)\n",
      "                                  (NN area)))))\n",
      "                          (PP (IN under)\n",
      "                            (NP\n",
      "                              (NP (DT the) (NN curve))\n",
      "                              (PP (IN of)\n",
      "                                (NP (NN glucose) (, ,) (NN insulin) (, ,) (NN total)\n",
      "                                  (CC and)\n",
      "                                  (JJ active) (JJ GLP-1) (NNS excursions)))\n",
      "                              (VP (VBN calculated)))))))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "case(study-4, In-1)\n",
      "det(study-4, a-2)\n",
      "amod(study-4, randomized-3)\n",
      "nmod:in(aged-20, study-4)\n",
      "case(design-8, with-5)\n",
      "det(design-8, a-6)\n",
      "compound(design-8, crossover-7)\n",
      "nmod:with(study-4, design-8)\n",
      "amod(patients-11, T2D-10)\n",
      "nsubj(aged-20, patients-11)\n",
      "compound(=-14, n-13)\n",
      "dep(patients-11, =-14)\n",
      "nummod(=-14, 10-15)\n",
      "nummod(men-18, 6-17)\n",
      "appos(=-14, men-18)\n",
      "root(ROOT-0, aged-20)\n",
      "compound(5.8-22, 65.1-21)\n",
      "dobj(aged-20, 5.8-22)\n",
      "case(hemoglobin-26, with-24)\n",
      "amod(hemoglobin-26, glycosylated-25)\n",
      "nmod:with(aged-20, hemoglobin-26)\n",
      "appos(hemoglobin-26, HbA1c-28)\n",
      "nummod(%-31, 6.6-30)\n",
      "amod(hemoglobin-26, %-31)\n",
      "nummod(%-33, 0.7-32)\n",
      "dep(%-31, %-33)\n",
      "compound(8-36, 48-35)\n",
      "nummod(mmol/mol-37, 8-36)\n",
      "dep(%-31, mmol/mol-37)\n",
      "acl(hemoglobin-26, received-40)\n",
      "amod(L-glutamine-42, oral-41)\n",
      "nsubj(followed-56, L-glutamine-42)\n",
      "compound(g-45, 25-44)\n",
      "dep(L-glutamine-42, g-45)\n",
      "appos(L-glutamine-42, protein-48)\n",
      "compound(g-51, 25-50)\n",
      "dep(protein-48, g-51)\n",
      "cc(protein-48, or-53)\n",
      "appos(L-glutamine-42, water-54)\n",
      "conj:or(protein-48, water-54)\n",
      "ccomp(received-40, followed-56)\n",
      "case(bolus-61, by-57)\n",
      "det(bolus-61, an-58)\n",
      "amod(bolus-61, intravenous-59)\n",
      "compound(bolus-61, glucose-60)\n",
      "nmod:by(followed-56, bolus-61)\n",
      "nummod(g/kg-64, 0.3-63)\n",
      "appos(bolus-61, g/kg-64)\n",
      "cc(bolus-61, and-66)\n",
      "amod(clamp-69, hyperglycemic-67)\n",
      "compound(clamp-69, glucose-68)\n",
      "nmod:by(followed-56, clamp-69)\n",
      "conj:and(bolus-61, clamp-69)\n",
      "mark(collected-76, for-70)\n",
      "nummod(Blood-73, 2-71)\n",
      "compound(Blood-73, h.-72)\n",
      "nsubjpass(collected-76, Blood-73)\n",
      "auxpass(collected-76, was-74)\n",
      "advmod(collected-76, frequently-75)\n",
      "advcl(followed-56, collected-76)\n",
      "case(analyses-78, for-77)\n",
      "nmod:for(collected-76, analyses-78)\n",
      "case(insulin-83, of-79)\n",
      "compound(insulin-83, glucose-80)\n",
      "dep(insulin-83, serum-82)\n",
      "nmod:of(analyses-78, insulin-83)\n",
      "cc(insulin-83, and-84)\n",
      "compound(total-86, plasma-85)\n",
      "nmod:of(analyses-78, total-86)\n",
      "conj:and(insulin-83, total-86)\n",
      "cc(insulin-83, and-87)\n",
      "amod(GLP-1-89, active-88)\n",
      "nmod:of(analyses-78, GLP-1-89)\n",
      "conj:and(insulin-83, GLP-1-89)\n",
      "cc(insulin-83, and-90)\n",
      "nmod:of(analyses-78, area-91)\n",
      "conj:and(insulin-83, area-91)\n",
      "case(curve-94, under-92)\n",
      "det(curve-94, the-93)\n",
      "nmod:under(collected-76, curve-94)\n",
      "case(excursions-104, of-95)\n",
      "compound(total-100, glucose-96)\n",
      "conj:and(total-100, insulin-98)\n",
      "compound(excursions-104, insulin-98)\n",
      "compound(excursions-104, total-100)\n",
      "cc(total-100, and-101)\n",
      "conj:and(total-100, active-102)\n",
      "compound(excursions-104, active-102)\n",
      "amod(excursions-104, GLP-1-103)\n",
      "nmod:of(curve-94, excursions-104)\n",
      "acl(curve-94, calculated-105)\n",
      "\n",
      "Parsing [sent. 10 len. 14]: Total GLP-1 was increased by both L-glutamine and protein -LRB- p 0.02 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ Total) (NNS GLP-1))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (DT both) (NN L-glutamine)\n",
      "              (CC and)\n",
      "              (NN protein))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p) (CD 0.02))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(GLP-1-2, Total-1)\n",
      "nsubjpass(increased-4, GLP-1-2)\n",
      "auxpass(increased-4, was-3)\n",
      "root(ROOT-0, increased-4)\n",
      "case(L-glutamine-7, by-5)\n",
      "cc:preconj(L-glutamine-7, both-6)\n",
      "nmod:by(increased-4, L-glutamine-7)\n",
      "cc(L-glutamine-7, and-8)\n",
      "nmod:by(increased-4, protein-9)\n",
      "conj:and(L-glutamine-7, protein-9)\n",
      "appos(L-glutamine-7, p-11)\n",
      "nummod(p-11, 0.02-12)\n",
      "\n",
      "Parsing [sent. 11 len. 14]: L-glutamine is an efficacious glucagon-like peptide -LRB- GLP -RRB- -1 secretagogue in vitro .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP L-glutamine))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an)\n",
      "          (ADJP (JJ efficacious) (JJ glucagon-like))\n",
      "          (NNP peptide)\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NNP GLP))\n",
      "            (-RRB- -RRB-))\n",
      "          (JJ -1) (NN secretagogue))\n",
      "        (PP (IN in)\n",
      "          (NP (NNP vitro)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(secretagogue-11, L-glutamine-1)\n",
      "cop(secretagogue-11, is-2)\n",
      "det(secretagogue-11, an-3)\n",
      "amod(glucagon-like-5, efficacious-4)\n",
      "amod(secretagogue-11, glucagon-like-5)\n",
      "compound(secretagogue-11, peptide-6)\n",
      "appos(secretagogue-11, GLP-8)\n",
      "amod(secretagogue-11, -1-10)\n",
      "root(ROOT-0, secretagogue-11)\n",
      "case(vitro-13, in-12)\n",
      "nmod:in(secretagogue-11, vitro-13)\n",
      "\n",
      "Parsing [sent. 12 len. 63]: The plasma glucagon-like peptide-1 concentration in a mesenteric vein draining only the looped region of the intestine was increased after infusion of 139 mmol/l solutions of D-glucose , D-galactose , D-glucuronic acid , 3-0-methyl-D-glucose , maltose , sucrose or maltitol into the intestinal lumen , but not after infusion of solutions of D-fructose , D-fucose , D-mannose , D-xylose or lactose . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (JJ plasma) (JJ glucagon-like) (JJ peptide-1) (NN concentration))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ mesenteric) (NN vein))\n",
      "          (VP (VBG draining)\n",
      "            (NP\n",
      "              (NP (RB only) (DT the) (JJ looped) (NN region))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN intestine))))))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN after)\n",
      "          (NP\n",
      "            (NP (NN infusion))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (CD 139) (JJ mmol/l) (NNS solutions))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ D-glucose) (, ,) (JJ D-galactose) (, ,) (JJ D-glucuronic) (NN acid)))\n",
      "                (, ,)\n",
      "                (ADJP (JJ 3-0-methyl-D-glucose) (, ,) (JJ maltose) (, ,) (JJ sucrose)\n",
      "                  (CC or)\n",
      "                  (JJ maltitol))))))\n",
      "        (PP\n",
      "          (PP (IN into)\n",
      "            (NP (DT the) (JJ intestinal) (NN lumen)))\n",
      "          (, ,)\n",
      "          (CC but)\n",
      "          (RB not)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (NN infusion))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NNS solutions))\n",
      "                  (PP (IN of)\n",
      "                    (ADJP (JJ D-fructose) (, ,) (JJ D-fucose) (, ,) (JJ D-mannose) (, ,) (JJ D-xylose)\n",
      "                      (CC or)\n",
      "                      (JJ lactose))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "det(concentration-5, The-1)\n",
      "amod(concentration-5, plasma-2)\n",
      "amod(concentration-5, glucagon-like-3)\n",
      "amod(concentration-5, peptide-1-4)\n",
      "nsubjpass(increased-19, concentration-5)\n",
      "nsubjpass(increased-19', concentration-5)\n",
      "case(vein-9, in-6)\n",
      "det(vein-9, a-7)\n",
      "amod(vein-9, mesenteric-8)\n",
      "nmod:in(concentration-5, vein-9)\n",
      "acl(vein-9, draining-10)\n",
      "advmod(region-14, only-11)\n",
      "det(region-14, the-12)\n",
      "amod(region-14, looped-13)\n",
      "dobj(draining-10, region-14)\n",
      "case(intestine-17, of-15)\n",
      "det(intestine-17, the-16)\n",
      "nmod:of(region-14, intestine-17)\n",
      "auxpass(increased-19, was-18)\n",
      "root(ROOT-0, increased-19)\n",
      "conj:but(increased-19, increased-19')\n",
      "case(infusion-21, after-20)\n",
      "nmod:after(increased-19, infusion-21)\n",
      "case(solutions-25, of-22)\n",
      "nummod(solutions-25, 139-23)\n",
      "amod(solutions-25, mmol/l-24)\n",
      "nmod:of(infusion-21, solutions-25)\n",
      "case(acid-32, of-26)\n",
      "amod(acid-32, D-glucose-27)\n",
      "amod(acid-32, D-galactose-29)\n",
      "amod(acid-32, D-glucuronic-31)\n",
      "nmod:of(solutions-25, acid-32)\n",
      "amod(solutions-25, 3-0-methyl-D-glucose-34)\n",
      "amod(solutions-25, maltose-36)\n",
      "conj:or(3-0-methyl-D-glucose-34, maltose-36)\n",
      "amod(solutions-25, sucrose-38)\n",
      "conj:or(3-0-methyl-D-glucose-34, sucrose-38)\n",
      "cc(3-0-methyl-D-glucose-34, or-39)\n",
      "amod(solutions-25, maltitol-40)\n",
      "conj:or(3-0-methyl-D-glucose-34, maltitol-40)\n",
      "case(lumen-44, into-41)\n",
      "det(lumen-44, the-42)\n",
      "amod(lumen-44, intestinal-43)\n",
      "nmod:into(increased-19, lumen-44)\n",
      "cc(increased-19, but-46)\n",
      "neg(infusion-49, not-47)\n",
      "case(infusion-49, after-48)\n",
      "nmod:after(increased-19', infusion-49)\n",
      "case(solutions-51, of-50)\n",
      "nmod:of(infusion-49, solutions-51)\n",
      "case(D-fructose-53, of-52)\n",
      "acl(solutions-51, D-fructose-53)\n",
      "acl(solutions-51, D-fucose-55)\n",
      "conj:or(D-fructose-53, D-fucose-55)\n",
      "acl(solutions-51, D-mannose-57)\n",
      "conj:or(D-fructose-53, D-mannose-57)\n",
      "acl(solutions-51, D-xylose-59)\n",
      "conj:or(D-fructose-53, D-xylose-59)\n",
      "cc(D-fructose-53, or-60)\n",
      "acl(solutions-51, lactose-61)\n",
      "conj:or(D-fructose-53, lactose-61)\n",
      "\n",
      "Parsing [sent. 13 len. 27]: In insulin-sensitive tissues , procyanidins modulate glucose uptake and lipogenesis and improve their oxidative/inflammatory state , the disruption of which is important in T2DM development . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (JJ insulin-sensitive) (NNS tissues)))\n",
      "    (, ,)\n",
      "    (NP (NNS procyanidins))\n",
      "    (VP\n",
      "      (VP (VBP modulate)\n",
      "        (NP\n",
      "          (NP (NN glucose) (NN uptake))\n",
      "          (CC and)\n",
      "          (NP (NNS lipogenesis))))\n",
      "      (CC and)\n",
      "      (VP (VB improve)\n",
      "        (NP\n",
      "          (NP (PRP$ their) (JJ oxidative/inflammatory) (NN state))\n",
      "          (, ,)\n",
      "          (SBAR\n",
      "            (WHNP\n",
      "              (NP (DT the) (NN disruption))\n",
      "              (WHPP (IN of)\n",
      "                (WHNP (WDT which))))\n",
      "            (S\n",
      "              (VP (VBZ is)\n",
      "                (ADJP (JJ important)\n",
      "                  (PP (IN in)\n",
      "                    (NP (JJ T2DM) (NN development))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "case(tissues-3, In-1)\n",
      "amod(tissues-3, insulin-sensitive-2)\n",
      "nmod:in(modulate-6, tissues-3)\n",
      "nsubj(modulate-6, procyanidins-5)\n",
      "nsubj(improve-12, procyanidins-5)\n",
      "root(ROOT-0, modulate-6)\n",
      "compound(uptake-8, glucose-7)\n",
      "dobj(modulate-6, uptake-8)\n",
      "cc(uptake-8, and-9)\n",
      "dobj(modulate-6, lipogenesis-10)\n",
      "conj:and(uptake-8, lipogenesis-10)\n",
      "cc(modulate-6, and-11)\n",
      "conj:and(modulate-6, improve-12)\n",
      "nmod:poss(state-15, their-13)\n",
      "amod(state-15, oxidative/inflammatory-14)\n",
      "dobj(improve-12, state-15)\n",
      "nmod:of(disruption-18, state-15)\n",
      "det(disruption-18, the-17)\n",
      "nsubj(important-22, disruption-18)\n",
      "case(which-20, of-19)\n",
      "ref(state-15, which-20)\n",
      "cop(important-22, is-21)\n",
      "acl:relcl(state-15, important-22)\n",
      "case(development-25, in-23)\n",
      "amod(development-25, T2DM-24)\n",
      "nmod:in(important-22, development-25)\n",
      "\n",
      "Parsing [sent. 14 len. 35]: Grape-seed procyanidin extracts -LRB- GSPE -RRB- modulate glucose homeostasis , and it was suggested that GSPE may achieve this by enhancing the secretion of incretin hormones such as glucagon-like peptide-1 -LRB- GLP-1 -RRB- . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (JJ Grape-seed) (NN procyanidin) (NNS extracts))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNP GSPE))\n",
      "          (-RRB- -RRB-)))\n",
      "      (VP (VBP modulate)\n",
      "        (NP (NN glucose) (NNS homeostasis))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN suggested)\n",
      "          (SBAR (IN that)\n",
      "            (S\n",
      "              (NP (NNP GSPE))\n",
      "              (VP (MD may)\n",
      "                (VP (VB achieve)\n",
      "                  (NP (DT this))\n",
      "                  (PP (IN by)\n",
      "                    (S\n",
      "                      (VP (VBG enhancing)\n",
      "                        (NP\n",
      "                          (NP (DT the) (NN secretion))\n",
      "                          (PP (IN of)\n",
      "                            (NP\n",
      "                              (NP (JJ incretin) (NNS hormones))\n",
      "                              (PP (JJ such) (IN as)\n",
      "                                (NP (JJ glucagon-like) (NN peptide-1)))))))))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (ADJP (JJ GLP-1))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "amod(extracts-3, Grape-seed-1)\n",
      "compound(extracts-3, procyanidin-2)\n",
      "nsubj(modulate-7, extracts-3)\n",
      "appos(extracts-3, GSPE-5)\n",
      "root(ROOT-0, modulate-7)\n",
      "compound(homeostasis-9, glucose-8)\n",
      "dobj(modulate-7, homeostasis-9)\n",
      "cc(modulate-7, and-11)\n",
      "nsubjpass(suggested-14, it-12)\n",
      "auxpass(suggested-14, was-13)\n",
      "conj:and(modulate-7, suggested-14)\n",
      "mark(achieve-18, that-15)\n",
      "nsubj(achieve-18, GSPE-16)\n",
      "aux(achieve-18, may-17)\n",
      "ccomp(suggested-14, achieve-18)\n",
      "dobj(achieve-18, this-19)\n",
      "mark(enhancing-21, by-20)\n",
      "advcl(achieve-18, enhancing-21)\n",
      "det(secretion-23, the-22)\n",
      "dobj(enhancing-21, secretion-23)\n",
      "case(hormones-26, of-24)\n",
      "amod(hormones-26, incretin-25)\n",
      "nmod:of(secretion-23, hormones-26)\n",
      "case(peptide-1-30, such-27)\n",
      "mwe(such-27, as-28)\n",
      "amod(peptide-1-30, glucagon-like-29)\n",
      "nmod:such_as(hormones-26, peptide-1-30)\n",
      "dep(achieve-18, GLP-1-32)\n",
      "\n",
      "Parsing [sent. 15 len. 314]: This issue focuses on the following selection of drugs : ABI-007 , adalimumab , adefovir dipivoxil , alefacept , alemtuzumab , 3-AP , AP-12009 , APC-8015 , L-Arginine hydrochloride , aripiprazole , arundic acid , avasimibe ; Bevacizumab , bivatuzumab , BMS-181176 , BMS-184476 , BMS-188797 , bortezomib , bosentan , botulinum toxin type B , BQ-123 , BRL-55730 , bryostatin 1 ; CEP-1347 , cetuximab , cinacalcet hydrochloride , CP-461 , CpG-7909 ; D-003 , dabuzalgron hydrochloride , darbepoetin alfa , desloratadine , desoxyepothilone B , dexmethylphenidate hydrochloride , DHA-paclitaxel , diflomotecan , DN-101 , DP-b99 , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride , duramycin ; Eculizumab , Efalizumab , EKB-569 , elcometrine , enfuvirtide , eplerenone , erlotinib hydrochloride , ertapenem sodium , eszopiclone , everolimus , exatecan mesilate , ezetimibe ; Fenretinide , fosamprenavir calcium , frovatriptan ; GD2L-KLH conjugate vaccine , gefitinib , glufosfamide , GTI-2040 ; Hexyl insulin M2 , human insulin , hydroquinone , gamma-Hydroxybutyrate sodium ; IL-4 -LRB- 38-37 -RRB- - PE38KDEL , imatinib mesylate , indisulam , inhaled insulin , ixabepilone ; KRN-5500 ; LY-544344 ; MDX-210 , melatonin , mepolizumab , motexafin gadolinium ; Natalizumab , NSC-330507 , NSC-683864 ; 1-Octanol , omalizumab , ortataxel ; Pagoclone , peginterferon alfa-2a , peginterferon alfa-2b , pemetrexed disodium , phenoxodiol , pimecrolimus , plevitrexed , polyphenon E , pramlintide acetate , prasterone , pregabalin , PX-12 ; QS-21 ; Ragaglitazar , ranelic acid distrontium salt , RDP-58 , recombinant glucagon-like peptide-1 -LRB- 7-36 -RRB- amide , repinotan hydrochloride , rhEndostatin , rh-Lactoferrin , -LRB- R -RRB- - roscovitine ; S-8184 , semaxanib , sitafloxacin hydrate , sitaxsentan sodium , sorafenib , synthadotin ; Tadalafil , tesmilifene hydrochloride , theratope , tipifarnib , tirapazamine , topixantrone hydrochloride , trabectedin , traxoprodil , Tri-Luma ; Valdecoxib , valganciclovir hydrochloride , vinflunine ; Ximelagatran ; Ziconotide . ''\n",
      "\n",
      "*******************************************************\n",
      "***  WARNING!! OUT OF MEMORY! THERE WAS NOT ENOUGH  ***\n",
      "***  MEMORY TO RUN ALL PARSERS.  EITHER GIVE THE    ***\n",
      "***  JVM MORE MEMORY, SET THE MAXIMUM SENTENCE      ***\n",
      "***  LENGTH WITH -maxLength, OR PERHAPS YOU ARE     ***\n",
      "***  HAPPY TO HAVE THE PARSER FALL BACK TO USING    ***\n",
      "***  A SIMPLER PARSER FOR VERY LONG SENTENCES.      ***\n",
      "*******************************************************\n",
      "\n",
      "Sentence has no parse using PCFG grammar (or no PCFG fallback).  Skipping...\n",
      "Exception in thread \"main\" edu.stanford.nlp.parser.common.NoSuchParseException\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParserQuery.getBestParse(LexicalizedParserQuery.java:404)\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParserQuery.getBestParse(LexicalizedParserQuery.java:376)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.processResults(ParseFiles.java:272)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.parseFiles(ParseFiles.java:216)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.parseFiles(ParseFiles.java:75)\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParser.main(LexicalizedParser.java:1517)\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz ... done [0.7 sec].\n",
      "Parsing file: sent_files/ssa_glp.txt\n",
      "Parsing [sent. 1 len. 44]: sentence Casein -LRB- 1 % w/v -RRB- , safflower oil -LRB- 3.35 % w/v -RRB- , sucrose -LRB- 50mM -RRB- and rebaudioside A -LRB- 12.5 mM -RRB- stimulated GLP-1 release from intestinal segments , whereas casein only stimulated PYY and CCK release . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN sentence) (NN Casein))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD 1) (NN %))\n",
      "              (NP (NNP w/v)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NNP safflower) (NNP oil))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD 3.35) (NN %))\n",
      "              (NP (NNP w/v)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NNP sucrose))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NNP 50mM))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (NNP rebaudioside) (NNP A)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 12.5) (NNS mM))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBN stimulated)\n",
      "      (NP (JJ GLP-1) (NN release))\n",
      "      (PP (IN from)\n",
      "        (NP (JJ intestinal) (NNS segments)))\n",
      "      (, ,)\n",
      "      (SBAR (IN whereas)\n",
      "        (S\n",
      "          (NP (NNP casein))\n",
      "          (ADVP (RB only))\n",
      "          (VP (VBN stimulated)\n",
      "            (NP\n",
      "              (NP (NNP PYY))\n",
      "              (CC and)\n",
      "              (NP (NNP CCK) (NNP release)))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "compound(Casein-2, sentence-1)\n",
      "nsubj(stimulated-28, Casein-2)\n",
      "nummod(%-5, 1-4)\n",
      "dep(Casein-2, %-5)\n",
      "appos(%-5, w/v-6)\n",
      "compound(oil-10, safflower-9)\n",
      "conj:and(Casein-2, oil-10)\n",
      "nsubj(stimulated-28, oil-10)\n",
      "nummod(%-13, 3.35-12)\n",
      "dep(oil-10, %-13)\n",
      "appos(%-13, w/v-14)\n",
      "conj:and(Casein-2, sucrose-17)\n",
      "nsubj(stimulated-28, sucrose-17)\n",
      "appos(sucrose-17, 50mM-19)\n",
      "cc(Casein-2, and-21)\n",
      "compound(A-23, rebaudioside-22)\n",
      "conj:and(Casein-2, A-23)\n",
      "nsubj(stimulated-28, A-23)\n",
      "nummod(mM-26, 12.5-25)\n",
      "appos(Casein-2, mM-26)\n",
      "root(ROOT-0, stimulated-28)\n",
      "amod(release-30, GLP-1-29)\n",
      "dobj(stimulated-28, release-30)\n",
      "case(segments-33, from-31)\n",
      "amod(segments-33, intestinal-32)\n",
      "nmod:from(stimulated-28, segments-33)\n",
      "mark(stimulated-38, whereas-35)\n",
      "nsubj(stimulated-38, casein-36)\n",
      "advmod(stimulated-38, only-37)\n",
      "advcl(stimulated-28, stimulated-38)\n",
      "dobj(stimulated-38, PYY-39)\n",
      "cc(PYY-39, and-40)\n",
      "compound(release-42, CCK-41)\n",
      "dobj(stimulated-38, release-42)\n",
      "conj:and(PYY-39, release-42)\n",
      "\n",
      "Parsing [sent. 2 len. 21]: The distribution of Glucagon-like peptide 1 -LRB- GLP-1 -RRB- was investigated in the gastrointestinal tract of the pheasant using immunohistochemistry .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT The) (NN distribution))\n",
      "        (PP (IN of)\n",
      "          (NP (JJ Glucagon-like) (NNP peptide) (CD 1))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NNP GLP-1))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN investigated)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ gastrointestinal) (NN tract))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT the) (NN pheasant))\n",
      "                (VP (VBG using)\n",
      "                  (ADVP (RB immunohistochemistry)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(distribution-2, The-1)\n",
      "nsubjpass(investigated-11, distribution-2)\n",
      "case(peptide-5, of-3)\n",
      "amod(peptide-5, Glucagon-like-4)\n",
      "nmod:of(distribution-2, peptide-5)\n",
      "nummod(peptide-5, 1-6)\n",
      "appos(distribution-2, GLP-1-8)\n",
      "auxpass(investigated-11, was-10)\n",
      "root(ROOT-0, investigated-11)\n",
      "case(tract-15, in-12)\n",
      "det(tract-15, the-13)\n",
      "amod(tract-15, gastrointestinal-14)\n",
      "nmod:in(investigated-11, tract-15)\n",
      "case(pheasant-18, of-16)\n",
      "det(pheasant-18, the-17)\n",
      "nmod:of(tract-15, pheasant-18)\n",
      "acl(pheasant-18, using-19)\n",
      "advmod(using-19, immunohistochemistry-20)\n",
      "\n",
      "Parsing [sent. 3 len. 24]: Our findings indicate that GLP-1 might have an inhibitory effect on gastric and crop emptying and on acid secretion also in the pheasant .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (NNS findings))\n",
      "    (VP (VBP indicate)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP GLP-1))\n",
      "          (VP (MD might)\n",
      "            (VP (VB have)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ inhibitory) (NN effect))\n",
      "                (PP\n",
      "                  (PP (IN on)\n",
      "                    (NP (NN gastric)\n",
      "                      (CC and)\n",
      "                      (NN crop) (NN emptying)))\n",
      "                  (CC and)\n",
      "                  (PP (IN on)\n",
      "                    (NP (JJ acid) (NN secretion)))))\n",
      "              (PP\n",
      "                (ADVP (RB also))\n",
      "                (IN in)\n",
      "                (NP (DT the) (NN pheasant))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(findings-2, Our-1)\n",
      "nsubj(indicate-3, findings-2)\n",
      "root(ROOT-0, indicate-3)\n",
      "mark(have-7, that-4)\n",
      "nsubj(have-7, GLP-1-5)\n",
      "aux(have-7, might-6)\n",
      "ccomp(indicate-3, have-7)\n",
      "det(effect-10, an-8)\n",
      "amod(effect-10, inhibitory-9)\n",
      "dobj(have-7, effect-10)\n",
      "dobj(have-7, effect-10')\n",
      "conj:and(effect-10, effect-10')\n",
      "case(emptying-15, on-11)\n",
      "compound(emptying-15, gastric-12)\n",
      "cc(gastric-12, and-13)\n",
      "conj:and(gastric-12, crop-14)\n",
      "compound(emptying-15, crop-14)\n",
      "nmod:on(effect-10, emptying-15)\n",
      "cc(effect-10, and-16)\n",
      "case(secretion-19, on-17)\n",
      "amod(secretion-19, acid-18)\n",
      "nmod:on(effect-10', secretion-19)\n",
      "advmod(pheasant-23, also-20)\n",
      "case(pheasant-23, in-21)\n",
      "det(pheasant-23, the-22)\n",
      "nmod:in(have-7, pheasant-23)\n",
      "\n",
      "Parsing [sent. 4 len. 46]: Here , we investigated the effect of a FPH , Slimpro -LRB- -RRB- , obtained from blue whiting -LRB- Micromesistius poutassou -RRB- muscle by enzymatic hydrolysis , on body composition and on stimulating cholecystokinin -LRB- CCK -RRB- and glucagon-like peptide-1 -LRB- GLP-1 -RRB- secretion . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB Here))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD investigated)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN effect))\n",
      "            (PP (IN of)\n",
      "              (NP (DT a) (NN FPH))))\n",
      "          (, ,)\n",
      "          (NP (NNP Slimpro) (NNP -LRB-))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (VP (VBN obtained)\n",
      "          (PP (IN from)\n",
      "            (NP (NNP blue) (NNP whiting)\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP Micromesistius) (NNP poutassou))\n",
      "                (-RRB- -RRB-))\n",
      "              (NN muscle)))\n",
      "          (PP (IN by)\n",
      "            (NP (JJ enzymatic) (NNS hydrolysis))))\n",
      "        (, ,))\n",
      "      (PP\n",
      "        (PP (IN on)\n",
      "          (NP (NN body) (NN composition)))\n",
      "        (CC and)\n",
      "        (PP (IN on)\n",
      "          (S\n",
      "            (VP (VBG stimulating)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NNP cholecystokinin))\n",
      "                  (PRN (-LRB- -LRB-) (NNP CCK) (-RRB- -RRB-)))\n",
      "                (CC and)\n",
      "                (NP (NNP glucagon-like) (NNP peptide-1)\n",
      "                  (PRN (-LRB- -LRB-) (JJ GLP-1) (-RRB- -RRB-))\n",
      "                  (NNP secretion))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "advmod(investigated-4, Here-1)\n",
      "nsubj(investigated-4, we-3)\n",
      "root(ROOT-0, investigated-4)\n",
      "det(effect-6, the-5)\n",
      "dobj(investigated-4, effect-6)\n",
      "case(FPH-9, of-7)\n",
      "det(FPH-9, a-8)\n",
      "nmod:of(effect-6, FPH-9)\n",
      "compound(-LRB--12, Slimpro-11)\n",
      "appos(effect-6, -LRB--12)\n",
      "acl(effect-6, obtained-15)\n",
      "case(muscle-23, from-16)\n",
      "compound(muscle-23, blue-17)\n",
      "compound(muscle-23, whiting-18)\n",
      "compound(poutassou-21, Micromesistius-20)\n",
      "appos(muscle-23, poutassou-21)\n",
      "nmod:from(obtained-15, muscle-23)\n",
      "case(hydrolysis-26, by-24)\n",
      "amod(hydrolysis-26, enzymatic-25)\n",
      "nmod:by(obtained-15, hydrolysis-26)\n",
      "case(composition-30, on-28)\n",
      "compound(composition-30, body-29)\n",
      "nmod:on(investigated-4, composition-30)\n",
      "cc(composition-30, and-31)\n",
      "mark(stimulating-33, on-32)\n",
      "nmod:on(investigated-4, stimulating-33)\n",
      "conj:and(composition-30, stimulating-33)\n",
      "dobj(stimulating-33, cholecystokinin-34)\n",
      "appos(cholecystokinin-34, CCK-36)\n",
      "cc(cholecystokinin-34, and-38)\n",
      "compound(secretion-44, glucagon-like-39)\n",
      "compound(secretion-44, peptide-1-40)\n",
      "dep(secretion-44, GLP-1-42)\n",
      "dobj(stimulating-33, secretion-44)\n",
      "conj:and(cholecystokinin-34, secretion-44)\n",
      "\n",
      "Parsing [sent. 5 len. 69]: The objectives of this study were to compare seasonal feeding behavior of non-transgenic wild-type -LRB- NT -RRB- and GH-transgenic -LRB- T -RRB- coho salmon -LRB- Oncorhynchus kisutch -RRB- , and to examine the effects of intraperitoneal injections of the appetite-regulating peptides cholecystokinin -LRB- CCK-8 -RRB- , bombesin -LRB- BBS -RRB- , glucagon-like peptide-1 -LRB- GLP-1 -RRB- , and alpha-melanocyte-stimulating hormone -LRB- - MSH -RRB- on feeding behavior . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NNS objectives))\n",
      "      (PP (IN of)\n",
      "        (NP (DT this) (NN study))))\n",
      "    (VP (VBD were)\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (TO to)\n",
      "            (VP (VB compare)\n",
      "              (NP\n",
      "                (NP (JJ seasonal) (VBG feeding) (NN behavior))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ non-transgenic) (NN wild-type))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP NT))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (CC and)\n",
      "                    (NP (JJ GH-transgenic) (-LRB- -LRB-) (NN T) (-RRB- -RRB-) (JJ coho) (NN salmon))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP Oncorhynchus) (NNP kisutch))\n",
      "                      (-RRB- -RRB-)))))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (VP (TO to)\n",
      "            (VP (VB examine)\n",
      "              (NP\n",
      "                (NP (DT the) (NNS effects))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ intraperitoneal) (NNS injections))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (NP (DT the) (JJ appetite-regulating) (NNS peptides) (NN cholecystokinin))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP CCK-8))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP (NNP bombesin))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP BBS))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP (JJ glucagon-like) (NN peptide-1))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP GLP-1))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP\n",
      "                          (NP (JJ alpha-melanocyte-stimulating) (NN hormone))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP -) (NNP MSH))\n",
      "                            (-RRB- -RRB-))))))))\n",
      "              (PP (IN on)\n",
      "                (NP (VBG feeding) (NN behavior))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "det(objectives-2, The-1)\n",
      "nsubj(were-6, objectives-2)\n",
      "case(study-5, of-3)\n",
      "det(study-5, this-4)\n",
      "nmod:of(objectives-2, study-5)\n",
      "root(ROOT-0, were-6)\n",
      "mark(compare-8, to-7)\n",
      "ccomp(were-6, compare-8)\n",
      "amod(behavior-11, seasonal-9)\n",
      "amod(behavior-11, feeding-10)\n",
      "dobj(compare-8, behavior-11)\n",
      "case(wild-type-14, of-12)\n",
      "amod(wild-type-14, non-transgenic-13)\n",
      "nmod:of(behavior-11, wild-type-14)\n",
      "appos(wild-type-14, NT-16)\n",
      "cc(wild-type-14, and-18)\n",
      "amod(salmon-24, GH-transgenic-19)\n",
      "compound(salmon-24, T-21)\n",
      "amod(salmon-24, coho-23)\n",
      "nmod:of(behavior-11, salmon-24)\n",
      "conj:and(wild-type-14, salmon-24)\n",
      "compound(kisutch-27, Oncorhynchus-26)\n",
      "appos(wild-type-14, kisutch-27)\n",
      "cc(compare-8, and-30)\n",
      "mark(examine-32, to-31)\n",
      "ccomp(were-6, examine-32)\n",
      "conj:and(compare-8, examine-32)\n",
      "det(effects-34, the-33)\n",
      "dobj(examine-32, effects-34)\n",
      "case(injections-37, of-35)\n",
      "amod(injections-37, intraperitoneal-36)\n",
      "nmod:of(effects-34, injections-37)\n",
      "case(cholecystokinin-42, of-38)\n",
      "det(cholecystokinin-42, the-39)\n",
      "amod(cholecystokinin-42, appetite-regulating-40)\n",
      "compound(cholecystokinin-42, peptides-41)\n",
      "nmod:of(injections-37, cholecystokinin-42)\n",
      "appos(cholecystokinin-42, CCK-8-44)\n",
      "nmod:of(injections-37, bombesin-47)\n",
      "conj:and(cholecystokinin-42, bombesin-47)\n",
      "appos(bombesin-47, BBS-49)\n",
      "amod(peptide-1-53, glucagon-like-52)\n",
      "nmod:of(injections-37, peptide-1-53)\n",
      "conj:and(cholecystokinin-42, peptide-1-53)\n",
      "appos(peptide-1-53, GLP-1-55)\n",
      "cc(cholecystokinin-42, and-58)\n",
      "amod(hormone-60, alpha-melanocyte-stimulating-59)\n",
      "nmod:of(injections-37, hormone-60)\n",
      "conj:and(cholecystokinin-42, hormone-60)\n",
      "compound(MSH-63, --62)\n",
      "appos(hormone-60, MSH-63)\n",
      "case(behavior-67, on-65)\n",
      "amod(behavior-67, feeding-66)\n",
      "nmod:on(examine-32, behavior-67)\n",
      "\n",
      "Parsing [sent. 6 len. 21]: Our previous studies have showed that ginseng total saponins -LRB- GTS -RRB- exhibited antidiabetic effects partly via modulating GLP-1 release .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (JJ previous) (NNS studies))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN showed)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ ginseng) (JJ total) (NNS saponins))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP GTS))\n",
      "                (-RRB- -RRB-)))\n",
      "            (VP (VBD exhibited)\n",
      "              (NP (JJ antidiabetic) (NNS effects))\n",
      "              (PP (RB partly) (IN via)\n",
      "                (S\n",
      "                  (VP (VBG modulating)\n",
      "                    (NP (JJ GLP-1) (NN release))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(studies-3, Our-1)\n",
      "amod(studies-3, previous-2)\n",
      "nsubj(showed-5, studies-3)\n",
      "aux(showed-5, have-4)\n",
      "root(ROOT-0, showed-5)\n",
      "mark(exhibited-13, that-6)\n",
      "amod(saponins-9, ginseng-7)\n",
      "amod(saponins-9, total-8)\n",
      "nsubj(exhibited-13, saponins-9)\n",
      "appos(saponins-9, GTS-11)\n",
      "ccomp(showed-5, exhibited-13)\n",
      "amod(effects-15, antidiabetic-14)\n",
      "dobj(exhibited-13, effects-15)\n",
      "advmod(modulating-18, partly-16)\n",
      "mark(modulating-18, via-17)\n",
      "advcl(exhibited-13, modulating-18)\n",
      "amod(release-20, GLP-1-19)\n",
      "dobj(modulating-18, release-20)\n",
      "\n",
      "Parsing [sent. 7 len. 32]: Previously we have reported that , cycloart-23-ene-3 , 25-diol -LRB- called as B2 -RRB- and L-glutamine stimulated glucagon like peptide-1 -LRB- GLP-1 -RRB- -LRB- 7-36 -RRB- amide secretion diabetic rats . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (ADVP (RB Previously))\n",
      "      (NP (PRP we))\n",
      "      (VP (VBP have)\n",
      "        (VP (VBN reported)\n",
      "          (NP\n",
      "            (NP (DT that))\n",
      "            (, ,)\n",
      "            (ADJP (JJ cycloart-23-ene-3) (, ,) (JJ 25-diol)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN called)\n",
      "              (PP (IN as)\n",
      "                (NP (NN B2))))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (NNP L-glutamine) (NNP stimulated) (NNP glucagon))\n",
      "        (PP (IN like)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN peptide-1))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP GLP-1))\n",
      "                (-RRB- -RRB-)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (CD 7-36))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (VP (VBP amide)\n",
      "        (NP (NNP secretion) (NNP diabetic) (NNS rats))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "advmod(reported-4, Previously-1)\n",
      "nsubj(reported-4, we-2)\n",
      "aux(reported-4, have-3)\n",
      "root(ROOT-0, reported-4)\n",
      "dobj(reported-4, that-5)\n",
      "amod(25-diol-9, cycloart-23-ene-3-7)\n",
      "amod(that-5, 25-diol-9)\n",
      "dep(reported-4, called-11)\n",
      "case(B2-13, as-12)\n",
      "nmod:as(called-11, B2-13)\n",
      "cc(reported-4, and-15)\n",
      "compound(glucagon-18, L-glutamine-16)\n",
      "compound(glucagon-18, stimulated-17)\n",
      "nsubj(amide-27, glucagon-18)\n",
      "case(peptide-1-20, like-19)\n",
      "nmod:like(glucagon-18, peptide-1-20)\n",
      "appos(peptide-1-20, GLP-1-22)\n",
      "appos(peptide-1-20, 7-36-25)\n",
      "conj:and(reported-4, amide-27)\n",
      "compound(rats-30, secretion-28)\n",
      "compound(rats-30, diabetic-29)\n",
      "dobj(amide-27, rats-30)\n",
      "\n",
      "Parsing [sent. 8 len. 37]: L-glutamine triggers glucagon-like peptide-1 -LRB- GLP-1 -RRB- release from L cells in vitro and when ingested pre-meal , decreases postprandial glycaemia and increases circulating insulin and GLP-1 in type 2 diabetes -LRB- T2D -RRB- patients . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP L-glutamine))\n",
      "    (VP\n",
      "      (VP (VBZ triggers)\n",
      "        (NP (JJ glucagon-like)\n",
      "          (UCP\n",
      "            (NP\n",
      "              (NP (JJ peptide-1)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP GLP-1))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NN release))\n",
      "              (PP (IN from)\n",
      "                (NP\n",
      "                  (NP (NNP L) (NNS cells))\n",
      "                  (PP (IN in)\n",
      "                    (NP (NNP vitro))))))\n",
      "            (CC and)\n",
      "            (ADJP\n",
      "              (WHADVP (WRB when))\n",
      "              (JJ ingested)))\n",
      "          (NN pre-meal)))\n",
      "      (, ,)\n",
      "      (VP (VBZ decreases)\n",
      "        (NP (NNP postprandial) (NNP glycaemia)))\n",
      "      (CC and)\n",
      "      (VP (VBZ increases)\n",
      "        (S\n",
      "          (VP (VBG circulating)\n",
      "            (NP\n",
      "              (NP (NN insulin))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (ADJP (JJ GLP-1)\n",
      "                  (PP (IN in)\n",
      "                    (NP (NN type) (CD 2))))\n",
      "                (NN diabetes)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP T2D))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS patients)))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "nsubj(triggers-2, L-glutamine-1)\n",
      "nsubj(decreases-19, L-glutamine-1)\n",
      "nsubj(increases-23, L-glutamine-1)\n",
      "root(ROOT-0, triggers-2)\n",
      "amod(pre-meal-17, glucagon-like-3)\n",
      "amod(release-8, peptide-1-4)\n",
      "appos(release-8, GLP-1-6)\n",
      "compound(pre-meal-17, release-8)\n",
      "case(cells-11, from-9)\n",
      "compound(cells-11, L-10)\n",
      "nmod:from(release-8, cells-11)\n",
      "case(vitro-13, in-12)\n",
      "nmod:in(cells-11, vitro-13)\n",
      "cc(release-8, and-14)\n",
      "advmod(ingested-16, when-15)\n",
      "conj:and(release-8, ingested-16)\n",
      "compound(pre-meal-17, ingested-16)\n",
      "dobj(triggers-2, pre-meal-17)\n",
      "conj:and(triggers-2, decreases-19)\n",
      "compound(glycaemia-21, postprandial-20)\n",
      "dobj(decreases-19, glycaemia-21)\n",
      "cc(triggers-2, and-22)\n",
      "conj:and(triggers-2, increases-23)\n",
      "xcomp(increases-23, circulating-24)\n",
      "dobj(circulating-24, insulin-25)\n",
      "cc(insulin-25, and-26)\n",
      "amod(patients-35, GLP-1-27)\n",
      "case(type-29, in-28)\n",
      "nmod:in(GLP-1-27, type-29)\n",
      "nummod(type-29, 2-30)\n",
      "compound(patients-35, diabetes-31)\n",
      "appos(patients-35, T2D-33)\n",
      "dobj(circulating-24, patients-35)\n",
      "conj:and(insulin-25, patients-35)\n",
      "\n",
      "Parsing [sent. 9 len. 107]: In a randomized study with a crossover design , T2D patients -LRB- n = 10 , 6 men -RRB- aged 65.1 5.8 , with glycosylated hemoglobin -LRB- HbA1c -RRB- 6.6 % 0.7 % -LRB- 48 8 mmol/mol -RRB- , received oral L-glutamine -LRB- 25 g -RRB- , protein -LRB- 25 g -RRB- or water , followed by an intravenous glucose bolus -LRB- 0.3 g/kg -RRB- and hyperglycemic glucose clamp for 2 h. Blood was frequently collected for analyses of glucose , serum insulin and plasma total and active GLP-1 and area under the curve of glucose , insulin , total and active GLP-1 excursions calculated . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ randomized) (NN study))\n",
      "        (PP (IN with)\n",
      "          (NP (DT a) (NN crossover) (NN design)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (JJ T2D) (NNS patients))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NNP n) (NNP =) (CD 10))\n",
      "          (, ,)\n",
      "          (NP (CD 6) (NNS men)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBN aged)\n",
      "      (NP\n",
      "        (QP (CD 65.1) (CD 5.8)))\n",
      "      (, ,)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ glycosylated) (NN hemoglobin))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP HbA1c))\n",
      "              (-RRB- -RRB-)))\n",
      "          (ADJP\n",
      "            (ADJP\n",
      "              (NP (CD 6.6) (NN %))\n",
      "              (NP (CD 0.7) (NN %)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (QP (CD 48) (CD 8))\n",
      "                (NNS mmol/mol))\n",
      "              (-RRB- -RRB-)))\n",
      "          (, ,)\n",
      "          (VP (VBN received)\n",
      "            (SBAR\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (JJ oral) (NN L-glutamine))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (QP (CD 25) (CD g)))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN protein))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP\n",
      "                          (QP (CD 25) (CD g)))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (CC or)\n",
      "                    (NP (NN water)))\n",
      "                  (, ,))\n",
      "                (VP (VBD followed)\n",
      "                  (PP (IN by)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT an) (JJ intravenous) (NN glucose) (NNS bolus))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 0.3) (NN g/kg))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (CC and)\n",
      "                      (NP (JJ hyperglycemic) (NN glucose) (NN clamp))))\n",
      "                  (SBAR (IN for)\n",
      "                    (S\n",
      "                      (NP (CD 2) (NNP h.) (NN Blood))\n",
      "                      (VP (VBD was)\n",
      "                        (ADVP (RB frequently))\n",
      "                        (VP (VBN collected)\n",
      "                          (PP (IN for)\n",
      "                            (NP\n",
      "                              (NP (NNS analyses))\n",
      "                              (PP (IN of)\n",
      "                                (NP (NN glucose) (, ,) (NN serum) (NN insulin)\n",
      "                                  (CC and)\n",
      "                                  (NN plasma) (NN total)\n",
      "                                  (CC and)\n",
      "                                  (JJ active) (NNS GLP-1)\n",
      "                                  (CC and)\n",
      "                                  (NN area)))))\n",
      "                          (PP (IN under)\n",
      "                            (NP\n",
      "                              (NP (DT the) (NN curve))\n",
      "                              (PP (IN of)\n",
      "                                (NP (NN glucose) (, ,) (NN insulin) (, ,) (NN total)\n",
      "                                  (CC and)\n",
      "                                  (JJ active) (JJ GLP-1) (NNS excursions)))\n",
      "                              (VP (VBN calculated)))))))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "case(study-4, In-1)\n",
      "det(study-4, a-2)\n",
      "amod(study-4, randomized-3)\n",
      "nmod:in(aged-20, study-4)\n",
      "case(design-8, with-5)\n",
      "det(design-8, a-6)\n",
      "compound(design-8, crossover-7)\n",
      "nmod:with(study-4, design-8)\n",
      "amod(patients-11, T2D-10)\n",
      "nsubj(aged-20, patients-11)\n",
      "compound(=-14, n-13)\n",
      "dep(patients-11, =-14)\n",
      "nummod(=-14, 10-15)\n",
      "nummod(men-18, 6-17)\n",
      "appos(=-14, men-18)\n",
      "root(ROOT-0, aged-20)\n",
      "compound(5.8-22, 65.1-21)\n",
      "dobj(aged-20, 5.8-22)\n",
      "case(hemoglobin-26, with-24)\n",
      "amod(hemoglobin-26, glycosylated-25)\n",
      "nmod:with(aged-20, hemoglobin-26)\n",
      "appos(hemoglobin-26, HbA1c-28)\n",
      "nummod(%-31, 6.6-30)\n",
      "amod(hemoglobin-26, %-31)\n",
      "nummod(%-33, 0.7-32)\n",
      "dep(%-31, %-33)\n",
      "compound(8-36, 48-35)\n",
      "nummod(mmol/mol-37, 8-36)\n",
      "dep(%-31, mmol/mol-37)\n",
      "acl(hemoglobin-26, received-40)\n",
      "amod(L-glutamine-42, oral-41)\n",
      "nsubj(followed-56, L-glutamine-42)\n",
      "compound(g-45, 25-44)\n",
      "dep(L-glutamine-42, g-45)\n",
      "appos(L-glutamine-42, protein-48)\n",
      "compound(g-51, 25-50)\n",
      "dep(protein-48, g-51)\n",
      "cc(protein-48, or-53)\n",
      "appos(L-glutamine-42, water-54)\n",
      "conj:or(protein-48, water-54)\n",
      "ccomp(received-40, followed-56)\n",
      "case(bolus-61, by-57)\n",
      "det(bolus-61, an-58)\n",
      "amod(bolus-61, intravenous-59)\n",
      "compound(bolus-61, glucose-60)\n",
      "nmod:by(followed-56, bolus-61)\n",
      "nummod(g/kg-64, 0.3-63)\n",
      "appos(bolus-61, g/kg-64)\n",
      "cc(bolus-61, and-66)\n",
      "amod(clamp-69, hyperglycemic-67)\n",
      "compound(clamp-69, glucose-68)\n",
      "nmod:by(followed-56, clamp-69)\n",
      "conj:and(bolus-61, clamp-69)\n",
      "mark(collected-76, for-70)\n",
      "nummod(Blood-73, 2-71)\n",
      "compound(Blood-73, h.-72)\n",
      "nsubjpass(collected-76, Blood-73)\n",
      "auxpass(collected-76, was-74)\n",
      "advmod(collected-76, frequently-75)\n",
      "advcl(followed-56, collected-76)\n",
      "case(analyses-78, for-77)\n",
      "nmod:for(collected-76, analyses-78)\n",
      "case(insulin-83, of-79)\n",
      "compound(insulin-83, glucose-80)\n",
      "dep(insulin-83, serum-82)\n",
      "nmod:of(analyses-78, insulin-83)\n",
      "cc(insulin-83, and-84)\n",
      "compound(total-86, plasma-85)\n",
      "nmod:of(analyses-78, total-86)\n",
      "conj:and(insulin-83, total-86)\n",
      "cc(insulin-83, and-87)\n",
      "amod(GLP-1-89, active-88)\n",
      "nmod:of(analyses-78, GLP-1-89)\n",
      "conj:and(insulin-83, GLP-1-89)\n",
      "cc(insulin-83, and-90)\n",
      "nmod:of(analyses-78, area-91)\n",
      "conj:and(insulin-83, area-91)\n",
      "case(curve-94, under-92)\n",
      "det(curve-94, the-93)\n",
      "nmod:under(collected-76, curve-94)\n",
      "case(excursions-104, of-95)\n",
      "compound(total-100, glucose-96)\n",
      "conj:and(total-100, insulin-98)\n",
      "compound(excursions-104, insulin-98)\n",
      "compound(excursions-104, total-100)\n",
      "cc(total-100, and-101)\n",
      "conj:and(total-100, active-102)\n",
      "compound(excursions-104, active-102)\n",
      "amod(excursions-104, GLP-1-103)\n",
      "nmod:of(curve-94, excursions-104)\n",
      "acl(curve-94, calculated-105)\n",
      "\n",
      "Parsing [sent. 10 len. 14]: Total GLP-1 was increased by both L-glutamine and protein -LRB- p 0.02 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ Total) (NNS GLP-1))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (DT both) (NN L-glutamine)\n",
      "              (CC and)\n",
      "              (NN protein))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p) (CD 0.02))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(GLP-1-2, Total-1)\n",
      "nsubjpass(increased-4, GLP-1-2)\n",
      "auxpass(increased-4, was-3)\n",
      "root(ROOT-0, increased-4)\n",
      "case(L-glutamine-7, by-5)\n",
      "cc:preconj(L-glutamine-7, both-6)\n",
      "nmod:by(increased-4, L-glutamine-7)\n",
      "cc(L-glutamine-7, and-8)\n",
      "nmod:by(increased-4, protein-9)\n",
      "conj:and(L-glutamine-7, protein-9)\n",
      "appos(L-glutamine-7, p-11)\n",
      "nummod(p-11, 0.02-12)\n",
      "\n",
      "Parsing [sent. 11 len. 14]: L-glutamine is an efficacious glucagon-like peptide -LRB- GLP -RRB- -1 secretagogue in vitro .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP L-glutamine))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an)\n",
      "          (ADJP (JJ efficacious) (JJ glucagon-like))\n",
      "          (NNP peptide)\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NNP GLP))\n",
      "            (-RRB- -RRB-))\n",
      "          (JJ -1) (NN secretagogue))\n",
      "        (PP (IN in)\n",
      "          (NP (NNP vitro)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(secretagogue-11, L-glutamine-1)\n",
      "cop(secretagogue-11, is-2)\n",
      "det(secretagogue-11, an-3)\n",
      "amod(glucagon-like-5, efficacious-4)\n",
      "amod(secretagogue-11, glucagon-like-5)\n",
      "compound(secretagogue-11, peptide-6)\n",
      "appos(secretagogue-11, GLP-8)\n",
      "amod(secretagogue-11, -1-10)\n",
      "root(ROOT-0, secretagogue-11)\n",
      "case(vitro-13, in-12)\n",
      "nmod:in(secretagogue-11, vitro-13)\n",
      "\n",
      "Parsing [sent. 12 len. 63]: The plasma glucagon-like peptide-1 concentration in a mesenteric vein draining only the looped region of the intestine was increased after infusion of 139 mmol/l solutions of D-glucose , D-galactose , D-glucuronic acid , 3-0-methyl-D-glucose , maltose , sucrose or maltitol into the intestinal lumen , but not after infusion of solutions of D-fructose , D-fucose , D-mannose , D-xylose or lactose . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (JJ plasma) (JJ glucagon-like) (JJ peptide-1) (NN concentration))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ mesenteric) (NN vein))\n",
      "          (VP (VBG draining)\n",
      "            (NP\n",
      "              (NP (RB only) (DT the) (JJ looped) (NN region))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN intestine))))))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN after)\n",
      "          (NP\n",
      "            (NP (NN infusion))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (CD 139) (JJ mmol/l) (NNS solutions))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ D-glucose) (, ,) (JJ D-galactose) (, ,) (JJ D-glucuronic) (NN acid)))\n",
      "                (, ,)\n",
      "                (ADJP (JJ 3-0-methyl-D-glucose) (, ,) (JJ maltose) (, ,) (JJ sucrose)\n",
      "                  (CC or)\n",
      "                  (JJ maltitol))))))\n",
      "        (PP\n",
      "          (PP (IN into)\n",
      "            (NP (DT the) (JJ intestinal) (NN lumen)))\n",
      "          (, ,)\n",
      "          (CC but)\n",
      "          (RB not)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (NN infusion))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NNS solutions))\n",
      "                  (PP (IN of)\n",
      "                    (ADJP (JJ D-fructose) (, ,) (JJ D-fucose) (, ,) (JJ D-mannose) (, ,) (JJ D-xylose)\n",
      "                      (CC or)\n",
      "                      (JJ lactose))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "det(concentration-5, The-1)\n",
      "amod(concentration-5, plasma-2)\n",
      "amod(concentration-5, glucagon-like-3)\n",
      "amod(concentration-5, peptide-1-4)\n",
      "nsubjpass(increased-19, concentration-5)\n",
      "nsubjpass(increased-19', concentration-5)\n",
      "case(vein-9, in-6)\n",
      "det(vein-9, a-7)\n",
      "amod(vein-9, mesenteric-8)\n",
      "nmod:in(concentration-5, vein-9)\n",
      "acl(vein-9, draining-10)\n",
      "advmod(region-14, only-11)\n",
      "det(region-14, the-12)\n",
      "amod(region-14, looped-13)\n",
      "dobj(draining-10, region-14)\n",
      "case(intestine-17, of-15)\n",
      "det(intestine-17, the-16)\n",
      "nmod:of(region-14, intestine-17)\n",
      "auxpass(increased-19, was-18)\n",
      "root(ROOT-0, increased-19)\n",
      "conj:but(increased-19, increased-19')\n",
      "case(infusion-21, after-20)\n",
      "nmod:after(increased-19, infusion-21)\n",
      "case(solutions-25, of-22)\n",
      "nummod(solutions-25, 139-23)\n",
      "amod(solutions-25, mmol/l-24)\n",
      "nmod:of(infusion-21, solutions-25)\n",
      "case(acid-32, of-26)\n",
      "amod(acid-32, D-glucose-27)\n",
      "amod(acid-32, D-galactose-29)\n",
      "amod(acid-32, D-glucuronic-31)\n",
      "nmod:of(solutions-25, acid-32)\n",
      "amod(solutions-25, 3-0-methyl-D-glucose-34)\n",
      "amod(solutions-25, maltose-36)\n",
      "conj:or(3-0-methyl-D-glucose-34, maltose-36)\n",
      "amod(solutions-25, sucrose-38)\n",
      "conj:or(3-0-methyl-D-glucose-34, sucrose-38)\n",
      "cc(3-0-methyl-D-glucose-34, or-39)\n",
      "amod(solutions-25, maltitol-40)\n",
      "conj:or(3-0-methyl-D-glucose-34, maltitol-40)\n",
      "case(lumen-44, into-41)\n",
      "det(lumen-44, the-42)\n",
      "amod(lumen-44, intestinal-43)\n",
      "nmod:into(increased-19, lumen-44)\n",
      "cc(increased-19, but-46)\n",
      "neg(infusion-49, not-47)\n",
      "case(infusion-49, after-48)\n",
      "nmod:after(increased-19', infusion-49)\n",
      "case(solutions-51, of-50)\n",
      "nmod:of(infusion-49, solutions-51)\n",
      "case(D-fructose-53, of-52)\n",
      "acl(solutions-51, D-fructose-53)\n",
      "acl(solutions-51, D-fucose-55)\n",
      "conj:or(D-fructose-53, D-fucose-55)\n",
      "acl(solutions-51, D-mannose-57)\n",
      "conj:or(D-fructose-53, D-mannose-57)\n",
      "acl(solutions-51, D-xylose-59)\n",
      "conj:or(D-fructose-53, D-xylose-59)\n",
      "cc(D-fructose-53, or-60)\n",
      "acl(solutions-51, lactose-61)\n",
      "conj:or(D-fructose-53, lactose-61)\n",
      "\n",
      "Parsing [sent. 13 len. 27]: In insulin-sensitive tissues , procyanidins modulate glucose uptake and lipogenesis and improve their oxidative/inflammatory state , the disruption of which is important in T2DM development . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (JJ insulin-sensitive) (NNS tissues)))\n",
      "    (, ,)\n",
      "    (NP (NNS procyanidins))\n",
      "    (VP\n",
      "      (VP (VBP modulate)\n",
      "        (NP\n",
      "          (NP (NN glucose) (NN uptake))\n",
      "          (CC and)\n",
      "          (NP (NNS lipogenesis))))\n",
      "      (CC and)\n",
      "      (VP (VB improve)\n",
      "        (NP\n",
      "          (NP (PRP$ their) (JJ oxidative/inflammatory) (NN state))\n",
      "          (, ,)\n",
      "          (SBAR\n",
      "            (WHNP\n",
      "              (NP (DT the) (NN disruption))\n",
      "              (WHPP (IN of)\n",
      "                (WHNP (WDT which))))\n",
      "            (S\n",
      "              (VP (VBZ is)\n",
      "                (ADJP (JJ important)\n",
      "                  (PP (IN in)\n",
      "                    (NP (JJ T2DM) (NN development))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "case(tissues-3, In-1)\n",
      "amod(tissues-3, insulin-sensitive-2)\n",
      "nmod:in(modulate-6, tissues-3)\n",
      "nsubj(modulate-6, procyanidins-5)\n",
      "nsubj(improve-12, procyanidins-5)\n",
      "root(ROOT-0, modulate-6)\n",
      "compound(uptake-8, glucose-7)\n",
      "dobj(modulate-6, uptake-8)\n",
      "cc(uptake-8, and-9)\n",
      "dobj(modulate-6, lipogenesis-10)\n",
      "conj:and(uptake-8, lipogenesis-10)\n",
      "cc(modulate-6, and-11)\n",
      "conj:and(modulate-6, improve-12)\n",
      "nmod:poss(state-15, their-13)\n",
      "amod(state-15, oxidative/inflammatory-14)\n",
      "dobj(improve-12, state-15)\n",
      "nmod:of(disruption-18, state-15)\n",
      "det(disruption-18, the-17)\n",
      "nsubj(important-22, disruption-18)\n",
      "case(which-20, of-19)\n",
      "ref(state-15, which-20)\n",
      "cop(important-22, is-21)\n",
      "acl:relcl(state-15, important-22)\n",
      "case(development-25, in-23)\n",
      "amod(development-25, T2DM-24)\n",
      "nmod:in(important-22, development-25)\n",
      "\n",
      "Parsing [sent. 14 len. 35]: Grape-seed procyanidin extracts -LRB- GSPE -RRB- modulate glucose homeostasis , and it was suggested that GSPE may achieve this by enhancing the secretion of incretin hormones such as glucagon-like peptide-1 -LRB- GLP-1 -RRB- . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (JJ Grape-seed) (NN procyanidin) (NNS extracts))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNP GSPE))\n",
      "          (-RRB- -RRB-)))\n",
      "      (VP (VBP modulate)\n",
      "        (NP (NN glucose) (NNS homeostasis))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN suggested)\n",
      "          (SBAR (IN that)\n",
      "            (S\n",
      "              (NP (NNP GSPE))\n",
      "              (VP (MD may)\n",
      "                (VP (VB achieve)\n",
      "                  (NP (DT this))\n",
      "                  (PP (IN by)\n",
      "                    (S\n",
      "                      (VP (VBG enhancing)\n",
      "                        (NP\n",
      "                          (NP (DT the) (NN secretion))\n",
      "                          (PP (IN of)\n",
      "                            (NP\n",
      "                              (NP (JJ incretin) (NNS hormones))\n",
      "                              (PP (JJ such) (IN as)\n",
      "                                (NP (JJ glucagon-like) (NN peptide-1)))))))))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (ADJP (JJ GLP-1))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "amod(extracts-3, Grape-seed-1)\n",
      "compound(extracts-3, procyanidin-2)\n",
      "nsubj(modulate-7, extracts-3)\n",
      "appos(extracts-3, GSPE-5)\n",
      "root(ROOT-0, modulate-7)\n",
      "compound(homeostasis-9, glucose-8)\n",
      "dobj(modulate-7, homeostasis-9)\n",
      "cc(modulate-7, and-11)\n",
      "nsubjpass(suggested-14, it-12)\n",
      "auxpass(suggested-14, was-13)\n",
      "conj:and(modulate-7, suggested-14)\n",
      "mark(achieve-18, that-15)\n",
      "nsubj(achieve-18, GSPE-16)\n",
      "aux(achieve-18, may-17)\n",
      "ccomp(suggested-14, achieve-18)\n",
      "dobj(achieve-18, this-19)\n",
      "mark(enhancing-21, by-20)\n",
      "advcl(achieve-18, enhancing-21)\n",
      "det(secretion-23, the-22)\n",
      "dobj(enhancing-21, secretion-23)\n",
      "case(hormones-26, of-24)\n",
      "amod(hormones-26, incretin-25)\n",
      "nmod:of(secretion-23, hormones-26)\n",
      "case(peptide-1-30, such-27)\n",
      "mwe(such-27, as-28)\n",
      "amod(peptide-1-30, glucagon-like-29)\n",
      "nmod:such_as(hormones-26, peptide-1-30)\n",
      "dep(achieve-18, GLP-1-32)\n",
      "\n",
      "Parsing [sent. 15 len. 314]: This issue focuses on the following selection of drugs : ABI-007 , adalimumab , adefovir dipivoxil , alefacept , alemtuzumab , 3-AP , AP-12009 , APC-8015 , L-Arginine hydrochloride , aripiprazole , arundic acid , avasimibe ; Bevacizumab , bivatuzumab , BMS-181176 , BMS-184476 , BMS-188797 , bortezomib , bosentan , botulinum toxin type B , BQ-123 , BRL-55730 , bryostatin 1 ; CEP-1347 , cetuximab , cinacalcet hydrochloride , CP-461 , CpG-7909 ; D-003 , dabuzalgron hydrochloride , darbepoetin alfa , desloratadine , desoxyepothilone B , dexmethylphenidate hydrochloride , DHA-paclitaxel , diflomotecan , DN-101 , DP-b99 , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride , duramycin ; Eculizumab , Efalizumab , EKB-569 , elcometrine , enfuvirtide , eplerenone , erlotinib hydrochloride , ertapenem sodium , eszopiclone , everolimus , exatecan mesilate , ezetimibe ; Fenretinide , fosamprenavir calcium , frovatriptan ; GD2L-KLH conjugate vaccine , gefitinib , glufosfamide , GTI-2040 ; Hexyl insulin M2 , human insulin , hydroquinone , gamma-Hydroxybutyrate sodium ; IL-4 -LRB- 38-37 -RRB- - PE38KDEL , imatinib mesylate , indisulam , inhaled insulin , ixabepilone ; KRN-5500 ; LY-544344 ; MDX-210 , melatonin , mepolizumab , motexafin gadolinium ; Natalizumab , NSC-330507 , NSC-683864 ; 1-Octanol , omalizumab , ortataxel ; Pagoclone , peginterferon alfa-2a , peginterferon alfa-2b , pemetrexed disodium , phenoxodiol , pimecrolimus , plevitrexed , polyphenon E , pramlintide acetate , prasterone , pregabalin , PX-12 ; QS-21 ; Ragaglitazar , ranelic acid distrontium salt , RDP-58 , recombinant glucagon-like peptide-1 -LRB- 7-36 -RRB- amide , repinotan hydrochloride , rhEndostatin , rh-Lactoferrin , -LRB- R -RRB- - roscovitine ; S-8184 , semaxanib , sitafloxacin hydrate , sitaxsentan sodium , sorafenib , synthadotin ; Tadalafil , tesmilifene hydrochloride , theratope , tipifarnib , tirapazamine , topixantrone hydrochloride , trabectedin , traxoprodil , Tri-Luma ; Valdecoxib , valganciclovir hydrochloride , vinflunine ; Ximelagatran ; Ziconotide . ''\n",
      "\n",
      "*******************************************************\n",
      "***  WARNING!! OUT OF MEMORY! THERE WAS NOT ENOUGH  ***\n",
      "***  MEMORY TO RUN ALL PARSERS.  EITHER GIVE THE    ***\n",
      "***  JVM MORE MEMORY, SET THE MAXIMUM SENTENCE      ***\n",
      "***  LENGTH WITH -maxLength, OR PERHAPS YOU ARE     ***\n",
      "***  HAPPY TO HAVE THE PARSER FALL BACK TO USING    ***\n",
      "***  A SIMPLER PARSER FOR VERY LONG SENTENCES.      ***\n",
      "*******************************************************\n",
      "\n",
      "Sentence has no parse using PCFG grammar (or no PCFG fallback).  Skipping...\n",
      "Exception in thread \"main\" edu.stanford.nlp.parser.common.NoSuchParseException\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParserQuery.getBestParse(LexicalizedParserQuery.java:404)\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParserQuery.getBestParse(LexicalizedParserQuery.java:376)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.processResults(ParseFiles.java:272)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.parseFiles(ParseFiles.java:216)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.parseFiles(ParseFiles.java:75)\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParser.main(LexicalizedParser.java:1517)\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz ... done [0.7 sec].\n",
      "Parsing file: sent_files/ssa_glp.txt\n",
      "Parsing [sent. 1 len. 44]: sentence Casein -LRB- 1 % w/v -RRB- , safflower oil -LRB- 3.35 % w/v -RRB- , sucrose -LRB- 50mM -RRB- and rebaudioside A -LRB- 12.5 mM -RRB- stimulated GLP-1 release from intestinal segments , whereas casein only stimulated PYY and CCK release . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN sentence) (NN Casein))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD 1) (NN %))\n",
      "              (NP (NNP w/v)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NNP safflower) (NNP oil))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD 3.35) (NN %))\n",
      "              (NP (NNP w/v)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NNP sucrose))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NNP 50mM))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (NNP rebaudioside) (NNP A)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 12.5) (NNS mM))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBN stimulated)\n",
      "      (NP (JJ GLP-1) (NN release))\n",
      "      (PP (IN from)\n",
      "        (NP (JJ intestinal) (NNS segments)))\n",
      "      (, ,)\n",
      "      (SBAR (IN whereas)\n",
      "        (S\n",
      "          (NP (NNP casein))\n",
      "          (ADVP (RB only))\n",
      "          (VP (VBN stimulated)\n",
      "            (NP\n",
      "              (NP (NNP PYY))\n",
      "              (CC and)\n",
      "              (NP (NNP CCK) (NNP release)))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "compound(Casein-2, sentence-1)\n",
      "nsubj(stimulated-28, Casein-2)\n",
      "nummod(%-5, 1-4)\n",
      "dep(Casein-2, %-5)\n",
      "appos(%-5, w/v-6)\n",
      "compound(oil-10, safflower-9)\n",
      "conj:and(Casein-2, oil-10)\n",
      "nsubj(stimulated-28, oil-10)\n",
      "nummod(%-13, 3.35-12)\n",
      "dep(oil-10, %-13)\n",
      "appos(%-13, w/v-14)\n",
      "conj:and(Casein-2, sucrose-17)\n",
      "nsubj(stimulated-28, sucrose-17)\n",
      "appos(sucrose-17, 50mM-19)\n",
      "cc(Casein-2, and-21)\n",
      "compound(A-23, rebaudioside-22)\n",
      "conj:and(Casein-2, A-23)\n",
      "nsubj(stimulated-28, A-23)\n",
      "nummod(mM-26, 12.5-25)\n",
      "appos(Casein-2, mM-26)\n",
      "root(ROOT-0, stimulated-28)\n",
      "amod(release-30, GLP-1-29)\n",
      "dobj(stimulated-28, release-30)\n",
      "case(segments-33, from-31)\n",
      "amod(segments-33, intestinal-32)\n",
      "nmod:from(stimulated-28, segments-33)\n",
      "mark(stimulated-38, whereas-35)\n",
      "nsubj(stimulated-38, casein-36)\n",
      "advmod(stimulated-38, only-37)\n",
      "advcl(stimulated-28, stimulated-38)\n",
      "dobj(stimulated-38, PYY-39)\n",
      "cc(PYY-39, and-40)\n",
      "compound(release-42, CCK-41)\n",
      "dobj(stimulated-38, release-42)\n",
      "conj:and(PYY-39, release-42)\n",
      "\n",
      "Parsing [sent. 2 len. 21]: The distribution of Glucagon-like peptide 1 -LRB- GLP-1 -RRB- was investigated in the gastrointestinal tract of the pheasant using immunohistochemistry .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT The) (NN distribution))\n",
      "        (PP (IN of)\n",
      "          (NP (JJ Glucagon-like) (NNP peptide) (CD 1))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NNP GLP-1))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN investigated)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ gastrointestinal) (NN tract))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT the) (NN pheasant))\n",
      "                (VP (VBG using)\n",
      "                  (ADVP (RB immunohistochemistry)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(distribution-2, The-1)\n",
      "nsubjpass(investigated-11, distribution-2)\n",
      "case(peptide-5, of-3)\n",
      "amod(peptide-5, Glucagon-like-4)\n",
      "nmod:of(distribution-2, peptide-5)\n",
      "nummod(peptide-5, 1-6)\n",
      "appos(distribution-2, GLP-1-8)\n",
      "auxpass(investigated-11, was-10)\n",
      "root(ROOT-0, investigated-11)\n",
      "case(tract-15, in-12)\n",
      "det(tract-15, the-13)\n",
      "amod(tract-15, gastrointestinal-14)\n",
      "nmod:in(investigated-11, tract-15)\n",
      "case(pheasant-18, of-16)\n",
      "det(pheasant-18, the-17)\n",
      "nmod:of(tract-15, pheasant-18)\n",
      "acl(pheasant-18, using-19)\n",
      "advmod(using-19, immunohistochemistry-20)\n",
      "\n",
      "Parsing [sent. 3 len. 24]: Our findings indicate that GLP-1 might have an inhibitory effect on gastric and crop emptying and on acid secretion also in the pheasant .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (NNS findings))\n",
      "    (VP (VBP indicate)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP GLP-1))\n",
      "          (VP (MD might)\n",
      "            (VP (VB have)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ inhibitory) (NN effect))\n",
      "                (PP\n",
      "                  (PP (IN on)\n",
      "                    (NP (NN gastric)\n",
      "                      (CC and)\n",
      "                      (NN crop) (NN emptying)))\n",
      "                  (CC and)\n",
      "                  (PP (IN on)\n",
      "                    (NP (JJ acid) (NN secretion)))))\n",
      "              (PP\n",
      "                (ADVP (RB also))\n",
      "                (IN in)\n",
      "                (NP (DT the) (NN pheasant))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(findings-2, Our-1)\n",
      "nsubj(indicate-3, findings-2)\n",
      "root(ROOT-0, indicate-3)\n",
      "mark(have-7, that-4)\n",
      "nsubj(have-7, GLP-1-5)\n",
      "aux(have-7, might-6)\n",
      "ccomp(indicate-3, have-7)\n",
      "det(effect-10, an-8)\n",
      "amod(effect-10, inhibitory-9)\n",
      "dobj(have-7, effect-10)\n",
      "dobj(have-7, effect-10')\n",
      "conj:and(effect-10, effect-10')\n",
      "case(emptying-15, on-11)\n",
      "compound(emptying-15, gastric-12)\n",
      "cc(gastric-12, and-13)\n",
      "conj:and(gastric-12, crop-14)\n",
      "compound(emptying-15, crop-14)\n",
      "nmod:on(effect-10, emptying-15)\n",
      "cc(effect-10, and-16)\n",
      "case(secretion-19, on-17)\n",
      "amod(secretion-19, acid-18)\n",
      "nmod:on(effect-10', secretion-19)\n",
      "advmod(pheasant-23, also-20)\n",
      "case(pheasant-23, in-21)\n",
      "det(pheasant-23, the-22)\n",
      "nmod:in(have-7, pheasant-23)\n",
      "\n",
      "Parsing [sent. 4 len. 46]: Here , we investigated the effect of a FPH , Slimpro -LRB- -RRB- , obtained from blue whiting -LRB- Micromesistius poutassou -RRB- muscle by enzymatic hydrolysis , on body composition and on stimulating cholecystokinin -LRB- CCK -RRB- and glucagon-like peptide-1 -LRB- GLP-1 -RRB- secretion . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB Here))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD investigated)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN effect))\n",
      "            (PP (IN of)\n",
      "              (NP (DT a) (NN FPH))))\n",
      "          (, ,)\n",
      "          (NP (NNP Slimpro) (NNP -LRB-))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (VP (VBN obtained)\n",
      "          (PP (IN from)\n",
      "            (NP (NNP blue) (NNP whiting)\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP Micromesistius) (NNP poutassou))\n",
      "                (-RRB- -RRB-))\n",
      "              (NN muscle)))\n",
      "          (PP (IN by)\n",
      "            (NP (JJ enzymatic) (NNS hydrolysis))))\n",
      "        (, ,))\n",
      "      (PP\n",
      "        (PP (IN on)\n",
      "          (NP (NN body) (NN composition)))\n",
      "        (CC and)\n",
      "        (PP (IN on)\n",
      "          (S\n",
      "            (VP (VBG stimulating)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NNP cholecystokinin))\n",
      "                  (PRN (-LRB- -LRB-) (NNP CCK) (-RRB- -RRB-)))\n",
      "                (CC and)\n",
      "                (NP (NNP glucagon-like) (NNP peptide-1)\n",
      "                  (PRN (-LRB- -LRB-) (JJ GLP-1) (-RRB- -RRB-))\n",
      "                  (NNP secretion))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "advmod(investigated-4, Here-1)\n",
      "nsubj(investigated-4, we-3)\n",
      "root(ROOT-0, investigated-4)\n",
      "det(effect-6, the-5)\n",
      "dobj(investigated-4, effect-6)\n",
      "case(FPH-9, of-7)\n",
      "det(FPH-9, a-8)\n",
      "nmod:of(effect-6, FPH-9)\n",
      "compound(-LRB--12, Slimpro-11)\n",
      "appos(effect-6, -LRB--12)\n",
      "acl(effect-6, obtained-15)\n",
      "case(muscle-23, from-16)\n",
      "compound(muscle-23, blue-17)\n",
      "compound(muscle-23, whiting-18)\n",
      "compound(poutassou-21, Micromesistius-20)\n",
      "appos(muscle-23, poutassou-21)\n",
      "nmod:from(obtained-15, muscle-23)\n",
      "case(hydrolysis-26, by-24)\n",
      "amod(hydrolysis-26, enzymatic-25)\n",
      "nmod:by(obtained-15, hydrolysis-26)\n",
      "case(composition-30, on-28)\n",
      "compound(composition-30, body-29)\n",
      "nmod:on(investigated-4, composition-30)\n",
      "cc(composition-30, and-31)\n",
      "mark(stimulating-33, on-32)\n",
      "nmod:on(investigated-4, stimulating-33)\n",
      "conj:and(composition-30, stimulating-33)\n",
      "dobj(stimulating-33, cholecystokinin-34)\n",
      "appos(cholecystokinin-34, CCK-36)\n",
      "cc(cholecystokinin-34, and-38)\n",
      "compound(secretion-44, glucagon-like-39)\n",
      "compound(secretion-44, peptide-1-40)\n",
      "dep(secretion-44, GLP-1-42)\n",
      "dobj(stimulating-33, secretion-44)\n",
      "conj:and(cholecystokinin-34, secretion-44)\n",
      "\n",
      "Parsing [sent. 5 len. 69]: The objectives of this study were to compare seasonal feeding behavior of non-transgenic wild-type -LRB- NT -RRB- and GH-transgenic -LRB- T -RRB- coho salmon -LRB- Oncorhynchus kisutch -RRB- , and to examine the effects of intraperitoneal injections of the appetite-regulating peptides cholecystokinin -LRB- CCK-8 -RRB- , bombesin -LRB- BBS -RRB- , glucagon-like peptide-1 -LRB- GLP-1 -RRB- , and alpha-melanocyte-stimulating hormone -LRB- - MSH -RRB- on feeding behavior . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NNS objectives))\n",
      "      (PP (IN of)\n",
      "        (NP (DT this) (NN study))))\n",
      "    (VP (VBD were)\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (TO to)\n",
      "            (VP (VB compare)\n",
      "              (NP\n",
      "                (NP (JJ seasonal) (VBG feeding) (NN behavior))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ non-transgenic) (NN wild-type))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP NT))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (CC and)\n",
      "                    (NP (JJ GH-transgenic) (-LRB- -LRB-) (NN T) (-RRB- -RRB-) (JJ coho) (NN salmon))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP Oncorhynchus) (NNP kisutch))\n",
      "                      (-RRB- -RRB-)))))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (VP (TO to)\n",
      "            (VP (VB examine)\n",
      "              (NP\n",
      "                (NP (DT the) (NNS effects))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ intraperitoneal) (NNS injections))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (NP (DT the) (JJ appetite-regulating) (NNS peptides) (NN cholecystokinin))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP CCK-8))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP (NNP bombesin))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP BBS))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP (JJ glucagon-like) (NN peptide-1))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP GLP-1))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP\n",
      "                          (NP (JJ alpha-melanocyte-stimulating) (NN hormone))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP -) (NNP MSH))\n",
      "                            (-RRB- -RRB-))))))))\n",
      "              (PP (IN on)\n",
      "                (NP (VBG feeding) (NN behavior))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "det(objectives-2, The-1)\n",
      "nsubj(were-6, objectives-2)\n",
      "case(study-5, of-3)\n",
      "det(study-5, this-4)\n",
      "nmod:of(objectives-2, study-5)\n",
      "root(ROOT-0, were-6)\n",
      "mark(compare-8, to-7)\n",
      "ccomp(were-6, compare-8)\n",
      "amod(behavior-11, seasonal-9)\n",
      "amod(behavior-11, feeding-10)\n",
      "dobj(compare-8, behavior-11)\n",
      "case(wild-type-14, of-12)\n",
      "amod(wild-type-14, non-transgenic-13)\n",
      "nmod:of(behavior-11, wild-type-14)\n",
      "appos(wild-type-14, NT-16)\n",
      "cc(wild-type-14, and-18)\n",
      "amod(salmon-24, GH-transgenic-19)\n",
      "compound(salmon-24, T-21)\n",
      "amod(salmon-24, coho-23)\n",
      "nmod:of(behavior-11, salmon-24)\n",
      "conj:and(wild-type-14, salmon-24)\n",
      "compound(kisutch-27, Oncorhynchus-26)\n",
      "appos(wild-type-14, kisutch-27)\n",
      "cc(compare-8, and-30)\n",
      "mark(examine-32, to-31)\n",
      "ccomp(were-6, examine-32)\n",
      "conj:and(compare-8, examine-32)\n",
      "det(effects-34, the-33)\n",
      "dobj(examine-32, effects-34)\n",
      "case(injections-37, of-35)\n",
      "amod(injections-37, intraperitoneal-36)\n",
      "nmod:of(effects-34, injections-37)\n",
      "case(cholecystokinin-42, of-38)\n",
      "det(cholecystokinin-42, the-39)\n",
      "amod(cholecystokinin-42, appetite-regulating-40)\n",
      "compound(cholecystokinin-42, peptides-41)\n",
      "nmod:of(injections-37, cholecystokinin-42)\n",
      "appos(cholecystokinin-42, CCK-8-44)\n",
      "nmod:of(injections-37, bombesin-47)\n",
      "conj:and(cholecystokinin-42, bombesin-47)\n",
      "appos(bombesin-47, BBS-49)\n",
      "amod(peptide-1-53, glucagon-like-52)\n",
      "nmod:of(injections-37, peptide-1-53)\n",
      "conj:and(cholecystokinin-42, peptide-1-53)\n",
      "appos(peptide-1-53, GLP-1-55)\n",
      "cc(cholecystokinin-42, and-58)\n",
      "amod(hormone-60, alpha-melanocyte-stimulating-59)\n",
      "nmod:of(injections-37, hormone-60)\n",
      "conj:and(cholecystokinin-42, hormone-60)\n",
      "compound(MSH-63, --62)\n",
      "appos(hormone-60, MSH-63)\n",
      "case(behavior-67, on-65)\n",
      "amod(behavior-67, feeding-66)\n",
      "nmod:on(examine-32, behavior-67)\n",
      "\n",
      "Parsing [sent. 6 len. 21]: Our previous studies have showed that ginseng total saponins -LRB- GTS -RRB- exhibited antidiabetic effects partly via modulating GLP-1 release .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (JJ previous) (NNS studies))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN showed)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ ginseng) (JJ total) (NNS saponins))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP GTS))\n",
      "                (-RRB- -RRB-)))\n",
      "            (VP (VBD exhibited)\n",
      "              (NP (JJ antidiabetic) (NNS effects))\n",
      "              (PP (RB partly) (IN via)\n",
      "                (S\n",
      "                  (VP (VBG modulating)\n",
      "                    (NP (JJ GLP-1) (NN release))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(studies-3, Our-1)\n",
      "amod(studies-3, previous-2)\n",
      "nsubj(showed-5, studies-3)\n",
      "aux(showed-5, have-4)\n",
      "root(ROOT-0, showed-5)\n",
      "mark(exhibited-13, that-6)\n",
      "amod(saponins-9, ginseng-7)\n",
      "amod(saponins-9, total-8)\n",
      "nsubj(exhibited-13, saponins-9)\n",
      "appos(saponins-9, GTS-11)\n",
      "ccomp(showed-5, exhibited-13)\n",
      "amod(effects-15, antidiabetic-14)\n",
      "dobj(exhibited-13, effects-15)\n",
      "advmod(modulating-18, partly-16)\n",
      "mark(modulating-18, via-17)\n",
      "advcl(exhibited-13, modulating-18)\n",
      "amod(release-20, GLP-1-19)\n",
      "dobj(modulating-18, release-20)\n",
      "\n",
      "Parsing [sent. 7 len. 32]: Previously we have reported that , cycloart-23-ene-3 , 25-diol -LRB- called as B2 -RRB- and L-glutamine stimulated glucagon like peptide-1 -LRB- GLP-1 -RRB- -LRB- 7-36 -RRB- amide secretion diabetic rats . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (ADVP (RB Previously))\n",
      "      (NP (PRP we))\n",
      "      (VP (VBP have)\n",
      "        (VP (VBN reported)\n",
      "          (NP\n",
      "            (NP (DT that))\n",
      "            (, ,)\n",
      "            (ADJP (JJ cycloart-23-ene-3) (, ,) (JJ 25-diol)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN called)\n",
      "              (PP (IN as)\n",
      "                (NP (NN B2))))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (NNP L-glutamine) (NNP stimulated) (NNP glucagon))\n",
      "        (PP (IN like)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN peptide-1))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP GLP-1))\n",
      "                (-RRB- -RRB-)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (CD 7-36))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (VP (VBP amide)\n",
      "        (NP (NNP secretion) (NNP diabetic) (NNS rats))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "advmod(reported-4, Previously-1)\n",
      "nsubj(reported-4, we-2)\n",
      "aux(reported-4, have-3)\n",
      "root(ROOT-0, reported-4)\n",
      "dobj(reported-4, that-5)\n",
      "amod(25-diol-9, cycloart-23-ene-3-7)\n",
      "amod(that-5, 25-diol-9)\n",
      "dep(reported-4, called-11)\n",
      "case(B2-13, as-12)\n",
      "nmod:as(called-11, B2-13)\n",
      "cc(reported-4, and-15)\n",
      "compound(glucagon-18, L-glutamine-16)\n",
      "compound(glucagon-18, stimulated-17)\n",
      "nsubj(amide-27, glucagon-18)\n",
      "case(peptide-1-20, like-19)\n",
      "nmod:like(glucagon-18, peptide-1-20)\n",
      "appos(peptide-1-20, GLP-1-22)\n",
      "appos(peptide-1-20, 7-36-25)\n",
      "conj:and(reported-4, amide-27)\n",
      "compound(rats-30, secretion-28)\n",
      "compound(rats-30, diabetic-29)\n",
      "dobj(amide-27, rats-30)\n",
      "\n",
      "Parsing [sent. 8 len. 37]: L-glutamine triggers glucagon-like peptide-1 -LRB- GLP-1 -RRB- release from L cells in vitro and when ingested pre-meal , decreases postprandial glycaemia and increases circulating insulin and GLP-1 in type 2 diabetes -LRB- T2D -RRB- patients . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP L-glutamine))\n",
      "    (VP\n",
      "      (VP (VBZ triggers)\n",
      "        (NP (JJ glucagon-like)\n",
      "          (UCP\n",
      "            (NP\n",
      "              (NP (JJ peptide-1)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP GLP-1))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NN release))\n",
      "              (PP (IN from)\n",
      "                (NP\n",
      "                  (NP (NNP L) (NNS cells))\n",
      "                  (PP (IN in)\n",
      "                    (NP (NNP vitro))))))\n",
      "            (CC and)\n",
      "            (ADJP\n",
      "              (WHADVP (WRB when))\n",
      "              (JJ ingested)))\n",
      "          (NN pre-meal)))\n",
      "      (, ,)\n",
      "      (VP (VBZ decreases)\n",
      "        (NP (NNP postprandial) (NNP glycaemia)))\n",
      "      (CC and)\n",
      "      (VP (VBZ increases)\n",
      "        (S\n",
      "          (VP (VBG circulating)\n",
      "            (NP\n",
      "              (NP (NN insulin))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (ADJP (JJ GLP-1)\n",
      "                  (PP (IN in)\n",
      "                    (NP (NN type) (CD 2))))\n",
      "                (NN diabetes)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP T2D))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS patients)))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "nsubj(triggers-2, L-glutamine-1)\n",
      "nsubj(decreases-19, L-glutamine-1)\n",
      "nsubj(increases-23, L-glutamine-1)\n",
      "root(ROOT-0, triggers-2)\n",
      "amod(pre-meal-17, glucagon-like-3)\n",
      "amod(release-8, peptide-1-4)\n",
      "appos(release-8, GLP-1-6)\n",
      "compound(pre-meal-17, release-8)\n",
      "case(cells-11, from-9)\n",
      "compound(cells-11, L-10)\n",
      "nmod:from(release-8, cells-11)\n",
      "case(vitro-13, in-12)\n",
      "nmod:in(cells-11, vitro-13)\n",
      "cc(release-8, and-14)\n",
      "advmod(ingested-16, when-15)\n",
      "conj:and(release-8, ingested-16)\n",
      "compound(pre-meal-17, ingested-16)\n",
      "dobj(triggers-2, pre-meal-17)\n",
      "conj:and(triggers-2, decreases-19)\n",
      "compound(glycaemia-21, postprandial-20)\n",
      "dobj(decreases-19, glycaemia-21)\n",
      "cc(triggers-2, and-22)\n",
      "conj:and(triggers-2, increases-23)\n",
      "xcomp(increases-23, circulating-24)\n",
      "dobj(circulating-24, insulin-25)\n",
      "cc(insulin-25, and-26)\n",
      "amod(patients-35, GLP-1-27)\n",
      "case(type-29, in-28)\n",
      "nmod:in(GLP-1-27, type-29)\n",
      "nummod(type-29, 2-30)\n",
      "compound(patients-35, diabetes-31)\n",
      "appos(patients-35, T2D-33)\n",
      "dobj(circulating-24, patients-35)\n",
      "conj:and(insulin-25, patients-35)\n",
      "\n",
      "Parsing [sent. 9 len. 107]: In a randomized study with a crossover design , T2D patients -LRB- n = 10 , 6 men -RRB- aged 65.1 5.8 , with glycosylated hemoglobin -LRB- HbA1c -RRB- 6.6 % 0.7 % -LRB- 48 8 mmol/mol -RRB- , received oral L-glutamine -LRB- 25 g -RRB- , protein -LRB- 25 g -RRB- or water , followed by an intravenous glucose bolus -LRB- 0.3 g/kg -RRB- and hyperglycemic glucose clamp for 2 h. Blood was frequently collected for analyses of glucose , serum insulin and plasma total and active GLP-1 and area under the curve of glucose , insulin , total and active GLP-1 excursions calculated . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ randomized) (NN study))\n",
      "        (PP (IN with)\n",
      "          (NP (DT a) (NN crossover) (NN design)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (JJ T2D) (NNS patients))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NNP n) (NNP =) (CD 10))\n",
      "          (, ,)\n",
      "          (NP (CD 6) (NNS men)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBN aged)\n",
      "      (NP\n",
      "        (QP (CD 65.1) (CD 5.8)))\n",
      "      (, ,)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ glycosylated) (NN hemoglobin))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP HbA1c))\n",
      "              (-RRB- -RRB-)))\n",
      "          (ADJP\n",
      "            (ADJP\n",
      "              (NP (CD 6.6) (NN %))\n",
      "              (NP (CD 0.7) (NN %)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (QP (CD 48) (CD 8))\n",
      "                (NNS mmol/mol))\n",
      "              (-RRB- -RRB-)))\n",
      "          (, ,)\n",
      "          (VP (VBN received)\n",
      "            (SBAR\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (JJ oral) (NN L-glutamine))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (QP (CD 25) (CD g)))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN protein))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP\n",
      "                          (QP (CD 25) (CD g)))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (CC or)\n",
      "                    (NP (NN water)))\n",
      "                  (, ,))\n",
      "                (VP (VBD followed)\n",
      "                  (PP (IN by)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT an) (JJ intravenous) (NN glucose) (NNS bolus))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 0.3) (NN g/kg))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (CC and)\n",
      "                      (NP (JJ hyperglycemic) (NN glucose) (NN clamp))))\n",
      "                  (SBAR (IN for)\n",
      "                    (S\n",
      "                      (NP (CD 2) (NNP h.) (NN Blood))\n",
      "                      (VP (VBD was)\n",
      "                        (ADVP (RB frequently))\n",
      "                        (VP (VBN collected)\n",
      "                          (PP (IN for)\n",
      "                            (NP\n",
      "                              (NP (NNS analyses))\n",
      "                              (PP (IN of)\n",
      "                                (NP (NN glucose) (, ,) (NN serum) (NN insulin)\n",
      "                                  (CC and)\n",
      "                                  (NN plasma) (NN total)\n",
      "                                  (CC and)\n",
      "                                  (JJ active) (NNS GLP-1)\n",
      "                                  (CC and)\n",
      "                                  (NN area)))))\n",
      "                          (PP (IN under)\n",
      "                            (NP\n",
      "                              (NP (DT the) (NN curve))\n",
      "                              (PP (IN of)\n",
      "                                (NP (NN glucose) (, ,) (NN insulin) (, ,) (NN total)\n",
      "                                  (CC and)\n",
      "                                  (JJ active) (JJ GLP-1) (NNS excursions)))\n",
      "                              (VP (VBN calculated)))))))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "case(study-4, In-1)\n",
      "det(study-4, a-2)\n",
      "amod(study-4, randomized-3)\n",
      "nmod:in(aged-20, study-4)\n",
      "case(design-8, with-5)\n",
      "det(design-8, a-6)\n",
      "compound(design-8, crossover-7)\n",
      "nmod:with(study-4, design-8)\n",
      "amod(patients-11, T2D-10)\n",
      "nsubj(aged-20, patients-11)\n",
      "compound(=-14, n-13)\n",
      "dep(patients-11, =-14)\n",
      "nummod(=-14, 10-15)\n",
      "nummod(men-18, 6-17)\n",
      "appos(=-14, men-18)\n",
      "root(ROOT-0, aged-20)\n",
      "compound(5.8-22, 65.1-21)\n",
      "dobj(aged-20, 5.8-22)\n",
      "case(hemoglobin-26, with-24)\n",
      "amod(hemoglobin-26, glycosylated-25)\n",
      "nmod:with(aged-20, hemoglobin-26)\n",
      "appos(hemoglobin-26, HbA1c-28)\n",
      "nummod(%-31, 6.6-30)\n",
      "amod(hemoglobin-26, %-31)\n",
      "nummod(%-33, 0.7-32)\n",
      "dep(%-31, %-33)\n",
      "compound(8-36, 48-35)\n",
      "nummod(mmol/mol-37, 8-36)\n",
      "dep(%-31, mmol/mol-37)\n",
      "acl(hemoglobin-26, received-40)\n",
      "amod(L-glutamine-42, oral-41)\n",
      "nsubj(followed-56, L-glutamine-42)\n",
      "compound(g-45, 25-44)\n",
      "dep(L-glutamine-42, g-45)\n",
      "appos(L-glutamine-42, protein-48)\n",
      "compound(g-51, 25-50)\n",
      "dep(protein-48, g-51)\n",
      "cc(protein-48, or-53)\n",
      "appos(L-glutamine-42, water-54)\n",
      "conj:or(protein-48, water-54)\n",
      "ccomp(received-40, followed-56)\n",
      "case(bolus-61, by-57)\n",
      "det(bolus-61, an-58)\n",
      "amod(bolus-61, intravenous-59)\n",
      "compound(bolus-61, glucose-60)\n",
      "nmod:by(followed-56, bolus-61)\n",
      "nummod(g/kg-64, 0.3-63)\n",
      "appos(bolus-61, g/kg-64)\n",
      "cc(bolus-61, and-66)\n",
      "amod(clamp-69, hyperglycemic-67)\n",
      "compound(clamp-69, glucose-68)\n",
      "nmod:by(followed-56, clamp-69)\n",
      "conj:and(bolus-61, clamp-69)\n",
      "mark(collected-76, for-70)\n",
      "nummod(Blood-73, 2-71)\n",
      "compound(Blood-73, h.-72)\n",
      "nsubjpass(collected-76, Blood-73)\n",
      "auxpass(collected-76, was-74)\n",
      "advmod(collected-76, frequently-75)\n",
      "advcl(followed-56, collected-76)\n",
      "case(analyses-78, for-77)\n",
      "nmod:for(collected-76, analyses-78)\n",
      "case(insulin-83, of-79)\n",
      "compound(insulin-83, glucose-80)\n",
      "dep(insulin-83, serum-82)\n",
      "nmod:of(analyses-78, insulin-83)\n",
      "cc(insulin-83, and-84)\n",
      "compound(total-86, plasma-85)\n",
      "nmod:of(analyses-78, total-86)\n",
      "conj:and(insulin-83, total-86)\n",
      "cc(insulin-83, and-87)\n",
      "amod(GLP-1-89, active-88)\n",
      "nmod:of(analyses-78, GLP-1-89)\n",
      "conj:and(insulin-83, GLP-1-89)\n",
      "cc(insulin-83, and-90)\n",
      "nmod:of(analyses-78, area-91)\n",
      "conj:and(insulin-83, area-91)\n",
      "case(curve-94, under-92)\n",
      "det(curve-94, the-93)\n",
      "nmod:under(collected-76, curve-94)\n",
      "case(excursions-104, of-95)\n",
      "compound(total-100, glucose-96)\n",
      "conj:and(total-100, insulin-98)\n",
      "compound(excursions-104, insulin-98)\n",
      "compound(excursions-104, total-100)\n",
      "cc(total-100, and-101)\n",
      "conj:and(total-100, active-102)\n",
      "compound(excursions-104, active-102)\n",
      "amod(excursions-104, GLP-1-103)\n",
      "nmod:of(curve-94, excursions-104)\n",
      "acl(curve-94, calculated-105)\n",
      "\n",
      "Parsing [sent. 10 len. 14]: Total GLP-1 was increased by both L-glutamine and protein -LRB- p 0.02 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ Total) (NNS GLP-1))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (DT both) (NN L-glutamine)\n",
      "              (CC and)\n",
      "              (NN protein))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p) (CD 0.02))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(GLP-1-2, Total-1)\n",
      "nsubjpass(increased-4, GLP-1-2)\n",
      "auxpass(increased-4, was-3)\n",
      "root(ROOT-0, increased-4)\n",
      "case(L-glutamine-7, by-5)\n",
      "cc:preconj(L-glutamine-7, both-6)\n",
      "nmod:by(increased-4, L-glutamine-7)\n",
      "cc(L-glutamine-7, and-8)\n",
      "nmod:by(increased-4, protein-9)\n",
      "conj:and(L-glutamine-7, protein-9)\n",
      "appos(L-glutamine-7, p-11)\n",
      "nummod(p-11, 0.02-12)\n",
      "\n",
      "Parsing [sent. 11 len. 14]: L-glutamine is an efficacious glucagon-like peptide -LRB- GLP -RRB- -1 secretagogue in vitro .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP L-glutamine))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an)\n",
      "          (ADJP (JJ efficacious) (JJ glucagon-like))\n",
      "          (NNP peptide)\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NNP GLP))\n",
      "            (-RRB- -RRB-))\n",
      "          (JJ -1) (NN secretagogue))\n",
      "        (PP (IN in)\n",
      "          (NP (NNP vitro)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(secretagogue-11, L-glutamine-1)\n",
      "cop(secretagogue-11, is-2)\n",
      "det(secretagogue-11, an-3)\n",
      "amod(glucagon-like-5, efficacious-4)\n",
      "amod(secretagogue-11, glucagon-like-5)\n",
      "compound(secretagogue-11, peptide-6)\n",
      "appos(secretagogue-11, GLP-8)\n",
      "amod(secretagogue-11, -1-10)\n",
      "root(ROOT-0, secretagogue-11)\n",
      "case(vitro-13, in-12)\n",
      "nmod:in(secretagogue-11, vitro-13)\n",
      "\n",
      "Parsing [sent. 12 len. 63]: The plasma glucagon-like peptide-1 concentration in a mesenteric vein draining only the looped region of the intestine was increased after infusion of 139 mmol/l solutions of D-glucose , D-galactose , D-glucuronic acid , 3-0-methyl-D-glucose , maltose , sucrose or maltitol into the intestinal lumen , but not after infusion of solutions of D-fructose , D-fucose , D-mannose , D-xylose or lactose . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (JJ plasma) (JJ glucagon-like) (JJ peptide-1) (NN concentration))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ mesenteric) (NN vein))\n",
      "          (VP (VBG draining)\n",
      "            (NP\n",
      "              (NP (RB only) (DT the) (JJ looped) (NN region))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN intestine))))))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN after)\n",
      "          (NP\n",
      "            (NP (NN infusion))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (CD 139) (JJ mmol/l) (NNS solutions))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ D-glucose) (, ,) (JJ D-galactose) (, ,) (JJ D-glucuronic) (NN acid)))\n",
      "                (, ,)\n",
      "                (ADJP (JJ 3-0-methyl-D-glucose) (, ,) (JJ maltose) (, ,) (JJ sucrose)\n",
      "                  (CC or)\n",
      "                  (JJ maltitol))))))\n",
      "        (PP\n",
      "          (PP (IN into)\n",
      "            (NP (DT the) (JJ intestinal) (NN lumen)))\n",
      "          (, ,)\n",
      "          (CC but)\n",
      "          (RB not)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (NN infusion))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NNS solutions))\n",
      "                  (PP (IN of)\n",
      "                    (ADJP (JJ D-fructose) (, ,) (JJ D-fucose) (, ,) (JJ D-mannose) (, ,) (JJ D-xylose)\n",
      "                      (CC or)\n",
      "                      (JJ lactose))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "det(concentration-5, The-1)\n",
      "amod(concentration-5, plasma-2)\n",
      "amod(concentration-5, glucagon-like-3)\n",
      "amod(concentration-5, peptide-1-4)\n",
      "nsubjpass(increased-19, concentration-5)\n",
      "nsubjpass(increased-19', concentration-5)\n",
      "case(vein-9, in-6)\n",
      "det(vein-9, a-7)\n",
      "amod(vein-9, mesenteric-8)\n",
      "nmod:in(concentration-5, vein-9)\n",
      "acl(vein-9, draining-10)\n",
      "advmod(region-14, only-11)\n",
      "det(region-14, the-12)\n",
      "amod(region-14, looped-13)\n",
      "dobj(draining-10, region-14)\n",
      "case(intestine-17, of-15)\n",
      "det(intestine-17, the-16)\n",
      "nmod:of(region-14, intestine-17)\n",
      "auxpass(increased-19, was-18)\n",
      "root(ROOT-0, increased-19)\n",
      "conj:but(increased-19, increased-19')\n",
      "case(infusion-21, after-20)\n",
      "nmod:after(increased-19, infusion-21)\n",
      "case(solutions-25, of-22)\n",
      "nummod(solutions-25, 139-23)\n",
      "amod(solutions-25, mmol/l-24)\n",
      "nmod:of(infusion-21, solutions-25)\n",
      "case(acid-32, of-26)\n",
      "amod(acid-32, D-glucose-27)\n",
      "amod(acid-32, D-galactose-29)\n",
      "amod(acid-32, D-glucuronic-31)\n",
      "nmod:of(solutions-25, acid-32)\n",
      "amod(solutions-25, 3-0-methyl-D-glucose-34)\n",
      "amod(solutions-25, maltose-36)\n",
      "conj:or(3-0-methyl-D-glucose-34, maltose-36)\n",
      "amod(solutions-25, sucrose-38)\n",
      "conj:or(3-0-methyl-D-glucose-34, sucrose-38)\n",
      "cc(3-0-methyl-D-glucose-34, or-39)\n",
      "amod(solutions-25, maltitol-40)\n",
      "conj:or(3-0-methyl-D-glucose-34, maltitol-40)\n",
      "case(lumen-44, into-41)\n",
      "det(lumen-44, the-42)\n",
      "amod(lumen-44, intestinal-43)\n",
      "nmod:into(increased-19, lumen-44)\n",
      "cc(increased-19, but-46)\n",
      "neg(infusion-49, not-47)\n",
      "case(infusion-49, after-48)\n",
      "nmod:after(increased-19', infusion-49)\n",
      "case(solutions-51, of-50)\n",
      "nmod:of(infusion-49, solutions-51)\n",
      "case(D-fructose-53, of-52)\n",
      "acl(solutions-51, D-fructose-53)\n",
      "acl(solutions-51, D-fucose-55)\n",
      "conj:or(D-fructose-53, D-fucose-55)\n",
      "acl(solutions-51, D-mannose-57)\n",
      "conj:or(D-fructose-53, D-mannose-57)\n",
      "acl(solutions-51, D-xylose-59)\n",
      "conj:or(D-fructose-53, D-xylose-59)\n",
      "cc(D-fructose-53, or-60)\n",
      "acl(solutions-51, lactose-61)\n",
      "conj:or(D-fructose-53, lactose-61)\n",
      "\n",
      "Parsing [sent. 13 len. 27]: In insulin-sensitive tissues , procyanidins modulate glucose uptake and lipogenesis and improve their oxidative/inflammatory state , the disruption of which is important in T2DM development . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (JJ insulin-sensitive) (NNS tissues)))\n",
      "    (, ,)\n",
      "    (NP (NNS procyanidins))\n",
      "    (VP\n",
      "      (VP (VBP modulate)\n",
      "        (NP\n",
      "          (NP (NN glucose) (NN uptake))\n",
      "          (CC and)\n",
      "          (NP (NNS lipogenesis))))\n",
      "      (CC and)\n",
      "      (VP (VB improve)\n",
      "        (NP\n",
      "          (NP (PRP$ their) (JJ oxidative/inflammatory) (NN state))\n",
      "          (, ,)\n",
      "          (SBAR\n",
      "            (WHNP\n",
      "              (NP (DT the) (NN disruption))\n",
      "              (WHPP (IN of)\n",
      "                (WHNP (WDT which))))\n",
      "            (S\n",
      "              (VP (VBZ is)\n",
      "                (ADJP (JJ important)\n",
      "                  (PP (IN in)\n",
      "                    (NP (JJ T2DM) (NN development))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "case(tissues-3, In-1)\n",
      "amod(tissues-3, insulin-sensitive-2)\n",
      "nmod:in(modulate-6, tissues-3)\n",
      "nsubj(modulate-6, procyanidins-5)\n",
      "nsubj(improve-12, procyanidins-5)\n",
      "root(ROOT-0, modulate-6)\n",
      "compound(uptake-8, glucose-7)\n",
      "dobj(modulate-6, uptake-8)\n",
      "cc(uptake-8, and-9)\n",
      "dobj(modulate-6, lipogenesis-10)\n",
      "conj:and(uptake-8, lipogenesis-10)\n",
      "cc(modulate-6, and-11)\n",
      "conj:and(modulate-6, improve-12)\n",
      "nmod:poss(state-15, their-13)\n",
      "amod(state-15, oxidative/inflammatory-14)\n",
      "dobj(improve-12, state-15)\n",
      "nmod:of(disruption-18, state-15)\n",
      "det(disruption-18, the-17)\n",
      "nsubj(important-22, disruption-18)\n",
      "case(which-20, of-19)\n",
      "ref(state-15, which-20)\n",
      "cop(important-22, is-21)\n",
      "acl:relcl(state-15, important-22)\n",
      "case(development-25, in-23)\n",
      "amod(development-25, T2DM-24)\n",
      "nmod:in(important-22, development-25)\n",
      "\n",
      "Parsing [sent. 14 len. 35]: Grape-seed procyanidin extracts -LRB- GSPE -RRB- modulate glucose homeostasis , and it was suggested that GSPE may achieve this by enhancing the secretion of incretin hormones such as glucagon-like peptide-1 -LRB- GLP-1 -RRB- . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (JJ Grape-seed) (NN procyanidin) (NNS extracts))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNP GSPE))\n",
      "          (-RRB- -RRB-)))\n",
      "      (VP (VBP modulate)\n",
      "        (NP (NN glucose) (NNS homeostasis))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN suggested)\n",
      "          (SBAR (IN that)\n",
      "            (S\n",
      "              (NP (NNP GSPE))\n",
      "              (VP (MD may)\n",
      "                (VP (VB achieve)\n",
      "                  (NP (DT this))\n",
      "                  (PP (IN by)\n",
      "                    (S\n",
      "                      (VP (VBG enhancing)\n",
      "                        (NP\n",
      "                          (NP (DT the) (NN secretion))\n",
      "                          (PP (IN of)\n",
      "                            (NP\n",
      "                              (NP (JJ incretin) (NNS hormones))\n",
      "                              (PP (JJ such) (IN as)\n",
      "                                (NP (JJ glucagon-like) (NN peptide-1)))))))))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (ADJP (JJ GLP-1))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "amod(extracts-3, Grape-seed-1)\n",
      "compound(extracts-3, procyanidin-2)\n",
      "nsubj(modulate-7, extracts-3)\n",
      "appos(extracts-3, GSPE-5)\n",
      "root(ROOT-0, modulate-7)\n",
      "compound(homeostasis-9, glucose-8)\n",
      "dobj(modulate-7, homeostasis-9)\n",
      "cc(modulate-7, and-11)\n",
      "nsubjpass(suggested-14, it-12)\n",
      "auxpass(suggested-14, was-13)\n",
      "conj:and(modulate-7, suggested-14)\n",
      "mark(achieve-18, that-15)\n",
      "nsubj(achieve-18, GSPE-16)\n",
      "aux(achieve-18, may-17)\n",
      "ccomp(suggested-14, achieve-18)\n",
      "dobj(achieve-18, this-19)\n",
      "mark(enhancing-21, by-20)\n",
      "advcl(achieve-18, enhancing-21)\n",
      "det(secretion-23, the-22)\n",
      "dobj(enhancing-21, secretion-23)\n",
      "case(hormones-26, of-24)\n",
      "amod(hormones-26, incretin-25)\n",
      "nmod:of(secretion-23, hormones-26)\n",
      "case(peptide-1-30, such-27)\n",
      "mwe(such-27, as-28)\n",
      "amod(peptide-1-30, glucagon-like-29)\n",
      "nmod:such_as(hormones-26, peptide-1-30)\n",
      "dep(achieve-18, GLP-1-32)\n",
      "\n",
      "Parsing [sent. 15 len. 314]: This issue focuses on the following selection of drugs : ABI-007 , adalimumab , adefovir dipivoxil , alefacept , alemtuzumab , 3-AP , AP-12009 , APC-8015 , L-Arginine hydrochloride , aripiprazole , arundic acid , avasimibe ; Bevacizumab , bivatuzumab , BMS-181176 , BMS-184476 , BMS-188797 , bortezomib , bosentan , botulinum toxin type B , BQ-123 , BRL-55730 , bryostatin 1 ; CEP-1347 , cetuximab , cinacalcet hydrochloride , CP-461 , CpG-7909 ; D-003 , dabuzalgron hydrochloride , darbepoetin alfa , desloratadine , desoxyepothilone B , dexmethylphenidate hydrochloride , DHA-paclitaxel , diflomotecan , DN-101 , DP-b99 , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride , duramycin ; Eculizumab , Efalizumab , EKB-569 , elcometrine , enfuvirtide , eplerenone , erlotinib hydrochloride , ertapenem sodium , eszopiclone , everolimus , exatecan mesilate , ezetimibe ; Fenretinide , fosamprenavir calcium , frovatriptan ; GD2L-KLH conjugate vaccine , gefitinib , glufosfamide , GTI-2040 ; Hexyl insulin M2 , human insulin , hydroquinone , gamma-Hydroxybutyrate sodium ; IL-4 -LRB- 38-37 -RRB- - PE38KDEL , imatinib mesylate , indisulam , inhaled insulin , ixabepilone ; KRN-5500 ; LY-544344 ; MDX-210 , melatonin , mepolizumab , motexafin gadolinium ; Natalizumab , NSC-330507 , NSC-683864 ; 1-Octanol , omalizumab , ortataxel ; Pagoclone , peginterferon alfa-2a , peginterferon alfa-2b , pemetrexed disodium , phenoxodiol , pimecrolimus , plevitrexed , polyphenon E , pramlintide acetate , prasterone , pregabalin , PX-12 ; QS-21 ; Ragaglitazar , ranelic acid distrontium salt , RDP-58 , recombinant glucagon-like peptide-1 -LRB- 7-36 -RRB- amide , repinotan hydrochloride , rhEndostatin , rh-Lactoferrin , -LRB- R -RRB- - roscovitine ; S-8184 , semaxanib , sitafloxacin hydrate , sitaxsentan sodium , sorafenib , synthadotin ; Tadalafil , tesmilifene hydrochloride , theratope , tipifarnib , tirapazamine , topixantrone hydrochloride , trabectedin , traxoprodil , Tri-Luma ; Valdecoxib , valganciclovir hydrochloride , vinflunine ; Ximelagatran ; Ziconotide . ''\n",
      "\n",
      "*******************************************************\n",
      "***  WARNING!! OUT OF MEMORY! THERE WAS NOT ENOUGH  ***\n",
      "***  MEMORY TO RUN ALL PARSERS.  EITHER GIVE THE    ***\n",
      "***  JVM MORE MEMORY, SET THE MAXIMUM SENTENCE      ***\n",
      "***  LENGTH WITH -maxLength, OR PERHAPS YOU ARE     ***\n",
      "***  HAPPY TO HAVE THE PARSER FALL BACK TO USING    ***\n",
      "***  A SIMPLER PARSER FOR VERY LONG SENTENCES.      ***\n",
      "*******************************************************\n",
      "\n",
      "Sentence has no parse using PCFG grammar (or no PCFG fallback).  Skipping...\n",
      "Exception in thread \"main\" edu.stanford.nlp.parser.common.NoSuchParseException\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParserQuery.getBestParse(LexicalizedParserQuery.java:404)\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParserQuery.getBestParse(LexicalizedParserQuery.java:376)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.processResults(ParseFiles.java:272)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.parseFiles(ParseFiles.java:216)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.parseFiles(ParseFiles.java:75)\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParser.main(LexicalizedParser.java:1517)\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz ... done [0.8 sec].\n",
      "Parsing file: sent_files/ssa_glp.txt\n",
      "Parsing [sent. 1 len. 44]: sentence Casein -LRB- 1 % w/v -RRB- , safflower oil -LRB- 3.35 % w/v -RRB- , sucrose -LRB- 50mM -RRB- and rebaudioside A -LRB- 12.5 mM -RRB- stimulated GLP-1 release from intestinal segments , whereas casein only stimulated PYY and CCK release . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN sentence) (NN Casein))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD 1) (NN %))\n",
      "              (NP (NNP w/v)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NNP safflower) (NNP oil))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD 3.35) (NN %))\n",
      "              (NP (NNP w/v)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NNP sucrose))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NNP 50mM))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (NNP rebaudioside) (NNP A)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 12.5) (NNS mM))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBN stimulated)\n",
      "      (NP (JJ GLP-1) (NN release))\n",
      "      (PP (IN from)\n",
      "        (NP (JJ intestinal) (NNS segments)))\n",
      "      (, ,)\n",
      "      (SBAR (IN whereas)\n",
      "        (S\n",
      "          (NP (NNP casein))\n",
      "          (ADVP (RB only))\n",
      "          (VP (VBN stimulated)\n",
      "            (NP\n",
      "              (NP (NNP PYY))\n",
      "              (CC and)\n",
      "              (NP (NNP CCK) (NNP release)))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "compound(Casein-2, sentence-1)\n",
      "nsubj(stimulated-28, Casein-2)\n",
      "nummod(%-5, 1-4)\n",
      "dep(Casein-2, %-5)\n",
      "appos(%-5, w/v-6)\n",
      "compound(oil-10, safflower-9)\n",
      "conj:and(Casein-2, oil-10)\n",
      "nsubj(stimulated-28, oil-10)\n",
      "nummod(%-13, 3.35-12)\n",
      "dep(oil-10, %-13)\n",
      "appos(%-13, w/v-14)\n",
      "conj:and(Casein-2, sucrose-17)\n",
      "nsubj(stimulated-28, sucrose-17)\n",
      "appos(sucrose-17, 50mM-19)\n",
      "cc(Casein-2, and-21)\n",
      "compound(A-23, rebaudioside-22)\n",
      "conj:and(Casein-2, A-23)\n",
      "nsubj(stimulated-28, A-23)\n",
      "nummod(mM-26, 12.5-25)\n",
      "appos(Casein-2, mM-26)\n",
      "root(ROOT-0, stimulated-28)\n",
      "amod(release-30, GLP-1-29)\n",
      "dobj(stimulated-28, release-30)\n",
      "case(segments-33, from-31)\n",
      "amod(segments-33, intestinal-32)\n",
      "nmod:from(stimulated-28, segments-33)\n",
      "mark(stimulated-38, whereas-35)\n",
      "nsubj(stimulated-38, casein-36)\n",
      "advmod(stimulated-38, only-37)\n",
      "advcl(stimulated-28, stimulated-38)\n",
      "dobj(stimulated-38, PYY-39)\n",
      "cc(PYY-39, and-40)\n",
      "compound(release-42, CCK-41)\n",
      "dobj(stimulated-38, release-42)\n",
      "conj:and(PYY-39, release-42)\n",
      "\n",
      "Parsing [sent. 2 len. 21]: The distribution of Glucagon-like peptide 1 -LRB- GLP-1 -RRB- was investigated in the gastrointestinal tract of the pheasant using immunohistochemistry .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT The) (NN distribution))\n",
      "        (PP (IN of)\n",
      "          (NP (JJ Glucagon-like) (NNP peptide) (CD 1))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NNP GLP-1))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN investigated)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ gastrointestinal) (NN tract))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT the) (NN pheasant))\n",
      "                (VP (VBG using)\n",
      "                  (ADVP (RB immunohistochemistry)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(distribution-2, The-1)\n",
      "nsubjpass(investigated-11, distribution-2)\n",
      "case(peptide-5, of-3)\n",
      "amod(peptide-5, Glucagon-like-4)\n",
      "nmod:of(distribution-2, peptide-5)\n",
      "nummod(peptide-5, 1-6)\n",
      "appos(distribution-2, GLP-1-8)\n",
      "auxpass(investigated-11, was-10)\n",
      "root(ROOT-0, investigated-11)\n",
      "case(tract-15, in-12)\n",
      "det(tract-15, the-13)\n",
      "amod(tract-15, gastrointestinal-14)\n",
      "nmod:in(investigated-11, tract-15)\n",
      "case(pheasant-18, of-16)\n",
      "det(pheasant-18, the-17)\n",
      "nmod:of(tract-15, pheasant-18)\n",
      "acl(pheasant-18, using-19)\n",
      "advmod(using-19, immunohistochemistry-20)\n",
      "\n",
      "Parsing [sent. 3 len. 24]: Our findings indicate that GLP-1 might have an inhibitory effect on gastric and crop emptying and on acid secretion also in the pheasant .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (NNS findings))\n",
      "    (VP (VBP indicate)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP GLP-1))\n",
      "          (VP (MD might)\n",
      "            (VP (VB have)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ inhibitory) (NN effect))\n",
      "                (PP\n",
      "                  (PP (IN on)\n",
      "                    (NP (NN gastric)\n",
      "                      (CC and)\n",
      "                      (NN crop) (NN emptying)))\n",
      "                  (CC and)\n",
      "                  (PP (IN on)\n",
      "                    (NP (JJ acid) (NN secretion)))))\n",
      "              (PP\n",
      "                (ADVP (RB also))\n",
      "                (IN in)\n",
      "                (NP (DT the) (NN pheasant))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(findings-2, Our-1)\n",
      "nsubj(indicate-3, findings-2)\n",
      "root(ROOT-0, indicate-3)\n",
      "mark(have-7, that-4)\n",
      "nsubj(have-7, GLP-1-5)\n",
      "aux(have-7, might-6)\n",
      "ccomp(indicate-3, have-7)\n",
      "det(effect-10, an-8)\n",
      "amod(effect-10, inhibitory-9)\n",
      "dobj(have-7, effect-10)\n",
      "dobj(have-7, effect-10')\n",
      "conj:and(effect-10, effect-10')\n",
      "case(emptying-15, on-11)\n",
      "compound(emptying-15, gastric-12)\n",
      "cc(gastric-12, and-13)\n",
      "conj:and(gastric-12, crop-14)\n",
      "compound(emptying-15, crop-14)\n",
      "nmod:on(effect-10, emptying-15)\n",
      "cc(effect-10, and-16)\n",
      "case(secretion-19, on-17)\n",
      "amod(secretion-19, acid-18)\n",
      "nmod:on(effect-10', secretion-19)\n",
      "advmod(pheasant-23, also-20)\n",
      "case(pheasant-23, in-21)\n",
      "det(pheasant-23, the-22)\n",
      "nmod:in(have-7, pheasant-23)\n",
      "\n",
      "Parsing [sent. 4 len. 46]: Here , we investigated the effect of a FPH , Slimpro -LRB- -RRB- , obtained from blue whiting -LRB- Micromesistius poutassou -RRB- muscle by enzymatic hydrolysis , on body composition and on stimulating cholecystokinin -LRB- CCK -RRB- and glucagon-like peptide-1 -LRB- GLP-1 -RRB- secretion . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB Here))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD investigated)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN effect))\n",
      "            (PP (IN of)\n",
      "              (NP (DT a) (NN FPH))))\n",
      "          (, ,)\n",
      "          (NP (NNP Slimpro) (NNP -LRB-))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (VP (VBN obtained)\n",
      "          (PP (IN from)\n",
      "            (NP (NNP blue) (NNP whiting)\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP Micromesistius) (NNP poutassou))\n",
      "                (-RRB- -RRB-))\n",
      "              (NN muscle)))\n",
      "          (PP (IN by)\n",
      "            (NP (JJ enzymatic) (NNS hydrolysis))))\n",
      "        (, ,))\n",
      "      (PP\n",
      "        (PP (IN on)\n",
      "          (NP (NN body) (NN composition)))\n",
      "        (CC and)\n",
      "        (PP (IN on)\n",
      "          (S\n",
      "            (VP (VBG stimulating)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NNP cholecystokinin))\n",
      "                  (PRN (-LRB- -LRB-) (NNP CCK) (-RRB- -RRB-)))\n",
      "                (CC and)\n",
      "                (NP (NNP glucagon-like) (NNP peptide-1)\n",
      "                  (PRN (-LRB- -LRB-) (JJ GLP-1) (-RRB- -RRB-))\n",
      "                  (NNP secretion))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "advmod(investigated-4, Here-1)\n",
      "nsubj(investigated-4, we-3)\n",
      "root(ROOT-0, investigated-4)\n",
      "det(effect-6, the-5)\n",
      "dobj(investigated-4, effect-6)\n",
      "case(FPH-9, of-7)\n",
      "det(FPH-9, a-8)\n",
      "nmod:of(effect-6, FPH-9)\n",
      "compound(-LRB--12, Slimpro-11)\n",
      "appos(effect-6, -LRB--12)\n",
      "acl(effect-6, obtained-15)\n",
      "case(muscle-23, from-16)\n",
      "compound(muscle-23, blue-17)\n",
      "compound(muscle-23, whiting-18)\n",
      "compound(poutassou-21, Micromesistius-20)\n",
      "appos(muscle-23, poutassou-21)\n",
      "nmod:from(obtained-15, muscle-23)\n",
      "case(hydrolysis-26, by-24)\n",
      "amod(hydrolysis-26, enzymatic-25)\n",
      "nmod:by(obtained-15, hydrolysis-26)\n",
      "case(composition-30, on-28)\n",
      "compound(composition-30, body-29)\n",
      "nmod:on(investigated-4, composition-30)\n",
      "cc(composition-30, and-31)\n",
      "mark(stimulating-33, on-32)\n",
      "nmod:on(investigated-4, stimulating-33)\n",
      "conj:and(composition-30, stimulating-33)\n",
      "dobj(stimulating-33, cholecystokinin-34)\n",
      "appos(cholecystokinin-34, CCK-36)\n",
      "cc(cholecystokinin-34, and-38)\n",
      "compound(secretion-44, glucagon-like-39)\n",
      "compound(secretion-44, peptide-1-40)\n",
      "dep(secretion-44, GLP-1-42)\n",
      "dobj(stimulating-33, secretion-44)\n",
      "conj:and(cholecystokinin-34, secretion-44)\n",
      "\n",
      "Parsing [sent. 5 len. 69]: The objectives of this study were to compare seasonal feeding behavior of non-transgenic wild-type -LRB- NT -RRB- and GH-transgenic -LRB- T -RRB- coho salmon -LRB- Oncorhynchus kisutch -RRB- , and to examine the effects of intraperitoneal injections of the appetite-regulating peptides cholecystokinin -LRB- CCK-8 -RRB- , bombesin -LRB- BBS -RRB- , glucagon-like peptide-1 -LRB- GLP-1 -RRB- , and alpha-melanocyte-stimulating hormone -LRB- - MSH -RRB- on feeding behavior . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NNS objectives))\n",
      "      (PP (IN of)\n",
      "        (NP (DT this) (NN study))))\n",
      "    (VP (VBD were)\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (TO to)\n",
      "            (VP (VB compare)\n",
      "              (NP\n",
      "                (NP (JJ seasonal) (VBG feeding) (NN behavior))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ non-transgenic) (NN wild-type))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP NT))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (CC and)\n",
      "                    (NP (JJ GH-transgenic) (-LRB- -LRB-) (NN T) (-RRB- -RRB-) (JJ coho) (NN salmon))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP Oncorhynchus) (NNP kisutch))\n",
      "                      (-RRB- -RRB-)))))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (VP (TO to)\n",
      "            (VP (VB examine)\n",
      "              (NP\n",
      "                (NP (DT the) (NNS effects))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ intraperitoneal) (NNS injections))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (NP (DT the) (JJ appetite-regulating) (NNS peptides) (NN cholecystokinin))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP CCK-8))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP (NNP bombesin))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP BBS))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP (JJ glucagon-like) (NN peptide-1))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP GLP-1))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP\n",
      "                          (NP (JJ alpha-melanocyte-stimulating) (NN hormone))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP -) (NNP MSH))\n",
      "                            (-RRB- -RRB-))))))))\n",
      "              (PP (IN on)\n",
      "                (NP (VBG feeding) (NN behavior))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "det(objectives-2, The-1)\n",
      "nsubj(were-6, objectives-2)\n",
      "case(study-5, of-3)\n",
      "det(study-5, this-4)\n",
      "nmod:of(objectives-2, study-5)\n",
      "root(ROOT-0, were-6)\n",
      "mark(compare-8, to-7)\n",
      "ccomp(were-6, compare-8)\n",
      "amod(behavior-11, seasonal-9)\n",
      "amod(behavior-11, feeding-10)\n",
      "dobj(compare-8, behavior-11)\n",
      "case(wild-type-14, of-12)\n",
      "amod(wild-type-14, non-transgenic-13)\n",
      "nmod:of(behavior-11, wild-type-14)\n",
      "appos(wild-type-14, NT-16)\n",
      "cc(wild-type-14, and-18)\n",
      "amod(salmon-24, GH-transgenic-19)\n",
      "compound(salmon-24, T-21)\n",
      "amod(salmon-24, coho-23)\n",
      "nmod:of(behavior-11, salmon-24)\n",
      "conj:and(wild-type-14, salmon-24)\n",
      "compound(kisutch-27, Oncorhynchus-26)\n",
      "appos(wild-type-14, kisutch-27)\n",
      "cc(compare-8, and-30)\n",
      "mark(examine-32, to-31)\n",
      "ccomp(were-6, examine-32)\n",
      "conj:and(compare-8, examine-32)\n",
      "det(effects-34, the-33)\n",
      "dobj(examine-32, effects-34)\n",
      "case(injections-37, of-35)\n",
      "amod(injections-37, intraperitoneal-36)\n",
      "nmod:of(effects-34, injections-37)\n",
      "case(cholecystokinin-42, of-38)\n",
      "det(cholecystokinin-42, the-39)\n",
      "amod(cholecystokinin-42, appetite-regulating-40)\n",
      "compound(cholecystokinin-42, peptides-41)\n",
      "nmod:of(injections-37, cholecystokinin-42)\n",
      "appos(cholecystokinin-42, CCK-8-44)\n",
      "nmod:of(injections-37, bombesin-47)\n",
      "conj:and(cholecystokinin-42, bombesin-47)\n",
      "appos(bombesin-47, BBS-49)\n",
      "amod(peptide-1-53, glucagon-like-52)\n",
      "nmod:of(injections-37, peptide-1-53)\n",
      "conj:and(cholecystokinin-42, peptide-1-53)\n",
      "appos(peptide-1-53, GLP-1-55)\n",
      "cc(cholecystokinin-42, and-58)\n",
      "amod(hormone-60, alpha-melanocyte-stimulating-59)\n",
      "nmod:of(injections-37, hormone-60)\n",
      "conj:and(cholecystokinin-42, hormone-60)\n",
      "compound(MSH-63, --62)\n",
      "appos(hormone-60, MSH-63)\n",
      "case(behavior-67, on-65)\n",
      "amod(behavior-67, feeding-66)\n",
      "nmod:on(examine-32, behavior-67)\n",
      "\n",
      "Parsing [sent. 6 len. 21]: Our previous studies have showed that ginseng total saponins -LRB- GTS -RRB- exhibited antidiabetic effects partly via modulating GLP-1 release .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (JJ previous) (NNS studies))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN showed)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ ginseng) (JJ total) (NNS saponins))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP GTS))\n",
      "                (-RRB- -RRB-)))\n",
      "            (VP (VBD exhibited)\n",
      "              (NP (JJ antidiabetic) (NNS effects))\n",
      "              (PP (RB partly) (IN via)\n",
      "                (S\n",
      "                  (VP (VBG modulating)\n",
      "                    (NP (JJ GLP-1) (NN release))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(studies-3, Our-1)\n",
      "amod(studies-3, previous-2)\n",
      "nsubj(showed-5, studies-3)\n",
      "aux(showed-5, have-4)\n",
      "root(ROOT-0, showed-5)\n",
      "mark(exhibited-13, that-6)\n",
      "amod(saponins-9, ginseng-7)\n",
      "amod(saponins-9, total-8)\n",
      "nsubj(exhibited-13, saponins-9)\n",
      "appos(saponins-9, GTS-11)\n",
      "ccomp(showed-5, exhibited-13)\n",
      "amod(effects-15, antidiabetic-14)\n",
      "dobj(exhibited-13, effects-15)\n",
      "advmod(modulating-18, partly-16)\n",
      "mark(modulating-18, via-17)\n",
      "advcl(exhibited-13, modulating-18)\n",
      "amod(release-20, GLP-1-19)\n",
      "dobj(modulating-18, release-20)\n",
      "\n",
      "Parsing [sent. 7 len. 32]: Previously we have reported that , cycloart-23-ene-3 , 25-diol -LRB- called as B2 -RRB- and L-glutamine stimulated glucagon like peptide-1 -LRB- GLP-1 -RRB- -LRB- 7-36 -RRB- amide secretion diabetic rats . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (ADVP (RB Previously))\n",
      "      (NP (PRP we))\n",
      "      (VP (VBP have)\n",
      "        (VP (VBN reported)\n",
      "          (NP\n",
      "            (NP (DT that))\n",
      "            (, ,)\n",
      "            (ADJP (JJ cycloart-23-ene-3) (, ,) (JJ 25-diol)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN called)\n",
      "              (PP (IN as)\n",
      "                (NP (NN B2))))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (NNP L-glutamine) (NNP stimulated) (NNP glucagon))\n",
      "        (PP (IN like)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN peptide-1))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP GLP-1))\n",
      "                (-RRB- -RRB-)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (CD 7-36))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (VP (VBP amide)\n",
      "        (NP (NNP secretion) (NNP diabetic) (NNS rats))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "advmod(reported-4, Previously-1)\n",
      "nsubj(reported-4, we-2)\n",
      "aux(reported-4, have-3)\n",
      "root(ROOT-0, reported-4)\n",
      "dobj(reported-4, that-5)\n",
      "amod(25-diol-9, cycloart-23-ene-3-7)\n",
      "amod(that-5, 25-diol-9)\n",
      "dep(reported-4, called-11)\n",
      "case(B2-13, as-12)\n",
      "nmod:as(called-11, B2-13)\n",
      "cc(reported-4, and-15)\n",
      "compound(glucagon-18, L-glutamine-16)\n",
      "compound(glucagon-18, stimulated-17)\n",
      "nsubj(amide-27, glucagon-18)\n",
      "case(peptide-1-20, like-19)\n",
      "nmod:like(glucagon-18, peptide-1-20)\n",
      "appos(peptide-1-20, GLP-1-22)\n",
      "appos(peptide-1-20, 7-36-25)\n",
      "conj:and(reported-4, amide-27)\n",
      "compound(rats-30, secretion-28)\n",
      "compound(rats-30, diabetic-29)\n",
      "dobj(amide-27, rats-30)\n",
      "\n",
      "Parsing [sent. 8 len. 37]: L-glutamine triggers glucagon-like peptide-1 -LRB- GLP-1 -RRB- release from L cells in vitro and when ingested pre-meal , decreases postprandial glycaemia and increases circulating insulin and GLP-1 in type 2 diabetes -LRB- T2D -RRB- patients . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP L-glutamine))\n",
      "    (VP\n",
      "      (VP (VBZ triggers)\n",
      "        (NP (JJ glucagon-like)\n",
      "          (UCP\n",
      "            (NP\n",
      "              (NP (JJ peptide-1)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP GLP-1))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NN release))\n",
      "              (PP (IN from)\n",
      "                (NP\n",
      "                  (NP (NNP L) (NNS cells))\n",
      "                  (PP (IN in)\n",
      "                    (NP (NNP vitro))))))\n",
      "            (CC and)\n",
      "            (ADJP\n",
      "              (WHADVP (WRB when))\n",
      "              (JJ ingested)))\n",
      "          (NN pre-meal)))\n",
      "      (, ,)\n",
      "      (VP (VBZ decreases)\n",
      "        (NP (NNP postprandial) (NNP glycaemia)))\n",
      "      (CC and)\n",
      "      (VP (VBZ increases)\n",
      "        (S\n",
      "          (VP (VBG circulating)\n",
      "            (NP\n",
      "              (NP (NN insulin))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (ADJP (JJ GLP-1)\n",
      "                  (PP (IN in)\n",
      "                    (NP (NN type) (CD 2))))\n",
      "                (NN diabetes)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP T2D))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS patients)))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "nsubj(triggers-2, L-glutamine-1)\n",
      "nsubj(decreases-19, L-glutamine-1)\n",
      "nsubj(increases-23, L-glutamine-1)\n",
      "root(ROOT-0, triggers-2)\n",
      "amod(pre-meal-17, glucagon-like-3)\n",
      "amod(release-8, peptide-1-4)\n",
      "appos(release-8, GLP-1-6)\n",
      "compound(pre-meal-17, release-8)\n",
      "case(cells-11, from-9)\n",
      "compound(cells-11, L-10)\n",
      "nmod:from(release-8, cells-11)\n",
      "case(vitro-13, in-12)\n",
      "nmod:in(cells-11, vitro-13)\n",
      "cc(release-8, and-14)\n",
      "advmod(ingested-16, when-15)\n",
      "conj:and(release-8, ingested-16)\n",
      "compound(pre-meal-17, ingested-16)\n",
      "dobj(triggers-2, pre-meal-17)\n",
      "conj:and(triggers-2, decreases-19)\n",
      "compound(glycaemia-21, postprandial-20)\n",
      "dobj(decreases-19, glycaemia-21)\n",
      "cc(triggers-2, and-22)\n",
      "conj:and(triggers-2, increases-23)\n",
      "xcomp(increases-23, circulating-24)\n",
      "dobj(circulating-24, insulin-25)\n",
      "cc(insulin-25, and-26)\n",
      "amod(patients-35, GLP-1-27)\n",
      "case(type-29, in-28)\n",
      "nmod:in(GLP-1-27, type-29)\n",
      "nummod(type-29, 2-30)\n",
      "compound(patients-35, diabetes-31)\n",
      "appos(patients-35, T2D-33)\n",
      "dobj(circulating-24, patients-35)\n",
      "conj:and(insulin-25, patients-35)\n",
      "\n",
      "Parsing [sent. 9 len. 107]: In a randomized study with a crossover design , T2D patients -LRB- n = 10 , 6 men -RRB- aged 65.1 5.8 , with glycosylated hemoglobin -LRB- HbA1c -RRB- 6.6 % 0.7 % -LRB- 48 8 mmol/mol -RRB- , received oral L-glutamine -LRB- 25 g -RRB- , protein -LRB- 25 g -RRB- or water , followed by an intravenous glucose bolus -LRB- 0.3 g/kg -RRB- and hyperglycemic glucose clamp for 2 h. Blood was frequently collected for analyses of glucose , serum insulin and plasma total and active GLP-1 and area under the curve of glucose , insulin , total and active GLP-1 excursions calculated . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ randomized) (NN study))\n",
      "        (PP (IN with)\n",
      "          (NP (DT a) (NN crossover) (NN design)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (JJ T2D) (NNS patients))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NNP n) (NNP =) (CD 10))\n",
      "          (, ,)\n",
      "          (NP (CD 6) (NNS men)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBN aged)\n",
      "      (NP\n",
      "        (QP (CD 65.1) (CD 5.8)))\n",
      "      (, ,)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ glycosylated) (NN hemoglobin))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP HbA1c))\n",
      "              (-RRB- -RRB-)))\n",
      "          (ADJP\n",
      "            (ADJP\n",
      "              (NP (CD 6.6) (NN %))\n",
      "              (NP (CD 0.7) (NN %)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (QP (CD 48) (CD 8))\n",
      "                (NNS mmol/mol))\n",
      "              (-RRB- -RRB-)))\n",
      "          (, ,)\n",
      "          (VP (VBN received)\n",
      "            (SBAR\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (JJ oral) (NN L-glutamine))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (QP (CD 25) (CD g)))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN protein))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP\n",
      "                          (QP (CD 25) (CD g)))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (CC or)\n",
      "                    (NP (NN water)))\n",
      "                  (, ,))\n",
      "                (VP (VBD followed)\n",
      "                  (PP (IN by)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT an) (JJ intravenous) (NN glucose) (NNS bolus))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 0.3) (NN g/kg))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (CC and)\n",
      "                      (NP (JJ hyperglycemic) (NN glucose) (NN clamp))))\n",
      "                  (SBAR (IN for)\n",
      "                    (S\n",
      "                      (NP (CD 2) (NNP h.) (NN Blood))\n",
      "                      (VP (VBD was)\n",
      "                        (ADVP (RB frequently))\n",
      "                        (VP (VBN collected)\n",
      "                          (PP (IN for)\n",
      "                            (NP\n",
      "                              (NP (NNS analyses))\n",
      "                              (PP (IN of)\n",
      "                                (NP (NN glucose) (, ,) (NN serum) (NN insulin)\n",
      "                                  (CC and)\n",
      "                                  (NN plasma) (NN total)\n",
      "                                  (CC and)\n",
      "                                  (JJ active) (NNS GLP-1)\n",
      "                                  (CC and)\n",
      "                                  (NN area)))))\n",
      "                          (PP (IN under)\n",
      "                            (NP\n",
      "                              (NP (DT the) (NN curve))\n",
      "                              (PP (IN of)\n",
      "                                (NP (NN glucose) (, ,) (NN insulin) (, ,) (NN total)\n",
      "                                  (CC and)\n",
      "                                  (JJ active) (JJ GLP-1) (NNS excursions)))\n",
      "                              (VP (VBN calculated)))))))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "case(study-4, In-1)\n",
      "det(study-4, a-2)\n",
      "amod(study-4, randomized-3)\n",
      "nmod:in(aged-20, study-4)\n",
      "case(design-8, with-5)\n",
      "det(design-8, a-6)\n",
      "compound(design-8, crossover-7)\n",
      "nmod:with(study-4, design-8)\n",
      "amod(patients-11, T2D-10)\n",
      "nsubj(aged-20, patients-11)\n",
      "compound(=-14, n-13)\n",
      "dep(patients-11, =-14)\n",
      "nummod(=-14, 10-15)\n",
      "nummod(men-18, 6-17)\n",
      "appos(=-14, men-18)\n",
      "root(ROOT-0, aged-20)\n",
      "compound(5.8-22, 65.1-21)\n",
      "dobj(aged-20, 5.8-22)\n",
      "case(hemoglobin-26, with-24)\n",
      "amod(hemoglobin-26, glycosylated-25)\n",
      "nmod:with(aged-20, hemoglobin-26)\n",
      "appos(hemoglobin-26, HbA1c-28)\n",
      "nummod(%-31, 6.6-30)\n",
      "amod(hemoglobin-26, %-31)\n",
      "nummod(%-33, 0.7-32)\n",
      "dep(%-31, %-33)\n",
      "compound(8-36, 48-35)\n",
      "nummod(mmol/mol-37, 8-36)\n",
      "dep(%-31, mmol/mol-37)\n",
      "acl(hemoglobin-26, received-40)\n",
      "amod(L-glutamine-42, oral-41)\n",
      "nsubj(followed-56, L-glutamine-42)\n",
      "compound(g-45, 25-44)\n",
      "dep(L-glutamine-42, g-45)\n",
      "appos(L-glutamine-42, protein-48)\n",
      "compound(g-51, 25-50)\n",
      "dep(protein-48, g-51)\n",
      "cc(protein-48, or-53)\n",
      "appos(L-glutamine-42, water-54)\n",
      "conj:or(protein-48, water-54)\n",
      "ccomp(received-40, followed-56)\n",
      "case(bolus-61, by-57)\n",
      "det(bolus-61, an-58)\n",
      "amod(bolus-61, intravenous-59)\n",
      "compound(bolus-61, glucose-60)\n",
      "nmod:by(followed-56, bolus-61)\n",
      "nummod(g/kg-64, 0.3-63)\n",
      "appos(bolus-61, g/kg-64)\n",
      "cc(bolus-61, and-66)\n",
      "amod(clamp-69, hyperglycemic-67)\n",
      "compound(clamp-69, glucose-68)\n",
      "nmod:by(followed-56, clamp-69)\n",
      "conj:and(bolus-61, clamp-69)\n",
      "mark(collected-76, for-70)\n",
      "nummod(Blood-73, 2-71)\n",
      "compound(Blood-73, h.-72)\n",
      "nsubjpass(collected-76, Blood-73)\n",
      "auxpass(collected-76, was-74)\n",
      "advmod(collected-76, frequently-75)\n",
      "advcl(followed-56, collected-76)\n",
      "case(analyses-78, for-77)\n",
      "nmod:for(collected-76, analyses-78)\n",
      "case(insulin-83, of-79)\n",
      "compound(insulin-83, glucose-80)\n",
      "dep(insulin-83, serum-82)\n",
      "nmod:of(analyses-78, insulin-83)\n",
      "cc(insulin-83, and-84)\n",
      "compound(total-86, plasma-85)\n",
      "nmod:of(analyses-78, total-86)\n",
      "conj:and(insulin-83, total-86)\n",
      "cc(insulin-83, and-87)\n",
      "amod(GLP-1-89, active-88)\n",
      "nmod:of(analyses-78, GLP-1-89)\n",
      "conj:and(insulin-83, GLP-1-89)\n",
      "cc(insulin-83, and-90)\n",
      "nmod:of(analyses-78, area-91)\n",
      "conj:and(insulin-83, area-91)\n",
      "case(curve-94, under-92)\n",
      "det(curve-94, the-93)\n",
      "nmod:under(collected-76, curve-94)\n",
      "case(excursions-104, of-95)\n",
      "compound(total-100, glucose-96)\n",
      "conj:and(total-100, insulin-98)\n",
      "compound(excursions-104, insulin-98)\n",
      "compound(excursions-104, total-100)\n",
      "cc(total-100, and-101)\n",
      "conj:and(total-100, active-102)\n",
      "compound(excursions-104, active-102)\n",
      "amod(excursions-104, GLP-1-103)\n",
      "nmod:of(curve-94, excursions-104)\n",
      "acl(curve-94, calculated-105)\n",
      "\n",
      "Parsing [sent. 10 len. 14]: Total GLP-1 was increased by both L-glutamine and protein -LRB- p 0.02 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ Total) (NNS GLP-1))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (DT both) (NN L-glutamine)\n",
      "              (CC and)\n",
      "              (NN protein))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p) (CD 0.02))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(GLP-1-2, Total-1)\n",
      "nsubjpass(increased-4, GLP-1-2)\n",
      "auxpass(increased-4, was-3)\n",
      "root(ROOT-0, increased-4)\n",
      "case(L-glutamine-7, by-5)\n",
      "cc:preconj(L-glutamine-7, both-6)\n",
      "nmod:by(increased-4, L-glutamine-7)\n",
      "cc(L-glutamine-7, and-8)\n",
      "nmod:by(increased-4, protein-9)\n",
      "conj:and(L-glutamine-7, protein-9)\n",
      "appos(L-glutamine-7, p-11)\n",
      "nummod(p-11, 0.02-12)\n",
      "\n",
      "Parsing [sent. 11 len. 14]: L-glutamine is an efficacious glucagon-like peptide -LRB- GLP -RRB- -1 secretagogue in vitro .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP L-glutamine))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an)\n",
      "          (ADJP (JJ efficacious) (JJ glucagon-like))\n",
      "          (NNP peptide)\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NNP GLP))\n",
      "            (-RRB- -RRB-))\n",
      "          (JJ -1) (NN secretagogue))\n",
      "        (PP (IN in)\n",
      "          (NP (NNP vitro)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(secretagogue-11, L-glutamine-1)\n",
      "cop(secretagogue-11, is-2)\n",
      "det(secretagogue-11, an-3)\n",
      "amod(glucagon-like-5, efficacious-4)\n",
      "amod(secretagogue-11, glucagon-like-5)\n",
      "compound(secretagogue-11, peptide-6)\n",
      "appos(secretagogue-11, GLP-8)\n",
      "amod(secretagogue-11, -1-10)\n",
      "root(ROOT-0, secretagogue-11)\n",
      "case(vitro-13, in-12)\n",
      "nmod:in(secretagogue-11, vitro-13)\n",
      "\n",
      "Parsing [sent. 12 len. 63]: The plasma glucagon-like peptide-1 concentration in a mesenteric vein draining only the looped region of the intestine was increased after infusion of 139 mmol/l solutions of D-glucose , D-galactose , D-glucuronic acid , 3-0-methyl-D-glucose , maltose , sucrose or maltitol into the intestinal lumen , but not after infusion of solutions of D-fructose , D-fucose , D-mannose , D-xylose or lactose . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (JJ plasma) (JJ glucagon-like) (JJ peptide-1) (NN concentration))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ mesenteric) (NN vein))\n",
      "          (VP (VBG draining)\n",
      "            (NP\n",
      "              (NP (RB only) (DT the) (JJ looped) (NN region))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN intestine))))))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN after)\n",
      "          (NP\n",
      "            (NP (NN infusion))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (CD 139) (JJ mmol/l) (NNS solutions))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ D-glucose) (, ,) (JJ D-galactose) (, ,) (JJ D-glucuronic) (NN acid)))\n",
      "                (, ,)\n",
      "                (ADJP (JJ 3-0-methyl-D-glucose) (, ,) (JJ maltose) (, ,) (JJ sucrose)\n",
      "                  (CC or)\n",
      "                  (JJ maltitol))))))\n",
      "        (PP\n",
      "          (PP (IN into)\n",
      "            (NP (DT the) (JJ intestinal) (NN lumen)))\n",
      "          (, ,)\n",
      "          (CC but)\n",
      "          (RB not)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (NN infusion))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NNS solutions))\n",
      "                  (PP (IN of)\n",
      "                    (ADJP (JJ D-fructose) (, ,) (JJ D-fucose) (, ,) (JJ D-mannose) (, ,) (JJ D-xylose)\n",
      "                      (CC or)\n",
      "                      (JJ lactose))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "det(concentration-5, The-1)\n",
      "amod(concentration-5, plasma-2)\n",
      "amod(concentration-5, glucagon-like-3)\n",
      "amod(concentration-5, peptide-1-4)\n",
      "nsubjpass(increased-19, concentration-5)\n",
      "nsubjpass(increased-19', concentration-5)\n",
      "case(vein-9, in-6)\n",
      "det(vein-9, a-7)\n",
      "amod(vein-9, mesenteric-8)\n",
      "nmod:in(concentration-5, vein-9)\n",
      "acl(vein-9, draining-10)\n",
      "advmod(region-14, only-11)\n",
      "det(region-14, the-12)\n",
      "amod(region-14, looped-13)\n",
      "dobj(draining-10, region-14)\n",
      "case(intestine-17, of-15)\n",
      "det(intestine-17, the-16)\n",
      "nmod:of(region-14, intestine-17)\n",
      "auxpass(increased-19, was-18)\n",
      "root(ROOT-0, increased-19)\n",
      "conj:but(increased-19, increased-19')\n",
      "case(infusion-21, after-20)\n",
      "nmod:after(increased-19, infusion-21)\n",
      "case(solutions-25, of-22)\n",
      "nummod(solutions-25, 139-23)\n",
      "amod(solutions-25, mmol/l-24)\n",
      "nmod:of(infusion-21, solutions-25)\n",
      "case(acid-32, of-26)\n",
      "amod(acid-32, D-glucose-27)\n",
      "amod(acid-32, D-galactose-29)\n",
      "amod(acid-32, D-glucuronic-31)\n",
      "nmod:of(solutions-25, acid-32)\n",
      "amod(solutions-25, 3-0-methyl-D-glucose-34)\n",
      "amod(solutions-25, maltose-36)\n",
      "conj:or(3-0-methyl-D-glucose-34, maltose-36)\n",
      "amod(solutions-25, sucrose-38)\n",
      "conj:or(3-0-methyl-D-glucose-34, sucrose-38)\n",
      "cc(3-0-methyl-D-glucose-34, or-39)\n",
      "amod(solutions-25, maltitol-40)\n",
      "conj:or(3-0-methyl-D-glucose-34, maltitol-40)\n",
      "case(lumen-44, into-41)\n",
      "det(lumen-44, the-42)\n",
      "amod(lumen-44, intestinal-43)\n",
      "nmod:into(increased-19, lumen-44)\n",
      "cc(increased-19, but-46)\n",
      "neg(infusion-49, not-47)\n",
      "case(infusion-49, after-48)\n",
      "nmod:after(increased-19', infusion-49)\n",
      "case(solutions-51, of-50)\n",
      "nmod:of(infusion-49, solutions-51)\n",
      "case(D-fructose-53, of-52)\n",
      "acl(solutions-51, D-fructose-53)\n",
      "acl(solutions-51, D-fucose-55)\n",
      "conj:or(D-fructose-53, D-fucose-55)\n",
      "acl(solutions-51, D-mannose-57)\n",
      "conj:or(D-fructose-53, D-mannose-57)\n",
      "acl(solutions-51, D-xylose-59)\n",
      "conj:or(D-fructose-53, D-xylose-59)\n",
      "cc(D-fructose-53, or-60)\n",
      "acl(solutions-51, lactose-61)\n",
      "conj:or(D-fructose-53, lactose-61)\n",
      "\n",
      "Parsing [sent. 13 len. 27]: In insulin-sensitive tissues , procyanidins modulate glucose uptake and lipogenesis and improve their oxidative/inflammatory state , the disruption of which is important in T2DM development . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (JJ insulin-sensitive) (NNS tissues)))\n",
      "    (, ,)\n",
      "    (NP (NNS procyanidins))\n",
      "    (VP\n",
      "      (VP (VBP modulate)\n",
      "        (NP\n",
      "          (NP (NN glucose) (NN uptake))\n",
      "          (CC and)\n",
      "          (NP (NNS lipogenesis))))\n",
      "      (CC and)\n",
      "      (VP (VB improve)\n",
      "        (NP\n",
      "          (NP (PRP$ their) (JJ oxidative/inflammatory) (NN state))\n",
      "          (, ,)\n",
      "          (SBAR\n",
      "            (WHNP\n",
      "              (NP (DT the) (NN disruption))\n",
      "              (WHPP (IN of)\n",
      "                (WHNP (WDT which))))\n",
      "            (S\n",
      "              (VP (VBZ is)\n",
      "                (ADJP (JJ important)\n",
      "                  (PP (IN in)\n",
      "                    (NP (JJ T2DM) (NN development))))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "case(tissues-3, In-1)\n",
      "amod(tissues-3, insulin-sensitive-2)\n",
      "nmod:in(modulate-6, tissues-3)\n",
      "nsubj(modulate-6, procyanidins-5)\n",
      "nsubj(improve-12, procyanidins-5)\n",
      "root(ROOT-0, modulate-6)\n",
      "compound(uptake-8, glucose-7)\n",
      "dobj(modulate-6, uptake-8)\n",
      "cc(uptake-8, and-9)\n",
      "dobj(modulate-6, lipogenesis-10)\n",
      "conj:and(uptake-8, lipogenesis-10)\n",
      "cc(modulate-6, and-11)\n",
      "conj:and(modulate-6, improve-12)\n",
      "nmod:poss(state-15, their-13)\n",
      "amod(state-15, oxidative/inflammatory-14)\n",
      "dobj(improve-12, state-15)\n",
      "nmod:of(disruption-18, state-15)\n",
      "det(disruption-18, the-17)\n",
      "nsubj(important-22, disruption-18)\n",
      "case(which-20, of-19)\n",
      "ref(state-15, which-20)\n",
      "cop(important-22, is-21)\n",
      "acl:relcl(state-15, important-22)\n",
      "case(development-25, in-23)\n",
      "amod(development-25, T2DM-24)\n",
      "nmod:in(important-22, development-25)\n",
      "\n",
      "Parsing [sent. 14 len. 35]: Grape-seed procyanidin extracts -LRB- GSPE -RRB- modulate glucose homeostasis , and it was suggested that GSPE may achieve this by enhancing the secretion of incretin hormones such as glucagon-like peptide-1 -LRB- GLP-1 -RRB- . ''\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (JJ Grape-seed) (NN procyanidin) (NNS extracts))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNP GSPE))\n",
      "          (-RRB- -RRB-)))\n",
      "      (VP (VBP modulate)\n",
      "        (NP (NN glucose) (NNS homeostasis))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN suggested)\n",
      "          (SBAR (IN that)\n",
      "            (S\n",
      "              (NP (NNP GSPE))\n",
      "              (VP (MD may)\n",
      "                (VP (VB achieve)\n",
      "                  (NP (DT this))\n",
      "                  (PP (IN by)\n",
      "                    (S\n",
      "                      (VP (VBG enhancing)\n",
      "                        (NP\n",
      "                          (NP (DT the) (NN secretion))\n",
      "                          (PP (IN of)\n",
      "                            (NP\n",
      "                              (NP (JJ incretin) (NNS hormones))\n",
      "                              (PP (JJ such) (IN as)\n",
      "                                (NP (JJ glucagon-like) (NN peptide-1)))))))))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (ADJP (JJ GLP-1))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .) ('' '')))\n",
      "\n",
      "amod(extracts-3, Grape-seed-1)\n",
      "compound(extracts-3, procyanidin-2)\n",
      "nsubj(modulate-7, extracts-3)\n",
      "appos(extracts-3, GSPE-5)\n",
      "root(ROOT-0, modulate-7)\n",
      "compound(homeostasis-9, glucose-8)\n",
      "dobj(modulate-7, homeostasis-9)\n",
      "cc(modulate-7, and-11)\n",
      "nsubjpass(suggested-14, it-12)\n",
      "auxpass(suggested-14, was-13)\n",
      "conj:and(modulate-7, suggested-14)\n",
      "mark(achieve-18, that-15)\n",
      "nsubj(achieve-18, GSPE-16)\n",
      "aux(achieve-18, may-17)\n",
      "ccomp(suggested-14, achieve-18)\n",
      "dobj(achieve-18, this-19)\n",
      "mark(enhancing-21, by-20)\n",
      "advcl(achieve-18, enhancing-21)\n",
      "det(secretion-23, the-22)\n",
      "dobj(enhancing-21, secretion-23)\n",
      "case(hormones-26, of-24)\n",
      "amod(hormones-26, incretin-25)\n",
      "nmod:of(secretion-23, hormones-26)\n",
      "case(peptide-1-30, such-27)\n",
      "mwe(such-27, as-28)\n",
      "amod(peptide-1-30, glucagon-like-29)\n",
      "nmod:such_as(hormones-26, peptide-1-30)\n",
      "dep(achieve-18, GLP-1-32)\n",
      "\n",
      "Parsing [sent. 15 len. 314]: This issue focuses on the following selection of drugs : ABI-007 , adalimumab , adefovir dipivoxil , alefacept , alemtuzumab , 3-AP , AP-12009 , APC-8015 , L-Arginine hydrochloride , aripiprazole , arundic acid , avasimibe ; Bevacizumab , bivatuzumab , BMS-181176 , BMS-184476 , BMS-188797 , bortezomib , bosentan , botulinum toxin type B , BQ-123 , BRL-55730 , bryostatin 1 ; CEP-1347 , cetuximab , cinacalcet hydrochloride , CP-461 , CpG-7909 ; D-003 , dabuzalgron hydrochloride , darbepoetin alfa , desloratadine , desoxyepothilone B , dexmethylphenidate hydrochloride , DHA-paclitaxel , diflomotecan , DN-101 , DP-b99 , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride , duramycin ; Eculizumab , Efalizumab , EKB-569 , elcometrine , enfuvirtide , eplerenone , erlotinib hydrochloride , ertapenem sodium , eszopiclone , everolimus , exatecan mesilate , ezetimibe ; Fenretinide , fosamprenavir calcium , frovatriptan ; GD2L-KLH conjugate vaccine , gefitinib , glufosfamide , GTI-2040 ; Hexyl insulin M2 , human insulin , hydroquinone , gamma-Hydroxybutyrate sodium ; IL-4 -LRB- 38-37 -RRB- - PE38KDEL , imatinib mesylate , indisulam , inhaled insulin , ixabepilone ; KRN-5500 ; LY-544344 ; MDX-210 , melatonin , mepolizumab , motexafin gadolinium ; Natalizumab , NSC-330507 , NSC-683864 ; 1-Octanol , omalizumab , ortataxel ; Pagoclone , peginterferon alfa-2a , peginterferon alfa-2b , pemetrexed disodium , phenoxodiol , pimecrolimus , plevitrexed , polyphenon E , pramlintide acetate , prasterone , pregabalin , PX-12 ; QS-21 ; Ragaglitazar , ranelic acid distrontium salt , RDP-58 , recombinant glucagon-like peptide-1 -LRB- 7-36 -RRB- amide , repinotan hydrochloride , rhEndostatin , rh-Lactoferrin , -LRB- R -RRB- - roscovitine ; S-8184 , semaxanib , sitafloxacin hydrate , sitaxsentan sodium , sorafenib , synthadotin ; Tadalafil , tesmilifene hydrochloride , theratope , tipifarnib , tirapazamine , topixantrone hydrochloride , trabectedin , traxoprodil , Tri-Luma ; Valdecoxib , valganciclovir hydrochloride , vinflunine ; Ximelagatran ; Ziconotide . ''\n",
      "\n",
      "*******************************************************\n",
      "***  WARNING!! OUT OF MEMORY! THERE WAS NOT ENOUGH  ***\n",
      "***  MEMORY TO RUN ALL PARSERS.  EITHER GIVE THE    ***\n",
      "***  JVM MORE MEMORY, SET THE MAXIMUM SENTENCE      ***\n",
      "***  LENGTH WITH -maxLength, OR PERHAPS YOU ARE     ***\n",
      "***  HAPPY TO HAVE THE PARSER FALL BACK TO USING    ***\n",
      "***  A SIMPLER PARSER FOR VERY LONG SENTENCES.      ***\n",
      "*******************************************************\n",
      "\n",
      "Sentence has no parse using PCFG grammar (or no PCFG fallback).  Skipping...\n",
      "Exception in thread \"main\" edu.stanford.nlp.parser.common.NoSuchParseException\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParserQuery.getBestParse(LexicalizedParserQuery.java:404)\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParserQuery.getBestParse(LexicalizedParserQuery.java:376)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.processResults(ParseFiles.java:272)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.parseFiles(ParseFiles.java:216)\n",
      "\tat edu.stanford.nlp.parser.lexparser.ParseFiles.parseFiles(ParseFiles.java:75)\n",
      "\tat edu.stanford.nlp.parser.lexparser.LexicalizedParser.main(LexicalizedParser.java:1517)\n",
      "1 loop, best of 3: 39.2 s per loop\n"
     ]
    }
   ],
   "source": [
    "%%timeit\n",
    "! ./lexparser_caseless.sh  sent_files/ssa_glp.txt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Command Line Sentiment Analysis\n",
    "\n",
    "This creates an output file with tuples and sentiments!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator tokenize\n",
      "[main] INFO edu.stanford.nlp.pipeline.TokenizerAnnotator - No tokenizer type provided. Defaulting to PTBTokenizer.\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator ssplit\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator pos\n",
      "[main] INFO edu.stanford.nlp.tagger.maxent.MaxentTagger - Loading POS tagger from edu/stanford/nlp/models/pos-tagger/english-left3words/english-left3words-distsim.tagger ... done [1.6 sec].\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator lemma\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator ner\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.all.3class.distsim.crf.ser.gz ... done [2.7 sec].\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.muc.7class.distsim.crf.ser.gz ... done [2.8 sec].\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.conll.4class.distsim.crf.ser.gz ... done [1.2 sec].\n",
      "[main] INFO edu.stanford.nlp.time.JollyDayHolidays - Initializing JollyDayHoliday for SUTime from classpath edu/stanford/nlp/models/sutime/jollyday/Holidays_sutime.xml as sutime.binder.1.\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator parse\n",
      "[main] INFO edu.stanford.nlp.parser.common.ParserGrammar - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [3.1 sec].\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator dcoref\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator sentiment\n",
      "\n",
      "Processing file /Users/lisabarcelo/Desktop/W266/food_drug_interaction/parsing/sent_files/ssa_glp.txt ... writing to /Users/lisabarcelo/Desktop/W266/food_drug_interaction/parsing/ssa_glp.txt.out\n",
      "Parsing of sentence failed, possibly because of out of memory.  Will ignore and continue: This issue focuses on the following selection of drugs : ABI 007 , adalimumab , adefovir dipivoxil , alefacept , alemtuzumab , 3 AP , AP 12009 , APC 8015 , L Arginine hydrochloride , aripiprazole , arundic acid , avasimibe Bevacizumab , bivatuzumab , BMS 181176 , BMS 184476 , BMS 188797 , bortezomib , bosentan , botulinum toxin type B , BQ 123 , BRL 55730 , bryostatin 1 CEP 1347 , cetuximab , cinacalcet hydrochloride , CP 461 , CpG 7909 D 003 , dabuzalgron hydrochloride , darbepoetin alfa , desloratadine , desoxyepothilone B , dexmethylphenidate hydrochloride , DHA paclitaxel , diflomotecan , DN 101 , DP b99 , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride , duramycin Eculizumab , Efalizumab , EKB 569 , elcometrine , enfuvirtide , eplerenone , erlotinib hydrochloride , ertapenem sodium , eszopiclone , everolimus , exatecan mesilate , ezetimibe Fenretinide , fosamprenavir calcium , frovatriptan GD2L KLH conjugate vaccine , gefitinib , glufosfamide , GTI 2040 Hexyl insulin M2 , human insulin , hydroquinone , gamma Hydroxybutyrate sodium IL 4 -LRB- 38 37 -RRB- PE38KDEL , imatinib mesylate , indisulam , inhaled insulin , ixabepilone KRN 5500 LY 544344 MDX 210 , melatonin , mepolizumab , motexafin gadolinium Natalizumab , NSC 330507 , NSC 683864 1 Octanol , omalizumab , ortataxel Pagoclone , peginterferon alfa 2a , peginterferon alfa 2b , pemetrexed disodium , phenoxodiol , pimecrolimus , plevitrexed , polyphenon E , pramlintide acetate , prasterone , pregabalin , PX 12 QS 21 Ragaglitazar , ranelic acid distrontium salt , RDP 58 , recombinant glucagon like peptide 1 -LRB- 7 36 -RRB- amide , repinotan hydrochloride , rhEndostatin , rh Lactoferrin , -LRB- R -RRB- roscovitine S 8184 , semaxanib , sitafloxacin hydrate , sitaxsentan sodium , sorafenib , synthadotin Tadalafil , tesmilifene hydrochloride , theratope , tipifarnib , tirapazamine , topixantrone hydrochloride , trabectedin , traxoprodil , Tri Luma Valdecoxib , valganciclovir hydrochloride , vinflunine Ximelagatran Ziconotide . ''\n",
      "Parsing of sentence failed, possibly because of out of memory.  Will ignore and continue: This issue focuses on the following selection of drugs : Abetimus sodium , Ad5 FGF4 , adeno Interferon gamma , AE 941 , AERx , alemtuzumab , alicaforsen sodium , almotriptan , alpharadin , anakinra , anatumomab mafenatox , ANG 453 , anti CTLA 4 Mab , AP 12009 , aprepitant , aripiprazole , arsenic trioxide , astemizole , atlizumab , atomoxetine hydrochloride Bevacizumab , BG 9928 , BMS 188667 , botulinum toxin type B , BufferGel Caffeine , CDP 870 , cetuximab , cilomilast , ciluprevir , clofarabine , continuous erythropoiesis receptor activator , CP 461 Darbepoetin alfa , deferasirox , desloratadine , desoxyepothilone B , diflomotecan , dolasetron , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride ED 71 , efalizumab , efaproxiral sodium , EKB 569 , eletriptan , EMD 72000 , enfuvirtide , erlotinib hydrochloride , escitalopram oxalate , etoricoxib Fampridine , ferumoxytol , fondaparinux sodium Gadofosveset sodium , gastrazole , gefitinib , gemtuzumab ozogamicin , gepirone hydrochloride glutamine hLM609 , HSPPC 96 , human insulin IDD 1 , imatinib mesylate , indisulam , inhaled insulin , ixabepilone Keratinocyte growth factor Lapatinib , laquinimod , LDP 02 , LE SN38 , levetiracetam , levosimendan , licofelone , liposomal doxorubicin , liposomal NDDP , lopinavir , lumiracoxib , LY 156735 Morphine hydrochloride , morphine 6 glucuronide , motexafin gadolinium , MS 27 275 , MVA 5T4 , MVA Muc1 IL 2 Nemifitide ditriflutate , neridronic acid nitronaproxen , NSC 683864 , NSC 703940 , NVP LAF 237 Oblimersen sodium , ocinaplon , oncomyc NG , OPC 28326 , ortataxel , ospemifene Palonosetron hydrochloride , PEG filgrastim peginterferon alfa 2 -LRB- a -RRB- , peginterferon alfa 2b , pegsunercept , pemetrexed disodium , pregabalin , prilocaine , pyridoxamine RDP 58 , recombinant glucagon like peptide 1 -LRB- 7 36 -RRB- amide , recombinant human ApoA I milano/phospholipid complex SB 715992 , soblidotin , sodium dichloroacetate , St. John 's Wort extract TAS 102 , terfenadine , TG 1024 , TG 5001 , 4 ' Thio ara C , tipranavir , topixantrone hydrochloride , trabectedin , transdermal selegiline , trimethoprim , troxacitabine , TT 232 Vatalanib succinate , vinflunine Ximelagatran Ziprasidone hydrochloride , Zoledronic acid monohydrate . ''\n",
      "Parsing of sentence failed, possibly because of out of memory.  Will ignore and continue: This issue focuses on the following selection of drugs : ABI 007 , adalimumab , adefovir dipivoxil , alefacept , alemtuzumab , 3 AP , AP 12009 , APC 8015 , L Arginine hydrochloride , aripiprazole , arundic acid , avasimibe Bevacizumab , bivatuzumab , BMS 181176 , BMS 184476 , BMS 188797 , bortezomib , bosentan , botulinum toxin type B , BQ 123 , BRL 55730 , bryostatin 1 CEP 1347 , cetuximab , cinacalcet hydrochloride , CP 461 , CpG 7909 D 003 , dabuzalgron hydrochloride , darbepoetin alfa , desloratadine , desoxyepothilone B , dexmethylphenidate hydrochloride , DHA paclitaxel , diflomotecan , DN 101 , DP b99 , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride , duramycin Eculizumab , Efalizumab , EKB 569 , elcometrine , enfuvirtide , eplerenone , erlotinib hydrochloride , ertapenem sodium , eszopiclone , everolimus , exatecan mesilate , ezetimibe Fenretinide , fosamprenavir calcium , frovatriptan GD2L KLH conjugate vaccine , gefitinib , glufosfamide , GTI 2040 Hexyl insulin M2 , human insulin , hydroquinone , gamma Hydroxybutyrate sodium IL 4 -LRB- 38 37 -RRB- PE38KDEL , imatinib mesylate , indisulam , inhaled insulin , ixabepilone KRN 5500 LY 544344 MDX 210 , melatonin , mepolizumab , motexafin gadolinium Natalizumab , NSC 330507 , NSC 683864 1 Octanol , omalizumab , ortataxel Pagoclone , peginterferon alfa 2a , peginterferon alfa 2b , pemetrexed disodium , phenoxodiol , pimecrolimus , plevitrexed , polyphenon E , pramlintide acetate , prasterone , pregabalin , PX 12 QS 21 Ragaglitazar , ranelic acid distrontium salt , RDP 58 , recombinant glucagon like peptide 1 -LRB- 7 36 -RRB- amide , repinotan hydrochloride , rhEndostatin , rh Lactoferrin , -LRB- R -RRB- roscovitine S 8184 , semaxanib , sitafloxacin hydrate , sitaxsentan sodium , sorafenib , synthadotin Tadalafil , tesmilifene hydrochloride , theratope , tipifarnib , tirapazamine , topixantrone hydrochloride , trabectedin , traxoprodil , Tri Luma Valdecoxib , valganciclovir hydrochloride , vinflunine Ximelagatran Ziconotide . ''\n",
      "Parsing of sentence failed, possibly because of out of memory.  Will ignore and continue: This issue focuses on the following selection of drugs : Abetimus sodium , Ad5 FGF4 , adeno Interferon gamma , AE 941 , AERx , alemtuzumab , alicaforsen sodium , almotriptan , alpharadin , anakinra , anatumomab mafenatox , ANG 453 , anti CTLA 4 Mab , AP 12009 , aprepitant , aripiprazole , arsenic trioxide , astemizole , atlizumab , atomoxetine hydrochloride Bevacizumab , BG 9928 , BMS 188667 , botulinum toxin type B , BufferGel Caffeine , CDP 870 , cetuximab , cilomilast , ciluprevir , clofarabine , continuous erythropoiesis receptor activator , CP 461 Darbepoetin alfa , deferasirox , desloratadine , desoxyepothilone B , diflomotecan , dolasetron , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride ED 71 , efalizumab , efaproxiral sodium , EKB 569 , eletriptan , EMD 72000 , enfuvirtide , erlotinib hydrochloride , escitalopram oxalate , etoricoxib Fampridine , ferumoxytol , fondaparinux sodium Gadofosveset sodium , gastrazole , gefitinib , gemtuzumab ozogamicin , gepirone hydrochloride glutamine hLM609 , HSPPC 96 , human insulin IDD 1 , imatinib mesylate , indisulam , inhaled insulin , ixabepilone Keratinocyte growth factor Lapatinib , laquinimod , LDP 02 , LE SN38 , levetiracetam , levosimendan , licofelone , liposomal doxorubicin , liposomal NDDP , lopinavir , lumiracoxib , LY 156735 Morphine hydrochloride , morphine 6 glucuronide , motexafin gadolinium , MS 27 275 , MVA 5T4 , MVA Muc1 IL 2 Nemifitide ditriflutate , neridronic acid nitronaproxen , NSC 683864 , NSC 703940 , NVP LAF 237 Oblimersen sodium , ocinaplon , oncomyc NG , OPC 28326 , ortataxel , ospemifene Palonosetron hydrochloride , PEG filgrastim peginterferon alfa 2 -LRB- a -RRB- , peginterferon alfa 2b , pegsunercept , pemetrexed disodium , pregabalin , prilocaine , pyridoxamine RDP 58 , recombinant glucagon like peptide 1 -LRB- 7 36 -RRB- amide , recombinant human ApoA I milano/phospholipid complex SB 715992 , soblidotin , sodium dichloroacetate , St. John 's Wort extract TAS 102 , terfenadine , TG 1024 , TG 5001 , 4 ' Thio ara C , tipranavir , topixantrone hydrochloride , trabectedin , transdermal selegiline , trimethoprim , troxacitabine , TT 232 Vatalanib succinate , vinflunine Ximelagatran Ziprasidone hydrochloride , Zoledronic acid monohydrate . ''\n",
      "Parsing of sentence failed, possibly because of out of memory.  Will ignore and continue: Investigational antiobesity agents consist of 1 -RRB- central nervous system agents that affect neurotransmitters or neural ion channels , including antidepressants -LRB- bupropion -RRB- , selective serotonin 2c receptor agonists , antiseizure agents -LRB- topiramate , zonisamide -RRB- , some dopamine antagonists , and cannabinoid 1 receptor antagonists -LRB- rimonabant -RRB- 2 -RRB- leptin/insulin/central nervous system pathway agents , including leptin analogues , leptin transport and/or leptin receptor promoters , ciliary neurotrophic factor -LRB- Axokine -RRB- , neuropeptide Y and agouti related peptide antagonists , proopiomelanocortin and cocaine and amphetamine regulated transcript promoters , alpha melanocyte stimulating hormone analogues , melanocortin 4 receptor agonists , and agents that affect insulin metabolism/activity , which include protein tyrosine phosphatase 1B inhibitors , peroxisome proliferator activated receptor gamma receptor antagonists , short acting bromocriptine -LRB- ergoset -RRB- , somatostatin agonists -LRB- octreotide -RRB- , and adiponectin 3 -RRB- gastrointestinal neural pathway agents , including those that increase cholecystokinin activity , increase glucagon like peptide 1 activity -LRB- extendin 4 , liraglutide , dipeptidyl peptidase IV inhibitors -RRB- , and increase protein YY3 36 activity and those that decrease ghrelin activity , as well as amylin analogues -LRB- pramlintide -RRB- 4 -RRB- agents that may increase resting metabolic rate -LRB- '' `` selective '' '' beta 3 stimulators/agonist , uncoupling protein homologues , and thyroid receptor agonists -RRB- and 5 -RRB- other more diverse agents , including melanin concentrating hormone antagonists , phytostanol analogues , functional oils , P57 , amylase inhibitors , growth hormone fragments , synthetic analogues of dehydroepiandrosterone sulfate , antagonists of adipocyte 11B hydroxysteroid dehydrogenase type 1 activity , corticotropin releasing hormone agonists , inhibitors of fatty acid synthesis , carboxypeptidase inhibitors , indanones/indanols , aminosterols , and other gastrointestinal lipase inhibitors -LRB- ATL962 -RRB- . ''\n",
      "Parsing of sentence failed, possibly because of out of memory.  Will ignore and continue: This issue focuses on the following selection of drugs : Abetimus sodium , Ad5 FGF4 , adeno Interferon gamma , AE 941 , AERx , alemtuzumab , alicaforsen sodium , almotriptan , alpharadin , anakinra , anatumomab mafenatox , ANG 453 , anti CTLA 4 Mab , AP 12009 , aprepitant , aripiprazole , arsenic trioxide , astemizole , atlizumab , atomoxetine hydrochloride Bevacizumab , BG 9928 , BMS 188667 , botulinum toxin type B , BufferGel Caffeine , CDP 870 , cetuximab , cilomilast , ciluprevir , clofarabine , continuous erythropoiesis receptor activator , CP 461 Darbepoetin alfa , deferasirox , desloratadine , desoxyepothilone B , diflomotecan , dolasetron , drotrecogin alfa -LRB- activated -RRB- , duloxetine hydrochloride ED 71 , efalizumab , efaproxiral sodium , EKB 569 , eletriptan , EMD 72000 , enfuvirtide , erlotinib hydrochloride , escitalopram oxalate , etoricoxib Fampridine , ferumoxytol , fondaparinux sodium Gadofosveset sodium , gastrazole , gefitinib , gemtuzumab ozogamicin , gepirone hydrochloride glutamine hLM609 , HSPPC 96 , human insulin IDD 1 , imatinib mesylate , indisulam , inhaled insulin , ixabepilone Keratinocyte growth factor Lapatinib , laquinimod , LDP 02 , LE SN38 , levetiracetam , levosimendan , licofelone , liposomal doxorubicin , liposomal NDDP , lopinavir , lumiracoxib , LY 156735 Morphine hydrochloride , morphine 6 glucuronide , motexafin gadolinium , MS 27 275 , MVA 5T4 , MVA Muc1 IL 2 Nemifitide ditriflutate , neridronic acid nitronaproxen , NSC 683864 , NSC 703940 , NVP LAF 237 Oblimersen sodium , ocinaplon , oncomyc NG , OPC 28326 , ortataxel , ospemifene Palonosetron hydrochloride , PEG filgrastim peginterferon alfa 2 -LRB- a -RRB- , peginterferon alfa 2b , pegsunercept , pemetrexed disodium , pregabalin , prilocaine , pyridoxamine RDP 58 , recombinant glucagon like peptide 1 -LRB- 7 36 -RRB- amide , recombinant human ApoA I milano/phospholipid complex SB 715992 , soblidotin , sodium dichloroacetate , St. John 's Wort extract TAS 102 , terfenadine , TG 1024 , TG 5001 , 4 ' Thio ara C , tipranavir , topixantrone hydrochloride , trabectedin , transdermal selegiline , trimethoprim , troxacitabine , TT 232 Vatalanib succinate , vinflunine Ximelagatran Ziprasidone hydrochloride , Zoledronic acid monohydrate . ''\n",
      "^C\n"
     ]
    }
   ],
   "source": [
    "!java -cp \"*\" -Xmx2g edu.stanford.nlp.pipeline.StanfordCoreNLP \\\n",
    "-annotators tokenize,ssplit,pos,lemma,ner,parse,dcoref,sentiment \\\n",
    "-file sent_files/ssa_glp.txt \\\n",
    "-outputFormat text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "cat: parsing/ssa_glp.txt.out: No such file or directory\r\n"
     ]
    }
   ],
   "source": [
    "!cat parsing/ssa_glp.txt.out > sent_files/output_file.json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sentence #1 (42 tokens, sentiment: Negative):\r\n",
      "clinically stable patients who underwent des implantation 12 months previously and received aspirin monotherapy were randomly assigned to receive either high-intensity (40mg atorvastatin, n = 1000) or low-intensity (20mg pravastatin, n = 1000) statin treatment.\r\n",
      "[Text=clinically CharacterOffsetBegin=0 CharacterOffsetEnd=10 PartOfSpeech=RB Lemma=clinically NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=stable CharacterOffsetBegin=11 CharacterOffsetEnd=17 PartOfSpeech=JJ Lemma=stable NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=patients CharacterOffsetBegin=18 CharacterOffsetEnd=26 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=who CharacterOffsetBegin=27 CharacterOffsetEnd=30 PartOfSpeech=WP Lemma=who NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=underwent CharacterOffsetBegin=31 CharacterOffsetEnd=40 PartOfSpeech=VBD Lemma=undergo NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=des CharacterOffsetBegin=41 CharacterOffsetEnd=44 PartOfSpeech=FW Lemma=des NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=implantation CharacterOffsetBegin=45 CharacterOffsetEnd=57 PartOfSpeech=NN Lemma=implantation NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=12 CharacterOffsetBegin=58 CharacterOffsetEnd=60 PartOfSpeech=CD Lemma=12 NamedEntityTag=DURATION NormalizedNamedEntityTag=P12M Timex=<TIMEX3 tid=\"t1\" type=\"DURATION\" value=\"P12M\">12 months</TIMEX3> SentimentClass=Neutral]\r\n"
     ]
    }
   ],
   "source": [
    "!head output_file.json"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Match with label"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Creating Dictionaries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "co_occurrence_dict = defaultdict(list)\n",
    "\n",
    "for line in open('KeywordSentences.txt.out').readlines():\n",
    "    if 'Sentence #' in line:\n",
    "        sentence = str(line.strip('\\n')).split(\" \")[1]\n",
    "        sentiment = str(line.strip('\\n')).split(\":\")[1]\n",
    "        sentiment = re.sub(\"\\d+\",\"\",re.sub(r'[^\\w\\s]','',sentiment))\n",
    "    elif line[0:5] == '[Text':\n",
    "        word = str(line.split(\"=\")[1]).split(\" \")[0].lower()\n",
    "        pos = str(line.split(\"=\")[4]).split(\" \")[0]\n",
    "        co_occurrence_dict[(sentiment, sentence)].append(word)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[((' Neutral', '#248'),\n",
      "  ['specifically',\n",
      "   ',',\n",
      "   'one',\n",
      "   'needs',\n",
      "   'to',\n",
      "   '-lrb-',\n",
      "   'i',\n",
      "   '-rrb-',\n",
      "   'recognize',\n",
      "   'the',\n",
      "   'types',\n",
      "   'of',\n",
      "   'biochemical',\n",
      "   'events',\n",
      "   'that',\n",
      "   'change',\n",
      "   'isotopic',\n",
      "   'enrichments',\n",
      "   ',',\n",
      "   '-lrb-',\n",
      "   'ii',\n",
      "   '-rrb-',\n",
      "   'appreciate',\n",
      "   'the',\n",
      "   'distinction',\n",
      "   'between',\n",
      "   'fractional',\n",
      "   'turnover',\n",
      "   'and',\n",
      "   'flux',\n",
      "   'rate',\n",
      "   'and',\n",
      "   '-lrb-',\n",
      "   'iii',\n",
      "   '-rrb-',\n",
      "   'be',\n",
      "   'aware',\n",
      "   'of',\n",
      "   'the',\n",
      "   'subtle',\n",
      "   'differences',\n",
      "   'between',\n",
      "   'tracer',\n",
      "   'kinetics',\n",
      "   'and',\n",
      "   'pharmacokinetics',\n",
      "   '.'])]\n"
     ]
    }
   ],
   "source": [
    "#Example of one of the entries in the dictionary\n",
    "\n",
    "from itertools import islice\n",
    "import  pprint\n",
    "def take(n, iterable):\n",
    "    \"Return first n items of the iterable as a list\"\n",
    "    return list(islice(iterable, n))\n",
    "\n",
    "n_items = take(1, co_occurrence_dict.iteritems())\n",
    "pp = pprint.PrettyPrinter(depth=6)\n",
    "pp.pprint(n_items)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# for k,v in co_occurrence_dict.iteritems():\n",
    "#     print v"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('-lsb-', 'statin')  Very negative 2\n",
      "('-lsb-', 'statin')  Very negative 2\n",
      "('-lsb-', 'statin')  Negative 2\n",
      "('-lsb-', 'statin')  Negative 2\n"
     ]
    }
   ],
   "source": [
    "# h = {('-lsb-', 'statin'): [' Very negative',\n",
    "#               ' Very negative',\n",
    "#               ' Negative',\n",
    "#               ' Negative']}\n",
    "\n",
    "# for k,v in h.iteritems():\n",
    "#     for vv in v:\n",
    "#         print k, vv, v.count(vv)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "sent_dict = defaultdict(list)\n",
    "words_dict = defaultdict(list)\n",
    "\n",
    "\n",
    "#Assuming these are the key words we are curious about.\n",
    "search_phrase = ['australian','statin']\n",
    "\n",
    "#Searching through the dictionary\n",
    "for k,v in co_occurrence_dict.iteritems():\n",
    "    for vv in v:\n",
    "        if \"acetaminophen\" in v:\n",
    "            words_dict[(vv, \"acetaminophen\")].append(k[0])\n",
    "\n",
    "for k, v in words_dict.iteritems():\n",
    "    for vv in set(v):\n",
    "        if \"-\" not in vv:\n",
    "            sent_dict[k].append({vv: v.count(vv)})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('connective', 'statin') {' Negative': 1}\n",
      "('-rrb-', 'statin') {' Negative': 67}\n",
      "('-rrb-', 'statin') {' Very negative': 20}\n",
      "('0.029', 'statin') {' Negative': 1}\n",
      "('particles', 'statin') {' Negative': 2}\n",
      "('factor-15', 'statin') {' Negative': 1}\n",
      "('consensus', 'statin') {' Negative': 1}\n",
      "('hypertension', 'statin') {' Negative': 3}\n",
      "('change', 'statin') {' Negative': 3}\n",
      "('selected', 'statin') {' Negative': 1}\n",
      "('might', 'statin') {' Negative': 1}\n",
      "('v', 'statin') {' Negative': 1}\n",
      "('considered', 'statin') {' Negative': 3}\n",
      "('prediagnostic', 'statin') {' Negative': 1}\n",
      "('low-dose', 'statin') {' Negative': 1}\n",
      "('0.4', 'statin') {' Negative': 1}\n",
      "('guideline-based', 'statin') {' Negative': 1}\n",
      "('rural', 'statin') {' Negative': 1}\n",
      "('decreased', 'statin') {' Negative': 2}\n",
      "('maximal-tolerated', 'statin') {' Very negative': 1}\n",
      "('bodies', 'statin') {' Negative': 1}\n",
      "('men', 'statin') {' Negative': 1}\n",
      "('pitavastatin', 'statin') {' Negative': 1}\n",
      "('homologous', 'statin') {' Negative': 1}\n",
      "('patients', 'statin') {' Negative': 27}\n",
      "('patients', 'statin') {' Neutral': 2}\n",
      "('patients', 'statin') {' Very negative': 1}\n",
      "('outcomes', 'statin') {' Negative': 1}\n",
      "('necessary', 'statin') {' Negative': 1}\n",
      "('receiving', 'statin') {' Negative': 3}\n",
      "('dyslipidemia', 'statin') {' Negative': 1}\n",
      "('could', 'statin') {' Negative': 1}\n",
      "('pectoris', 'statin') {' Very negative': 1}\n",
      "('dying', 'statin') {' Neutral': 1}\n",
      "('unit', 'statin') {' Negative': 1}\n",
      "('diabetic', 'statin') {' Negative': 1}\n",
      "('rhabdomyolysis', 'statin') {' Very negative': 1}\n",
      "('endpoint', 'statin') {' Negative': 1}\n",
      "('as', 'statin') {' Negative': 6}\n",
      "('as', 'statin') {' Neutral': 1}\n",
      "('as', 'statin') {' Very negative': 1}\n",
      "('intensity', 'statin') {' Negative': 4}\n",
      "('.', 'statin') {' Positive': 2}\n",
      "('.', 'statin') {' Negative': 88}\n",
      "('.', 'statin') {' Neutral': 3}\n",
      "('.', 'statin') {' Very negative': 4}\n",
      "('50.5', 'statin') {' Negative': 1}\n",
      "('occurring', 'statin') {' Negative': 1}\n",
      "('7.5', 'statin') {' Negative': 1}\n",
      "('hdl-c', 'statin') {' Very negative': 1}\n",
      "('levels', 'statin') {' Negative': 5}\n",
      "('0.1', 'statin') {' Negative': 1}\n",
      "('received', 'statin') {' Negative': 2}\n",
      "('received', 'statin') {' Very negative': 1}\n",
      "('mg/dl', 'statin') {' Negative': 1}\n",
      "('henan', 'statin') {' Very negative': 1}\n",
      "('profile', 'statin') {' Negative': 1}\n",
      "('42', 'statin') {' Negative': 1}\n",
      "('least', 'statin') {' Negative': 1}\n",
      "('using', 'statin') {' Negative': 2}\n",
      "('ali', 'statin') {' Very negative': 2}\n",
      "('specific', 'statin') {' Negative': 1}\n",
      "('individuals', 'statin') {' Negative': 3}\n",
      "('individuals', 'statin') {' Neutral': 1}\n",
      "('mean', 'statin') {' Negative': 1}\n",
      "('positively', 'statin') {' Negative': 1}\n",
      "('0.01', 'statin') {' Negative': 1}\n",
      "('underwent', 'statin') {' Negative': 2}\n",
      "('goals', 'statin') {' Negative': 1}\n",
      "('and/or', 'statin') {' Negative': 1}\n",
      "('cardiology/american', 'statin') {' Negative': 1}\n",
      "('cardiology/american', 'statin') {' Neutral': 1}\n",
      "('a', 'statin') {' Positive': 2}\n",
      "('a', 'statin') {' Negative': 23}\n",
      "('a', 'statin') {' Neutral': 2}\n",
      "('a', 'statin') {' Very negative': 2}\n",
      "('vte', 'statin') {' Negative': 2}\n",
      "('evolocumab', 'statin') {' Negative': 3}\n",
      "('evolocumab', 'statin') {' Very negative': 1}\n",
      "('enhance', 'statin') {' Negative': 1}\n",
      "('eligible', 'statin') {' Negative': 4}\n",
      "('adults', 'statin') {' Negative': 6}\n",
      "('cancer', 'statin') {' Negative': 9}\n",
      "('cancer', 'statin') {' Neutral': 2}\n",
      "('growth', 'statin') {' Negative': 2}\n",
      "('assigned', 'statin') {' Negative': 3}\n",
      "('20', 'statin') {' Negative': 1}\n",
      "('6.10', 'statin') {' Negative': 1}\n",
      "('affects', 'statin') {' Negative': 1}\n",
      "('can', 'statin') {' Negative': 4}\n",
      "('25', 'statin') {' Negative': 1}\n",
      "('evidence', 'statin') {' Negative': 2}\n",
      "('arterial', 'statin') {' Negative': 1}\n",
      "(',', 'statin') {' Positive': 3}\n",
      "(',', 'statin') {' Negative': 95}\n",
      "(',', 'statin') {' Neutral': 1}\n",
      "(',', 'statin') {' Very negative': 17}\n",
      "('evaluated', 'statin') {' Negative': 1}\n",
      "('evaluated', 'statin') {' Very negative': 1}\n",
      "('women', 'statin') {' Negative': 2}\n",
      "('standard-of-care', 'statin') {' Very negative': 1}\n",
      "('98', 'statin') {' Very negative': 1}\n",
      "('des', 'statin') {' Negative': 2}\n",
      "('des', 'statin') {' Neutral': 1}\n",
      "('requires', 'statin') {' Negative': 1}\n",
      "('respectively', 'statin') {' Negative': 4}\n",
      "('heart', 'statin') {' Negative': 3}\n",
      "('heart', 'statin') {' Neutral': 1}\n",
      "('performed', 'statin') {' Very negative': 1}\n",
      "('female', 'statin') {' Negative': 1}\n",
      "('then', 'statin') {' Very negative': 1}\n",
      "('appropriate', 'statin') {' Negative': 1}\n",
      "('varied', 'statin') {' Negative': 1}\n",
      "('possible', 'statin') {' Negative': 1}\n",
      "('ear', 'statin') {' Negative': 1}\n",
      "('hazards', 'statin') {' Negative': 1}\n",
      "('new', 'statin') {' Negative': 5}\n",
      "('c-index', 'statin') {' Negative': 1}\n",
      "('fu', 'statin') {' Negative': 1}\n",
      "('11.8', 'statin') {' Negative': 2}\n",
      "('many', 'statin') {' Positive': 1}\n",
      "('many', 'statin') {' Negative': 1}\n",
      "('negatively', 'statin') {' Negative': 1}\n",
      "('despite', 'statin') {' Negative': 2}\n",
      "('despite', 'statin') {' Very negative': 1}\n",
      "('0.36-0', 'statin') {' Negative': 1}\n",
      "('implantation', 'statin') {' Negative': 1}\n",
      "('implantation', 'statin') {' Neutral': 1}\n",
      "('scar', 'statin') {' Negative': 2}\n",
      "('40-75', 'statin') {' Negative': 1}\n",
      "('10', 'statin') {' Negative': 1}\n",
      "('0.80', 'statin') {' Negative': 1}\n",
      "('4', 'statin') {' Negative': 2}\n",
      "('40', 'statin') {' Negative': 2}\n",
      "('overall', 'statin') {' Negative': 2}\n",
      "('serious', 'statin') {' Negative': 1}\n",
      "('heterozygous', 'statin') {' Very negative': 1}\n",
      "(\"'s\", 'statin') {' Negative': 1}\n",
      "(\"'s\", 'statin') {' Very negative': 1}\n",
      "('confidence', 'statin') {' Negative': 3}\n",
      "('confidence', 'statin') {' Very negative': 1}\n",
      "('74-92', 'statin') {' Very negative': 1}\n",
      "('sixty-one', 'statin') {' Negative': 1}\n",
      "('type', 'statin') {' Positive': 2}\n",
      "('type', 'statin') {' Negative': 2}\n",
      "('type', 'statin') {' Very negative': 1}\n",
      "('kidney', 'statin') {' Very negative': 1}\n",
      "('-rsb-', 'statin') {' Negative': 2}\n",
      "('-rsb-', 'statin') {' Very negative': 2}\n",
      "('cholesterol', 'statin') {' Negative': 4}\n",
      "('cholesterol', 'statin') {' Very negative': 5}\n",
      "('analyzed', 'statin') {' Very negative': 1}\n",
      "('recommended', 'statin') {' Negative': 2}\n",
      "('51', 'statin') {' Negative': 1}\n",
      "('insufficient', 'statin') {' Very negative': 1}\n",
      "('inappropriate', 'statin') {' Negative': 1}\n",
      "('variable', 'statin') {' Negative': 1}\n",
      "('high-risk', 'statin') {' Negative': 4}\n",
      "('also', 'statin') {' Negative': 1}\n",
      "('previous', 'statin') {' Negative': 1}\n",
      "('side', 'statin') {' Negative': 1}\n",
      "('measures', 'statin') {' Negative': 1}\n",
      "('unknown', 'statin') {' Neutral': 1}\n",
      "('reductions', 'statin') {' Negative': 1}\n",
      "('2007', 'statin') {' Negative': 4}\n",
      "('8-yr', 'statin') {' Negative': 1}\n",
      "('benefit', 'statin') {' Negative': 1}\n",
      "('llt', 'statin') {' Very negative': 1}\n",
      "('control', 'statin') {' Negative': 2}\n",
      "('learning', 'statin') {' Negative': 1}\n",
      "('compared', 'statin') {' Negative': 7}\n",
      "('sample', 'statin') {' Negative': 1}\n",
      "('2', 'statin') {' Positive': 1}\n",
      "('2', 'statin') {' Negative': 4}\n",
      "('increase', 'statin') {' Positive': 1}\n",
      "('increase', 'statin') {' Negative': 1}\n",
      "('increase', 'statin') {' Very negative': 1}\n",
      "('regression', 'statin') {' Negative': 1}\n",
      "('inclusion', 'statin') {' Negative': 1}\n",
      "('persistently', 'statin') {' Negative': 1}\n",
      "('lmca', 'statin') {' Very negative': 1}\n",
      "('ldl-cholesterol', 'statin') {' Negative': 3}\n",
      "('have', 'statin') {' Negative': 3}\n",
      "('have', 'statin') {' Very negative': 1}\n",
      "('be', 'statin') {' Negative': 4}\n",
      "('\\xce\\xb4', 'statin') {' Negative': 2}\n",
      "('interval', 'statin') {' Negative': 3}\n",
      "('interval', 'statin') {' Very negative': 1}\n",
      "('-', 'statin') {' Negative': 1}\n",
      "('-', 'statin') {' Very negative': 1}\n",
      "('older', 'statin') {' Negative': 1}\n",
      "('differentiation', 'statin') {' Negative': 1}\n",
      "('observational', 'statin') {' Very negative': 1}\n",
      "('must', 'statin') {' Negative': 1}\n",
      "('2008', 'statin') {' Negative': 5}\n",
      "('chronic', 'statin') {' Negative': 2}\n",
      "('chronic', 'statin') {' Very negative': 1}\n",
      "('drugs', 'statin') {' Negative': 3}\n",
      "('which', 'statin') {' Negative': 2}\n",
      "('probucol', 'statin') {' Negative': 1}\n",
      "('drug-eluting', 'statin') {' Negative': 1}\n",
      "('ezetimibe', 'statin') {' Negative': 2}\n",
      "('days', 'statin') {' Negative': 2}\n",
      "('presence', 'statin') {' Negative': 1}\n",
      "('60-74', 'statin') {' Negative': 1}\n",
      "('5.52', 'statin') {' Negative': 1}\n",
      "('ultrasound', 'statin') {' Very negative': 1}\n",
      "('percutaneous', 'statin') {' Negative': 1}\n",
      "('history', 'statin') {' Negative': 1}\n",
      "('cholesterol-lowering', 'statin') {' Negative': 1}\n",
      "('association', 'statin') {' Negative': 4}\n",
      "('association', 'statin') {' Neutral': 1}\n",
      "('association', 'statin') {' Very negative': 1}\n",
      "('developing', 'statin') {' Negative': 2}\n",
      "('developing', 'statin') {' Neutral': 1}\n",
      "('characteristics', 'statin') {' Very negative': 2}\n",
      "('consecutively', 'statin') {' Negative': 1}\n",
      "('whether', 'statin') {' Negative': 5}\n",
      "('whether', 'statin') {' Neutral': 1}\n",
      "('groups', 'statin') {' Negative': 4}\n",
      "('infected', 'statin') {' Positive': 1}\n",
      "('primary', 'statin') {' Negative': 7}\n",
      "('reducing', 'statin') {' Negative': 1}\n",
      "('37', 'statin') {' Negative': 3}\n",
      "('utilization', 'statin') {' Negative': 2}\n",
      "('10-year', 'statin') {' Negative': 2}\n",
      "('significantly', 'statin') {' Negative': 2}\n",
      "('tissue', 'statin') {' Negative': 1}\n",
      "('tissue', 'statin') {' Very negative': 2}\n",
      "('half-life', 'statin') {' Negative': 1}\n",
      "('60', 'statin') {' Negative': 2}\n",
      "('%', 'statin') {' Negative': 39}\n",
      "('%', 'statin') {' Very negative': 9}\n",
      "('mtd', 'statin') {' Very negative': 1}\n",
      "('high-dose', 'statin') {' Negative': 3}\n",
      "('data', 'statin') {' Positive': 1}\n",
      "('0.005', 'statin') {' Negative': 1}\n",
      "('8185', 'statin') {' Negative': 1}\n",
      "('length', 'statin') {' Negative': 1}\n",
      "('three', 'statin') {' Negative': 1}\n",
      "('underwentpercutaneous', 'statin') {' Very negative': 1}\n",
      "('urine', 'statin') {' Negative': 1}\n",
      "('statin', 'statin') {' Positive': 3}\n",
      "('statin', 'statin') {' Negative': 96}\n",
      "('statin', 'statin') {' Neutral': 3}\n",
      "('statin', 'statin') {' Very negative': 4}\n",
      "('following', 'statin') {' Negative': 1}\n",
      "('0.29', 'statin') {' Negative': 1}\n",
      "('would', 'statin') {' Negative': 5}\n",
      "('other', 'statin') {' Neutral': 1}\n",
      "('associated', 'statin') {' Negative': 9}\n",
      "('accuracy', 'statin') {' Neutral': 1}\n",
      "('stabilization', 'statin') {' Negative': 1}\n",
      "('9.8', 'statin') {' Negative': 1}\n",
      "('are', 'statin') {' Negative': 4}\n",
      "('enrolled', 'statin') {' Negative': 1}\n",
      "('indication', 'statin') {' Negative': 1}\n",
      "('inhibitors', 'statin') {' Negative': 1}\n",
      "('inhibitors', 'statin') {' Very negative': 1}\n",
      "('0.7', 'statin') {' Negative': 1}\n",
      "('had', 'statin') {' Negative': 6}\n",
      "('relationship', 'statin') {' Negative': 1}\n",
      "('apob', 'statin') {' Very negative': 1}\n",
      "('non-statin', 'statin') {' Negative': 2}\n",
      "('cox', 'statin') {' Negative': 1}\n",
      "('lymph', 'statin') {' Negative': 1}\n",
      "('may', 'statin') {' Negative': 4}\n",
      "('may', 'statin') {' Very negative': 1}\n",
      "('acute', 'statin') {' Negative': 1}\n",
      "('acute', 'statin') {' Very negative': 1}\n",
      "('usa-1', 'statin') {' Negative': 3}\n",
      "('non-culprit', 'statin') {' Negative': 1}\n",
      "('frequently', 'statin') {' Negative': 1}\n",
      "('center', 'statin') {' Negative': 1}\n",
      "('17', 'statin') {' Negative': 2}\n",
      "('without', 'statin') {' Negative': 5}\n",
      "('patient', 'statin') {' Negative': 1}\n",
      "('prospectively', 'statin') {' Very negative': 1}\n",
      "('incidence', 'statin') {' Neutral': 1}\n",
      "('75-84', 'statin') {' Negative': 1}\n",
      "('concentration', 'statin') {' Negative': 1}\n",
      "('quasi-experimental', 'statin') {' Positive': 1}\n",
      "('often', 'statin') {' Negative': 1}\n",
      "('one-third', 'statin') {' Negative': 1}\n",
      "('0.320', 'statin') {' Negative': 1}\n",
      "('aged', 'statin') {' Negative': 3}\n",
      "('quantitative', 'statin') {' Negative': 1}\n",
      "('no', 'statin') {' Negative': 1}\n",
      "('cancer-related', 'statin') {' Negative': 1}\n",
      "('versus', 'statin') {' Negative': 2}\n",
      "('examined', 'statin') {' Negative': 3}\n",
      "('7.05', 'statin') {' Negative': 1}\n",
      "('randomly', 'statin') {' Negative': 3}\n",
      "('high-intensity', 'statin') {' Negative': 7}\n",
      "('high-intensity', 'statin') {' Neutral': 2}\n",
      "('simvastatin', 'statin') {' Negative': 2}\n",
      "('0', 'statin') {' Negative': 1}\n",
      "('good', 'statin') {' Very negative': 1}\n",
      "('focused', 'statin') {' Negative': 1}\n",
      "('again', 'statin') {' Negative': 1}\n",
      "('65', 'statin') {' Very negative': 1}\n",
      "('primarily', 'statin') {' Negative': 1}\n",
      "('increasing', 'statin') {' Very negative': 1}\n",
      "('proportional', 'statin') {' Negative': 1}\n",
      "('k', 'statin') {' Negative': 2}\n",
      "('silent', 'statin') {' Negative': 1}\n",
      "('pci', 'statin') {' Negative': 1}\n",
      "('attainment', 'statin') {' Negative': 1}\n",
      "('term', 'statin') {' Negative': 1}\n",
      "('pce', 'statin') {' Negative': 1}\n",
      "('proprotein', 'statin') {' Negative': 1}\n",
      "('proprotein', 'statin') {' Very negative': 1}\n",
      "('apoa1', 'statin') {' Very negative': 1}\n",
      "('30', 'statin') {' Negative': 1}\n",
      "('9', 'statin') {' Negative': 1}\n",
      "('9', 'statin') {' Very negative': 1}\n",
      "('image', 'statin') {' Negative': 1}\n",
      "('prostate', 'statin') {' Negative': 6}\n",
      "('guideline', 'statin') {' Negative': 6}\n",
      "('interference', 'statin') {' Negative': 1}\n",
      "('suggest', 'statin') {' Negative': 3}\n",
      "('suggest', 'statin') {' Very negative': 1}\n",
      "('vessel', 'statin') {' Negative': 2}\n",
      "('from', 'statin') {' Negative': 5}\n",
      "('from', 'statin') {' Very negative': 2}\n",
      "('assure', 'statin') {' Negative': 1}\n",
      "('1', 'statin') {' Positive': 1}\n",
      "('1', 'statin') {' Negative': 1}\n",
      "('2,196', 'statin') {' Negative': 2}\n",
      "('driven', 'statin') {' Negative': 1}\n",
      "('denmark', 'statin') {' Negative': 1}\n",
      "('combined', 'statin') {' Negative': 3}\n",
      "('including', 'statin') {' Negative': 5}\n",
      "('including', 'statin') {' Very negative': 1}\n",
      "('given', 'statin') {' Negative': 1}\n",
      "('participants', 'statin') {' Negative': 4}\n",
      "('level', 'statin') {' Negative': 1}\n",
      "('level', 'statin') {' Very negative': 1}\n",
      "('node', 'statin') {' Negative': 1}\n",
      "('june', 'statin') {' Very negative': 2}\n",
      "('during', 'statin') {' Negative': 1}\n",
      "('less', 'statin') {' Negative': 1}\n",
      "('taken', 'statin') {' Negative': 1}\n",
      "('prevalent', 'statin') {' Negative': 4}\n",
      "('prescribing', 'statin') {' Negative': 4}\n",
      "('females', 'statin') {' Negative': 4}\n",
      "('mass', 'statin') {' Negative': 1}\n",
      "('approved', 'statin') {' Very negative': 1}\n",
      "('97', 'statin') {' Very negative': 1}\n",
      "('contains', 'statin') {' Negative': 1}\n",
      "('detect', 'statin') {' Negative': 1}\n",
      "('american', 'statin') {' Negative': 2}\n",
      "('american', 'statin') {' Neutral': 1}\n",
      "('apob/a1', 'statin') {' Very negative': 1}\n",
      "('served', 'statin') {' Negative': 1}\n",
      "('suggests', 'statin') {' Negative': 1}\n",
      "('individual', 'statin') {' Negative': 1}\n",
      "('their', 'statin') {' Very negative': 1}\n",
      "('we', 'statin') {' Positive': 1}\n",
      "('we', 'statin') {' Negative': 9}\n",
      "('we', 'statin') {' Neutral': 2}\n",
      "('negative', 'statin') {' Negative': 2}\n",
      "('having', 'statin') {' Negative': 1}\n",
      "('continuous', 'statin') {' Negative': 1}\n",
      "('continuous', 'statin') {' Neutral': 1}\n",
      "('812', 'statin') {' Negative': 1}\n",
      "('process', 'statin') {' Negative': 1}\n",
      "('\\xc2\\xb1', 'statin') {' Negative': 3}\n",
      "('pcsk9', 'statin') {' Negative': 1}\n",
      "('severe', 'statin') {' Very negative': 1}\n",
      "('blood', 'statin') {' Negative': 2}\n",
      "('blood', 'statin') {' Very negative': 1}\n",
      "('mainly', 'statin') {' Negative': 1}\n",
      "('submitted', 'statin') {' Negative': 1}\n",
      "('hundred', 'statin') {' Negative': 1}\n",
      "('our', 'statin') {' Negative': 2}\n",
      "('adherence', 'statin') {' Negative': 2}\n",
      "('adherence', 'statin') {' Very negative': 1}\n",
      "('baseline', 'statin') {' Negative': 4}\n",
      "('failure', 'statin') {' Negative': 1}\n",
      "('failure', 'statin') {' Very negative': 1}\n",
      "('343,438', 'statin') {' Negative': 1}\n",
      "('health', 'statin') {' Negative': 2}\n",
      "('stable', 'statin') {' Negative': 3}\n",
      "('stable', 'statin') {' Neutral': 1}\n",
      "('stable', 'statin') {' Very negative': 1}\n",
      "('at', 'statin') {' Negative': 10}\n",
      "('at', 'statin') {' Neutral': 1}\n",
      "('66', 'statin') {' Negative': 1}\n",
      "('virtualhistology', 'statin') {' Very negative': 1}\n",
      "('infarction', 'statin') {' Negative': 3}\n",
      "('17.81', 'statin') {' Negative': 1}\n",
      "('includes', 'statin') {' Negative': 1}\n",
      "('users', 'statin') {' Negative': 8}\n",
      "('potential', 'statin') {' Negative': 3}\n",
      "('oncology', 'statin') {' Negative': 1}\n",
      "('care', 'statin') {' Negative': 2}\n",
      "('<', 'statin') {' Negative': 2}\n",
      "('low-intensity', 'statin') {' Negative': 3}\n",
      "('design', 'statin') {' Positive': 1}\n",
      "('design', 'statin') {' Negative': 1}\n",
      "('stay', 'statin') {' Negative': 1}\n",
      "('delay', 'statin') {' Negative': 1}\n",
      "('50', 'statin') {' Negative': 1}\n",
      "('elevated', 'statin') {' Negative': 1}\n",
      "('male', 'statin') {' Negative': 1}\n",
      "('modification', 'statin') {' Negative': 1}\n",
      "('qrisk2', 'statin') {' Negative': 1}\n",
      "('cumulative', 'statin') {' Negative': 1}\n",
      "('was', 'statin') {' Negative': 16}\n",
      "('was', 'statin') {' Very negative': 1}\n",
      "('both', 'statin') {' Negative': 1}\n",
      "('both', 'statin') {' Very negative': 1}\n",
      "('receive', 'statin') {' Negative': 1}\n",
      "('reassess', 'statin') {' Negative': 1}\n",
      "('wide', 'statin') {' Negative': 1}\n",
      "('3', 'statin') {' Negative': 1}\n",
      "('consider', 'statin') {' Negative': 1}\n",
      "('monacolin', 'statin') {' Negative': 3}\n",
      "('factors', 'statin') {' Negative': 1}\n",
      "('randomised', 'statin') {' Negative': 1}\n",
      "('optimizing', 'statin') {' Negative': 1}\n",
      "('diabetes', 'statin') {' Negative': 3}\n",
      "('nonuse', 'statin') {' Negative': 1}\n",
      "('after', 'statin') {' Negative': 7}\n",
      "('after', 'statin') {' Neutral': 1}\n",
      "('95', 'statin') {' Negative': 8}\n",
      "('95', 'statin') {' Very negative': 3}\n",
      "('0.04', 'statin') {' Negative': 1}\n",
      "('result', 'statin') {' Neutral': 1}\n",
      "('daily', 'statin') {' Negative': 2}\n",
      "('0.0001', 'statin') {' Negative': 1}\n",
      "('most', 'statin') {' Negative': 3}\n",
      "('>', 'statin') {' Negative': 2}\n",
      "('current', 'statin') {' Positive': 1}\n",
      "('current', 'statin') {' Negative': 2}\n",
      "('nontarget', 'statin') {' Negative': 1}\n",
      "('picking', 'statin') {' Negative': 1}\n",
      "('between', 'statin') {' Negative': 6}\n",
      "('0.519', 'statin') {' Negative': 1}\n",
      "('repatha', 'statin') {' Very negative': 1}\n",
      "('residual', 'statin') {' Negative': 1}\n",
      "('convertase', 'statin') {' Negative': 1}\n",
      "('convertase', 'statin') {' Very negative': 1}\n",
      "('meta-analyses', 'statin') {' Negative': 1}\n",
      "('threshold', 'statin') {' Negative': 1}\n",
      "('diseases', 'statin') {' Negative': 1}\n",
      "('part', 'statin') {' Negative': 1}\n",
      "('ratio', 'statin') {' Negative': 2}\n",
      "('ratio', 'statin') {' Very negative': 2}\n",
      "('exceed', 'statin') {' Negative': 1}\n",
      "('method', 'statin') {' Negative': 2}\n",
      "('mortality', 'statin') {' Negative': 5}\n",
      "('distinguishable', 'statin') {' Negative': 1}\n",
      "('included.we', 'statin') {' Very negative': 1}\n",
      "('model', 'statin') {' Negative': 1}\n",
      "('improved', 'statin') {' Positive': 1}\n",
      "('improved', 'statin') {' Negative': 1}\n",
      "('alzheimer', 'statin') {' Negative': 1}\n",
      "('high-density', 'statin') {' Very negative': 1}\n",
      "('agents', 'statin') {' Negative': 1}\n",
      "('prescribed', 'statin') {' Negative': 3}\n",
      "('0.65-0', 'statin') {' Negative': 1}\n",
      "('controls', 'statin') {' Negative': 1}\n",
      "('muscle', 'statin') {' Negative': 1}\n",
      "('muscle', 'statin') {' Very negative': 1}\n",
      "('-lrb-', 'statin') {' Negative': 67}\n",
      "('-lrb-', 'statin') {' Very negative': 20}\n",
      "('investigated', 'statin') {' Negative': 1}\n",
      "('investigated', 'statin') {' Neutral': 1}\n",
      "('point', 'statin') {' Negative': 2}\n",
      "('.025', 'statin') {' Negative': 1}\n",
      "('mild-to-severe', 'statin') {' Negative': 1}\n",
      "('condition', 'statin') {' Negative': 1}\n",
      "('these', 'statin') {' Neutral': 1}\n",
      "('breast', 'statin') {' Negative': 3}\n",
      "('ratios', 'statin') {' Negative': 1}\n",
      "('among', 'statin') {' Negative': 7}\n",
      "('0.712', 'statin') {' Negative': 1}\n",
      "('dose', 'statin') {' Negative': 4}\n",
      "('dose', 'statin') {' Very negative': 2}\n",
      "('meet', 'statin') {' Very negative': 1}\n",
      "('included', 'statin') {' Negative': 2}\n",
      "('and', 'statin') {' Positive': 2}\n",
      "('and', 'statin') {' Negative': 71}\n",
      "('and', 'statin') {' Very negative': 5}\n",
      "('mellitus', 'statin') {' Negative': 1}\n",
      "('higher', 'statin') {' Negative': 4}\n",
      "('higher', 'statin') {' Neutral': 1}\n",
      "('discontinued', 'statin') {' Negative': 1}\n",
      "('discontinuation', 'statin') {' Positive': 1}\n",
      "('discontinuation', 'statin') {' Negative': 9}\n",
      "('atherosclerosis', 'statin') {' Negative': 2}\n",
      "('trials', 'statin') {' Negative': 1}\n",
      "('9.6', 'statin') {' Negative': 1}\n",
      "('either', 'statin') {' Negative': 1}\n",
      "('interactions', 'statin') {' Negative': 1}\n",
      "('effectiveness', 'statin') {' Positive': 1}\n",
      "('therapy', 'statin') {' Positive': 1}\n",
      "('therapy', 'statin') {' Negative': 27}\n",
      "('therapy', 'statin') {' Very negative': 3}\n",
      "('aki', 'statin') {' Negative': 1}\n",
      "('aki', 'statin') {' Very negative': 1}\n",
      "('', 'statin') {' Negative': 21}\n",
      "('', 'statin') {' Very negative': 3}\n",
      "('2016', 'statin') {' Negative': 1}\n",
      "('2016', 'statin') {' Very negative': 1}\n",
      "('further', 'statin') {' Negative': 2}\n",
      "('that', 'statin') {' Positive': 1}\n",
      "('that', 'statin') {' Negative': 9}\n",
      "('that', 'statin') {' Very negative': 1}\n",
      "('.8', 'statin') {' Negative': 1}\n",
      "('adjuncts', 'statin') {' Very negative': 1}\n",
      "('classified', 'statin') {' Negative': 1}\n",
      "('studies', 'statin') {' Negative': 2}\n",
      "('studies', 'statin') {' Very negative': 2}\n",
      "('contrast', 'statin') {' Negative': 1}\n",
      "('guidelines', 'statin') {' Negative': 9}\n",
      "('guidelines', 'statin') {' Very negative': 1}\n",
      "('danish', 'statin') {' Negative': 1}\n",
      "('attempts', 'statin') {' Negative': 1}\n",
      "('8.1', 'statin') {' Negative': 1}\n",
      "('took', 'statin') {' Very negative': 1}\n",
      "('proportion', 'statin') {' Negative': 1}\n",
      "('instead', 'statin') {' Negative': 1}\n",
      "('settings', 'statin') {' Negative': 1}\n",
      "('duration', 'statin') {' Positive': 1}\n",
      "('duration', 'statin') {' Negative': 1}\n",
      "('reductase', 'statin') {' Negative': 1}\n",
      "('examinations', 'statin') {' Negative': 1}\n",
      "('acc/aha', 'statin') {' Negative': 1}\n",
      "('exist', 'statin') {' Negative': 1}\n",
      "('none', 'statin') {' Very negative': 1}\n",
      "('group', 'statin') {' Negative': 2}\n",
      "('aspirin', 'statin') {' Negative': 2}\n",
      "('aspirin', 'statin') {' Neutral': 1}\n",
      "('assessed', 'statin') {' Negative': 1}\n",
      "('especially', 'statin') {' Negative': 1}\n",
      "('points', 'statin') {' Negative': 1}\n",
      "('na\\xc3\\xafve', 'statin') {' Negative': 1}\n",
      "('22.2', 'statin') {' Negative': 1}\n",
      "('currently', 'statin') {' Neutral': 1}\n",
      "('plasma', 'statin') {' Negative': 1}\n",
      "('2.274', 'statin') {' Negative': 1}\n",
      "('institute', 'statin') {' Negative': 1}\n",
      "('national', 'statin') {' Negative': 1}\n",
      "('death', 'statin') {' Negative': 5}\n",
      "('criterion', 'statin') {' Negative': 2}\n",
      "('purchases', 'statin') {' Positive': 1}\n",
      "('tacrolimus', 'statin') {' Negative': 1}\n",
      "('it', 'statin') {' Negative': 3}\n",
      "('validated', 'statin') {' Negative': 1}\n",
      "('distinguish', 'statin') {' Negative': 1}\n",
      "('community-based', 'statin') {' Negative': 2}\n",
      "('prescription', 'statin') {' Negative': 3}\n",
      "('intervention', 'statin') {' Negative': 1}\n",
      "('intervention', 'statin') {' Very negative': 1}\n",
      "('high', 'statin') {' Negative': 3}\n",
      "('attention', 'statin') {' Negative': 1}\n",
      "('continued', 'statin') {' Negative': 1}\n",
      "('in', 'statin') {' Positive': 1}\n",
      "('in', 'statin') {' Negative': 64}\n",
      "('in', 'statin') {' Neutral': 2}\n",
      "('in', 'statin') {' Very negative': 2}\n",
      "('21-42', 'statin') {' Very negative': 1}\n",
      "('cohort', 'statin') {' Negative': 1}\n",
      "('cohort', 'statin') {' Very negative': 1}\n",
      "('2010', 'statin') {' Very negative': 1}\n",
      "('some', 'statin') {' Negative': 1}\n",
      "('0.978', 'statin') {' Negative': 1}\n",
      "('newspaper', 'statin') {' Negative': 1}\n",
      "('pressure', 'statin') {' Negative': 1}\n",
      "('.98', 'statin') {' Negative': 1}\n",
      "('confirmed', 'statin') {' Negative': 1}\n",
      "('adjunct', 'statin') {' Negative': 1}\n",
      "('event', 'statin') {' Negative': 3}\n",
      "('months', 'statin') {' Negative': 2}\n",
      "('months', 'statin') {' Neutral': 1}\n",
      "('1458', 'statin') {' Negative': 1}\n",
      "('cardiac', 'statin') {' Negative': 1}\n",
      "('framingham', 'statin') {' Negative': 1}\n",
      "('-70', 'statin') {' Negative': 1}\n",
      "('rate', 'statin') {' Negative': 1}\n",
      "('anti-platelet', 'statin') {' Very negative': 1}\n",
      "('2014', 'statin') {' Negative': 2}\n",
      "('over', 'statin') {' Positive': 1}\n",
      "('40mg', 'statin') {' Negative': 1}\n",
      "('initiate', 'statin') {' Negative': 1}\n",
      "('however', 'statin') {' Negative': 2}\n",
      "('atherosclerotic', 'statin') {' Negative': 2}\n",
      "('atherosclerotic', 'statin') {' Very negative': 1}\n",
      "('future', 'statin') {' Negative': 1}\n",
      "('above', 'statin') {' Negative': 2}\n",
      "('status', 'statin') {' Negative': 1}\n",
      "('disease', 'statin') {' Negative': 5}\n",
      "('disease', 'statin') {' Very negative': 1}\n",
      "('long', 'statin') {' Negative': 2}\n",
      "('fourier', 'statin') {' Negative': 1}\n",
      "('subclinical', 'statin') {' Negative': 2}\n",
      "('d', 'statin') {' Negative': 1}\n",
      "('north', 'statin') {' Negative': 1}\n",
      "('sought', 'statin') {' Neutral': 1}\n",
      "('shown', 'statin') {' Negative': 2}\n",
      "('there', 'statin') {' Negative': 2}\n",
      "('there', 'statin') {' Very negative': 1}\n",
      "('evaluation', 'statin') {' Negative': 2}\n",
      "('.92', 'statin') {' Negative': 1}\n",
      "('candidates', 'statin') {' Negative': 3}\n",
      "('reason', 'statin') {' Negative': 2}\n",
      "('noncardiovascular', 'statin') {' Neutral': 1}\n",
      "('relies', 'statin') {' Positive': 1}\n",
      "('an', 'statin') {' Negative': 6}\n",
      "('known', 'statin') {' Negative': 2}\n",
      "('praluent', 'statin') {' Very negative': 1}\n",
      "('regards', 'statin') {' Very negative': 1}\n",
      "('based', 'statin') {' Negative': 2}\n",
      "('3-hydroxy-3-methylglutaryl', 'statin') {' Negative': 1}\n",
      "('0.023', 'statin') {' Negative': 1}\n",
      "('defined', 'statin') {' Negative': 1}\n",
      "('diagnosis', 'statin') {' Negative': 4}\n",
      "('lipoprotein', 'statin') {' Negative': 1}\n",
      "('lipoprotein', 'statin') {' Very negative': 4}\n",
      "('.018', 'statin') {' Negative': 1}\n",
      "('injury', 'statin') {' Negative': 1}\n",
      "('injury', 'statin') {' Very negative': 2}\n",
      "('pharmacokinetics', 'statin') {' Positive': 1}\n",
      "('demonstrated', 'statin') {' Negative': 3}\n",
      "('smallest', 'statin') {' Negative': 1}\n",
      "('0.339', 'statin') {' Negative': 1}\n",
      "('c', 'statin') {' Negative': 1}\n",
      "('late', 'statin') {' Negative': 1}\n",
      "('late', 'statin') {' Neutral': 2}\n",
      "('third-generation', 'statin') {' Negative': 1}\n",
      "('another', 'statin') {' Negative': 1}\n",
      "('potency', 'statin') {' Very negative': 1}\n",
      "('coronary', 'statin') {' Negative': 5}\n",
      "('coronary', 'statin') {' Very negative': 1}\n",
      "('impact', 'statin') {' Negative': 2}\n",
      "('impact', 'statin') {' Neutral': 1}\n",
      "('antiplatelet', 'statin') {' Negative': 1}\n",
      "('atorvastatin', 'statin') {' Positive': 1}\n",
      "('atorvastatin', 'statin') {' Negative': 2}\n",
      "('myocardial', 'statin') {' Negative': 4}\n",
      "('score', 'statin') {' Negative': 1}\n",
      "('monitoring', 'statin') {' Negative': 1}\n",
      "('the', 'statin') {' Positive': 3}\n",
      "('the', 'statin') {' Negative': 63}\n",
      "('the', 'statin') {' Neutral': 4}\n",
      "('the', 'statin') {' Very negative': 10}\n",
      "('all', 'statin') {' Negative': 7}\n",
      "('ivus-vh', 'statin') {' Very negative': 1}\n",
      "('tc', 'statin') {' Very negative': 1}\n",
      "('initiatives', 'statin') {' Negative': 1}\n",
      "('lovastatin', 'statin') {' Negative': 3}\n",
      "('maintenance', 'statin') {' Negative': 1}\n",
      "('reduction', 'statin') {' Negative': 1}\n",
      "('mechanism', 'statin') {' Negative': 1}\n",
      "('males', 'statin') {' Negative': 4}\n",
      "('all-cause', 'statin') {' Negative': 1}\n",
      "('people', 'statin') {' Negative': 1}\n",
      "('people', 'statin') {' Very negative': 1}\n",
      "('better', 'statin') {' Negative': 1}\n",
      "('progression', 'statin') {' Negative': 1}\n",
      "('time-dependent', 'statin') {' Negative': 1}\n",
      "('tumour', 'statin') {' Negative': 1}\n",
      "('1000', 'statin') {' Negative': 2}\n",
      "('aim', 'statin') {' Negative': 2}\n",
      "('83', 'statin') {' Negative': 1}\n",
      "('meeting', 'statin') {' Very negative': 1}\n",
      "('recommendations', 'statin') {' Negative': 1}\n",
      "('pathways', 'statin') {' Negative': 1}\n",
      "('undergone', 'statin') {' Negative': 1}\n",
      "('work', 'statin') {' Negative': 1}\n",
      "('prevent', 'statin') {' Negative': 2}\n",
      "('usa-2', 'statin') {' Negative': 2}\n",
      "('low', 'statin') {' Negative': 2}\n",
      "('prediction', 'statin') {' Negative': 2}\n",
      "('estimated', 'statin') {' Negative': 2}\n",
      "('osteomyelitis', 'statin') {' Negative': 2}\n",
      "('br-2', 'statin') {' Negative': 2}\n",
      "('diabetics', 'statin') {' Negative': 1}\n",
      "('clinically', 'statin') {' Negative': 2}\n",
      "('clinically', 'statin') {' Neutral': 1}\n",
      "('application', 'statin') {' Negative': 1}\n",
      "('before', 'statin') {' Negative': 2}\n",
      "('reduced', 'statin') {' Negative': 4}\n",
      "('20mg', 'statin') {' Negative': 1}\n",
      "('with', 'statin') {' Positive': 1}\n",
      "('with', 'statin') {' Negative': 40}\n",
      "('with', 'statin') {' Very negative': 5}\n",
      "('hrs', 'statin') {' Negative': 1}\n",
      "(';', 'statin') {' Negative': 18}\n",
      "(';', 'statin') {' Very negative': 5}\n",
      "('mrna', 'statin') {' Negative': 1}\n",
      "('uses', 'statin') {' Positive': 1}\n",
      "('index', 'statin') {' Negative': 1}\n",
      "('analysis', 'statin') {' Negative': 1}\n",
      "('determine', 'statin') {' Negative': 1}\n",
      "('determine', 'statin') {' Neutral': 1}\n",
      "('nature', 'statin') {' Negative': 1}\n",
      "('for', 'statin') {' Negative': 23}\n",
      "('clinical', 'statin') {' Negative': 5}\n",
      "('clinical', 'statin') {' Very negative': 1}\n",
      "('followed', 'statin') {' Negative': 1}\n",
      "('13', 'statin') {' Negative': 1}\n",
      "('offspring', 'statin') {' Negative': 1}\n",
      "('causes', 'statin') {' Neutral': 1}\n",
      "('where', 'statin') {' Very negative': 1}\n",
      "('estimate', 'statin') {' Negative': 1}\n",
      "('inconsistent', 'statin') {' Very negative': 1}\n",
      "('follow-up', 'statin') {' Negative': 2}\n",
      "('single', 'statin') {' Negative': 1}\n",
      "('should', 'statin') {' Negative': 2}\n",
      "('analysed', 'statin') {' Negative': 1}\n",
      "('percent', 'statin') {' Negative': 2}\n",
      "('risk', 'statin') {' Negative': 16}\n",
      "('risk', 'statin') {' Neutral': 1}\n",
      "('risk', 'statin') {' Very negative': 1}\n",
      "('determined', 'statin') {' Negative': 1}\n",
      "('longitudinal', 'statin') {' Negative': 1}\n",
      "('coenzyme-a', 'statin') {' Negative': 1}\n",
      "('2013', 'statin') {' Negative': 1}\n",
      "('2013', 'statin') {' Neutral': 1}\n",
      "('treatment', 'statin') {' Positive': 1}\n",
      "('treatment', 'statin') {' Negative': 24}\n",
      "('treatment', 'statin') {' Neutral': 2}\n",
      "('treatment', 'statin') {' Very negative': 1}\n",
      "('medication', 'statin') {' Negative': 1}\n",
      "('ideal', 'statin') {' Negative': 1}\n",
      "('body', 'statin') {' Negative': 1}\n",
      "('underused', 'statin') {' Negative': 1}\n",
      "('monotherapy', 'statin') {' Negative': 3}\n",
      "('monotherapy', 'statin') {' Neutral': 1}\n",
      "('mg', 'statin') {' Negative': 1}\n",
      "('homozygous', 'statin') {' Very negative': 1}\n",
      "('criteria', 'statin') {' Negative': 2}\n",
      "('criteria', 'statin') {' Neutral': 1}\n",
      "('by', 'statin') {' Negative': 12}\n",
      "('59', 'statin') {' Negative': 1}\n",
      "('ryr', 'statin') {' Negative': 1}\n",
      "('alirocumab', 'statin') {' Very negative': 1}\n",
      "('general', 'statin') {' Negative': 1}\n",
      "('0.780', 'statin') {' Negative': 1}\n",
      "('effects', 'statin') {' Negative': 1}\n",
      "('key', 'statin') {' Negative': 1}\n",
      "('rates', 'statin') {' Negative': 1}\n",
      "('fatty', 'statin') {' Negative': 1}\n",
      "('hypocholesterolemic', 'statin') {' Negative': 1}\n",
      "('demonstrate', 'statin') {' Negative': 1}\n",
      "('21.2', 'statin') {' Negative': 1}\n",
      "('report', 'statin') {' Negative': 1}\n",
      "('methods', 'statin') {' Negative': 1}\n",
      "('methods', 'statin') {' Very negative': 1}\n",
      "('to', 'statin') {' Positive': 2}\n",
      "('to', 'statin') {' Negative': 28}\n",
      "('to', 'statin') {' Neutral': 2}\n",
      "('to', 'statin') {' Very negative': 6}\n",
      "('isolated', 'statin') {' Negative': 1}\n",
      "('end', 'statin') {' Negative': 2}\n",
      "('media', 'statin') {' Negative': 3}\n",
      "('featuring', 'statin') {' Negative': 1}\n",
      "('used', 'statin') {' Negative': 2}\n",
      "('vldl', 'statin') {' Negative': 2}\n",
      "('two', 'statin') {' Negative': 1}\n",
      "('pre-diagnostic', 'statin') {' Negative': 2}\n",
      "('populations', 'statin') {' Negative': 1}\n",
      "('3.534', 'statin') {' Negative': 1}\n",
      "('fmd', 'statin') {' Negative': 2}\n",
      "('subjects', 'statin') {' Negative': 1}\n",
      "('study', 'statin') {' Positive': 2}\n",
      "('study', 'statin') {' Negative': 6}\n",
      "('6', 'statin') {' Negative': 1}\n",
      "('nice', 'statin') {' Negative': 3}\n",
      "('2.5', 'statin') {' Negative': 1}\n",
      "('ward', 'statin') {' Negative': 1}\n",
      "('recommend', 'statin') {' Negative': 3}\n",
      "('-lsb-', 'statin') {' Negative': 2}\n",
      "('-lsb-', 'statin') {' Very negative': 2}\n",
      "('lowering', 'statin') {' Negative': 1}\n",
      "('lowering', 'statin') {' Very negative': 2}\n",
      "('occurred', 'statin') {' Negative': 1}\n",
      "('n', 'statin') {' Negative': 4}\n",
      "('n', 'statin') {' Very negative': 3}\n",
      "('subtilisin/kexin', 'statin') {' Negative': 1}\n",
      "('subtilisin/kexin', 'statin') {' Very negative': 1}\n",
      "('is', 'statin') {' Negative': 11}\n",
      "('is', 'statin') {' Neutral': 1}\n",
      "('is', 'statin') {' Very negative': 1}\n",
      "('postdiagnostic', 'statin') {' Negative': 1}\n",
      "('angina', 'statin') {' Negative': 1}\n",
      "('angina', 'statin') {' Very negative': 1}\n",
      "('statistically', 'statin') {' Negative': 1}\n",
      "('important', 'statin') {' Negative': 1}\n",
      "('ldl-c', 'statin') {' Negative': 4}\n",
      "('ldl-c', 'statin') {' Very negative': 1}\n",
      "('exercise', 'statin') {' Negative': 1}\n",
      "('familial', 'statin') {' Negative': 1}\n",
      "('familial', 'statin') {' Very negative': 1}\n",
      "('31', 'statin') {' Very negative': 1}\n",
      "('was10', 'statin') {' Negative': 1}\n",
      "('conclusion', 'statin') {' Negative': 1}\n",
      "('experts', 'statin') {' Negative': 1}\n",
      "('only', 'statin') {' Negative': 1}\n",
      "('only', 'statin') {' Very negative': 1}\n",
      "('0.156', 'statin') {' Negative': 1}\n",
      "('per', 'statin') {' Negative': 1}\n",
      "('intolerant', 'statin') {' Negative': 1}\n",
      "('0.873', 'statin') {' Negative': 1}\n",
      "('plaque', 'statin') {' Negative': 1}\n",
      "('number', 'statin') {' Negative': 1}\n",
      "('large', 'statin') {' Negative': 1}\n",
      "('than', 'statin') {' Negative': 2}\n",
      "('404,052', 'statin') {' Negative': 1}\n",
      "('0.789', 'statin') {' Negative': 1}\n",
      "('nevertheless', 'statin') {' Negative': 1}\n",
      "('rabbit', 'statin') {' Negative': 1}\n",
      "('larger', 'statin') {' Negative': 1}\n",
      "('5', 'statin') {' Negative': 2}\n",
      "('st', 'statin') {' Negative': 2}\n",
      "('treated', 'statin') {' Positive': 1}\n",
      "('treated', 'statin') {' Negative': 4}\n",
      "('free', 'statin') {' Negative': 2}\n",
      "('definitions', 'statin') {' Negative': 1}\n",
      "('depending', 'statin') {' Negative': 2}\n",
      "('findings', 'statin') {' Negative': 1}\n",
      "('findings', 'statin') {' Very negative': 1}\n",
      "('benefits', 'statin') {' Negative': 1}\n",
      "('30-84', 'statin') {' Negative': 2}\n",
      "('guide', 'statin') {' Negative': 1}\n",
      "('guiding', 'statin') {' Negative': 1}\n",
      "('million', 'statin') {' Negative': 3}\n",
      "('stent', 'statin') {' Negative': 1}\n",
      "('under', 'statin') {' Negative': 4}\n",
      "('previously', 'statin') {' Negative': 2}\n",
      "('while', 'statin') {' Negative': 1}\n",
      "('one', 'statin') {' Negative': 3}\n",
      "('favoured', 'statin') {' Negative': 1}\n",
      "('k.', 'statin') {' Negative': 1}\n",
      "('drug', 'statin') {' Negative': 2}\n",
      "('aboved', 'statin') {' Very negative': 1}\n",
      "('lymph-node', 'statin') {' Negative': 1}\n",
      "('12', 'statin') {' Negative': 2}\n",
      "('12', 'statin') {' Neutral': 1}\n",
      "('particularly', 'statin') {' Negative': 1}\n",
      "('decision', 'statin') {' Negative': 1}\n",
      "('machine', 'statin') {' Negative': 1}\n",
      "('targets', 'statin') {' Negative': 1}\n",
      "('targets', 'statin') {' Very negative': 1}\n",
      "('ldl-c/hdl-c', 'statin') {' Very negative': 1}\n",
      "('resurveyed', 'statin') {' Negative': 1}\n",
      "('evaluate', 'statin') {' Negative': 1}\n",
      "('harrell', 'statin') {' Negative': 1}\n",
      "('largest', 'statin') {' Negative': 1}\n",
      "('0.02', 'statin') {' Negative': 3}\n",
      "('use', 'statin') {' Negative': 24}\n",
      "('practice', 'statin') {' Negative': 2}\n",
      "('independent', 'statin') {' Negative': 2}\n",
      "('5.0', 'statin') {' Negative': 2}\n",
      "('effect', 'statin') {' Negative': 1}\n",
      "('recorded', 'statin') {' Negative': 1}\n",
      "('tg', 'statin') {' Very negative': 1}\n",
      "('hypercholesterolemia', 'statin') {' Negative': 3}\n",
      "('hypercholesterolemia', 'statin') {' Very negative': 1}\n",
      "('.033', 'statin') {' Negative': 1}\n",
      "('prior', 'statin') {' Negative': 1}\n",
      "('1.6', 'statin') {' Negative': 1}\n",
      "('treatments', 'statin') {' Negative': 1}\n",
      "('events', 'statin') {' Negative': 2}\n",
      "('events', 'statin') {' Neutral': 2}\n",
      "('vs', 'statin') {' Negative': 4}\n",
      "('therefore', 'statin') {' Negative': 1}\n",
      "('because', 'statin') {' Negative': 1}\n",
      "('identify', 'statin') {' Negative': 1}\n",
      "('identify', 'statin') {' Neutral': 1}\n",
      "('pp', 'statin') {' Negative': 5}\n",
      "('2.97', 'statin') {' Negative': 1}\n",
      "('pravastatin', 'statin') {' Negative': 1}\n",
      "('been', 'statin') {' Negative': 2}\n",
      "('been', 'statin') {' Very negative': 1}\n",
      "('ascvd', 'statin') {' Negative': 1}\n",
      "('artery', 'statin') {' Negative': 1}\n",
      "('anticoagulant', 'statin') {' Negative': 2}\n",
      "('albumin-to-creatinine', 'statin') {' Negative': 1}\n",
      "('acs', 'statin') {' Negative': 1}\n",
      "('those', 'statin') {' Negative': 5}\n",
      "('donepezil', 'statin') {' Negative': 1}\n",
      "('91-100', 'statin') {' Very negative': 1}\n",
      "('time', 'statin') {' Negative': 1}\n",
      "('vh-ivus', 'statin') {' Negative': 1}\n",
      "('cancer-specific', 'statin') {' Negative': 2}\n",
      "('amount', 'statin') {' Negative': 1}\n",
      "('explore', 'statin') {' Positive': 1}\n",
      "('explore', 'statin') {' Negative': 1}\n",
      "('assessment', 'statin') {' Negative': 2}\n",
      "('but', 'statin') {' Negative': 4}\n",
      "('but', 'statin') {' Very negative': 1}\n",
      "('values', 'statin') {' Very negative': 2}\n",
      "('absolute', 'statin') {' Negative': 2}\n",
      "('four', 'statin') {' Negative': 1}\n",
      "('four', 'statin') {' Very negative': 1}\n",
      "('chd', 'statin') {' Negative': 1}\n",
      "('prasugrel', 'statin') {' Negative': 1}\n",
      "('differences', 'statin') {' Negative': 1}\n",
      "('trial', 'statin') {' Negative': 1}\n",
      "('almost', 'statin') {' Negative': 1}\n",
      "('risks', 'statin') {' Negative': 1}\n",
      "('registry', 'statin') {' Positive': 1}\n",
      "(':', 'statin') {' Negative': 2}\n",
      "(':', 'statin') {' Very negative': 1}\n",
      "('\\xe2\\x89\\xa4', 'statin') {' Negative': 1}\n",
      "('small', 'statin') {' Negative': 1}\n",
      "('syndrome', 'statin') {' Negative': 1}\n",
      "('investigation', 'statin') {' Negative': 1}\n",
      "('england', 'statin') {' Negative': 2}\n",
      "('chemically', 'statin') {' Negative': 1}\n",
      "('intensive', 'statin') {' Negative': 1}\n",
      "('considers', 'statin') {' Negative': 1}\n",
      "('group-patients', 'statin') {' Negative': 2}\n",
      "('\\xe2\\x89\\xa5', 'statin') {' Negative': 5}\n",
      "('factor', 'statin') {' Negative': 2}\n",
      "('reaction', 'statin') {' Negative': 2}\n",
      "('t2dm', 'statin') {' Negative': 2}\n",
      "('1.49', 'statin') {' Negative': 1}\n",
      "('24', 'statin') {' Negative': 1}\n",
      "('24', 'statin') {' Very negative': 1}\n",
      "('required', 'statin') {' Negative': 1}\n",
      "('peripheral', 'statin') {' Negative': 1}\n",
      "('h', 'statin') {' Negative': 1}\n",
      "('tomography', 'statin') {' Negative': 1}\n",
      "('combination', 'statin') {' Negative': 1}\n",
      "('4.1', 'statin') {' Negative': 1}\n",
      "('calcium', 'statin') {' Negative': 1}\n",
      "('one-year', 'statin') {' Negative': 1}\n",
      "('goal', 'statin') {' Negative': 1}\n",
      "('of', 'statin') {' Positive': 1}\n",
      "('of', 'statin') {' Negative': 66}\n",
      "('of', 'statin') {' Neutral': 7}\n",
      "('of', 'statin') {' Very negative': 8}\n",
      "('cvd', 'statin') {' Negative': 4}\n",
      "('cvd', 'statin') {' Very negative': 1}\n",
      "('eligibility', 'statin') {' Negative': 3}\n",
      "('eligibility', 'statin') {' Neutral': 1}\n",
      "('already', 'statin') {' Negative': 2}\n",
      "('college', 'statin') {' Negative': 1}\n",
      "('college', 'statin') {' Neutral': 1}\n",
      "('locations', 'statin') {' Negative': 1}\n",
      "('.12', 'statin') {' Negative': 1}\n",
      "('identified', 'statin') {' Negative': 1}\n",
      "('hdl', 'statin') {' Negative': 2}\n",
      "('discontinue', 'statin') {' Negative': 1}\n",
      "('article', 'statin') {' Negative': 2}\n",
      "('non-hdl-cholesterol', 'statin') {' Negative': 1}\n",
      "('in-hospital', 'statin') {' Negative': 1}\n",
      "('0.75-1', 'statin') {' Negative': 1}\n",
      "('differ', 'statin') {' Negative': 1}\n",
      "('hyperlipidemia', 'statin') {' Negative': 1}\n",
      "('through', 'statin') {' Negative': 2}\n",
      "('types', 'statin') {' Negative': 1}\n",
      "('3.8', 'statin') {' Negative': 1}\n",
      "('low-density', 'statin') {' Negative': 1}\n",
      "('low-density', 'statin') {' Very negative': 3}\n",
      "('on', 'statin') {' Positive': 2}\n",
      "('on', 'statin') {' Negative': 15}\n",
      "('on', 'statin') {' Neutral': 2}\n",
      "('user', 'statin') {' Negative': 1}\n",
      "('help', 'statin') {' Negative': 2}\n",
      "('12-month', 'statin') {' Negative': 1}\n",
      "('hazard', 'statin') {' Negative': 2}\n",
      "('them', 'statin') {' Negative': 1}\n",
      "('intravascular', 'statin') {' Very negative': 1}\n",
      "('fh', 'statin') {' Negative': 1}\n",
      "('province', 'statin') {' Very negative': 1}\n",
      "('adverse', 'statin') {' Negative': 4}\n",
      "('adverse', 'statin') {' Neutral': 2}\n",
      "('triglyceride', 'statin') {' Negative': 1}\n",
      "('triglyceride', 'statin') {' Very negative': 1}\n",
      "('assist', 'statin') {' Negative': 1}\n",
      "('anticoagulants', 'statin') {' Negative': 1}\n",
      "('recommendation', 'statin') {' Negative': 1}\n",
      "('routine', 'statin') {' Negative': 1}\n",
      "('ldlc', 'statin') {' Negative': 1}\n",
      "('ldlc', 'statin') {' Very negative': 2}\n",
      "('years', 'statin') {' Negative': 9}\n",
      "('0.766', 'statin') {' Negative': 1}\n",
      "('0.047', 'statin') {' Negative': 1}\n",
      "('cardiovascular', 'statin') {' Negative': 8}\n",
      "('cardiovascular', 'statin') {' Very negative': 1}\n",
      "('ages', 'statin') {' Negative': 2}\n",
      "('1.97', 'statin') {' Negative': 1}\n",
      "('age', 'statin') {' Negative': 3}\n",
      "('affect', 'statin') {' Negative': 1}\n",
      "('mixed', 'statin') {' Negative': 1}\n",
      "('gdf-15', 'statin') {' Negative': 3}\n",
      "('anti-hyperglycemic', 'statin') {' Negative': 1}\n",
      "('concurrent', 'statin') {' Negative': 1}\n",
      "('account', 'statin') {' Negative': 1}\n",
      "('account', 'statin') {' Very negative': 1}\n",
      "('more', 'statin') {' Negative': 1}\n",
      "('efficacy', 'statin') {' Negative': 2}\n",
      "('acids', 'statin') {' Negative': 1}\n",
      "('0.353', 'statin') {' Negative': 1}\n",
      "('hydrophobic', 'statin') {' Negative': 1}\n",
      "('intolerance', 'statin') {' Negative': 2}\n",
      "('require', 'statin') {' Negative': 4}\n",
      "('who', 'statin') {' Negative': 9}\n",
      "('who', 'statin') {' Very negative': 1}\n",
      "('were', 'statin') {' Negative': 17}\n",
      "('were', 'statin') {' Very negative': 3}\n",
      "('cohorts', 'statin') {' Negative': 1}\n",
      "('accurately', 'statin') {' Negative': 1}\n",
      "('drug-drug', 'statin') {' Negative': 1}\n",
      "('vitamin', 'statin') {' Negative': 1}\n",
      "('algorithm', 'statin') {' Negative': 1}\n",
      "('into', 'statin') {' Negative': 1}\n",
      "('into', 'statin') {' Very negative': 1}\n",
      "('0.03', 'statin') {' Negative': 2}\n",
      "('increased', 'statin') {' Negative': 2}\n",
      "('ischemia', 'statin') {' Negative': 1}\n",
      "('approximately', 'statin') {' Negative': 1}\n",
      "('interviewed', 'statin') {' Negative': 1}\n",
      "('des-treated', 'statin') {' Negative': 2}\n",
      "('hr', 'statin') {' Negative': 5}\n",
      "('lipids', 'statin') {' Very negative': 1}\n",
      "('decrease', 'statin') {' Negative': 1}\n",
      "('biosynthetic', 'statin') {' Negative': 1}\n",
      "('according', 'statin') {' Negative': 2}\n",
      "('serum', 'statin') {' Negative': 1}\n",
      "('hospital', 'statin') {' Negative': 1}\n",
      "('hospital', 'statin') {' Very negative': 1}\n",
      "('target', 'statin') {' Negative': 1}\n",
      "('target', 'statin') {' Very negative': 1}\n",
      "('prevention', 'statin') {' Negative': 6}\n",
      "('0.92', 'statin') {' Negative': 1}\n",
      "('eighty-five', 'statin') {' Negative': 1}\n",
      "('optimize', 'statin') {' Negative': 1}\n",
      "('covering', 'statin') {' Negative': 1}\n",
      "('mmol/l', 'statin') {' Negative': 2}\n",
      "('recognize', 'statin') {' Negative': 1}\n",
      "('established', 'statin') {' Negative': 1}\n",
      "('this', 'statin') {' Negative': 11}\n",
      "('proper', 'statin') {' Negative': 1}\n",
      "('nk', 'statin') {' Negative': 3}\n",
      "('75', 'statin') {' Negative': 1}\n",
      "('75', 'statin') {' Very negative': 1}\n",
      "('lipid', 'statin') {' Negative': 2}\n",
      "('4.9', 'statin') {' Negative': 2}\n",
      "('total', 'statin') {' Negative': 3}\n",
      "('total', 'statin') {' Very negative': 2}\n",
      "('retrospective', 'statin') {' Negative': 1}\n",
      "('not', 'statin') {' Negative': 10}\n",
      "('computed', 'statin') {' Negative': 1}\n",
      "('br-1', 'statin') {' Negative': 3}\n",
      "('population', 'statin') {' Negative': 1}\n",
      "('cac', 'statin') {' Negative': 1}\n",
      "('topical', 'statin') {' Negative': 1}\n",
      "('or', 'statin') {' Negative': 12}\n",
      "('or', 'statin') {' Neutral': 2}\n",
      "('or', 'statin') {' Very negative': 4}\n",
      "('3.66', 'statin') {' Negative': 1}\n",
      "('measured', 'statin') {' Very negative': 1}\n",
      "('percentage', 'statin') {' Negative': 1}\n",
      "('55', 'statin') {' Negative': 1}\n",
      "('ci', 'statin') {' Negative': 5}\n",
      "('ci', 'statin') {' Very negative': 3}\n",
      "('sex', 'statin') {' Negative': 1}\n",
      "('has', 'statin') {' Positive': 1}\n",
      "('has', 'statin') {' Negative': 3}\n",
      "('significant', 'statin') {' Negative': 1}\n",
      "('reduces', 'statin') {' Negative': 1}\n",
      "('reduces', 'statin') {' Neutral': 1}\n",
      "('did', 'statin') {' Negative': 1}\n",
      "('equal', 'statin') {' Negative': 1}\n",
      "('hefh', 'statin') {' Negative': 1}\n",
      "('hefh', 'statin') {' Very negative': 1}\n",
      "('0.58', 'statin') {' Negative': 1}\n",
      "('lower', 'statin') {' Negative': 3}\n",
      "('0.002', 'statin') {' Negative': 1}\n",
      "('when', 'statin') {' Negative': 4}\n",
      "('84', 'statin') {' Very negative': 1}\n",
      "('expression', 'statin') {' Negative': 2}\n",
      "('comprehensive', 'statin') {' Negative': 1}\n",
      "('mice', 'statin') {' Positive': 1}\n",
      "('mice', 'statin') {' Negative': 1}\n",
      "('brazilian', 'statin') {' Negative': 2}\n",
      "('review', 'statin') {' Negative': 2}\n",
      "('excellence', 'statin') {' Negative': 1}\n",
      "('incident', 'statin') {' Negative': 3}\n",
      "('difference', 'statin') {' Negative': 2}\n",
      "('evo', 'statin') {' Very negative': 3}\n",
      "('substantially', 'statin') {' Negative': 1}\n",
      "('30-day', 'statin') {' Negative': 1}\n",
      "('000', 'statin') {' Negative': 1}\n",
      "('p', 'statin') {' Negative': 18}\n",
      "('adjusted', 'statin') {' Negative': 1}\n",
      "('recent', 'statin') {' Negative': 2}\n",
      "('achieving', 'statin') {' Negative': 1}\n",
      "('icu', 'statin') {' Negative': 1}\n",
      "('statins', 'statin') {' Positive': 1}\n",
      "('statins', 'statin') {' Negative': 6}\n",
      "('statin-related', 'statin') {' Very negative': 1}\n"
     ]
    }
   ],
   "source": [
    "for k, v in sent_dict.iteritems():\n",
    "    for vv in v:\n",
    "        print k, vv"
   ]
  }
 ],
 "metadata": {
  "anaconda-cloud": {},
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
